Download C ANCER INSTITUTE NSW

1 Central Avenue
Australian Technology Park
Eveleigh NSW
www.cancerinstitute.org.au
CANCER INSTITUTE NSW
Level 1, Biomedical Building
CANCER INSTITUTE NSW ANNUAL REPORT 2005 - 2006
Cancer Institute NSW
ANNUAL REPORT 2005-2006
ANNUAL REPORT 2005-2006
CANCER ANNUAL REPORT COVER (12 spine).indd 1
7/11/2006 8:38:58 AM
Legislation administered
Cancer Institute (NSW) Act 2003
Copyright © Cancer Institute NSW October 2006
This work is copyright. It may be reproduced in whole
or part for study or training purposes subject to the
inclusion of acknowledgement of the source. It may
not be reproduced for commercial usage or sale.
Reproduction for purposes other than those indicated
above requires written permission from the
Cancer Institute NSW.
SHPH: (NCI) 060 162
ISBN: 1741870097
Suggested citation for manuscripts and publications:
Cancer Institute NSW: Annual Report 2005 - 2006
Cancer Institute NSW, Sydney, 2006
Further copies of this publication can be download from:
www.cancerinstitute.org.au
Cancer Institute NSW
Level 1, Biomedical Building
Central Avenue
Australian Technology Park, Eveleigh
PO Box 41, Alexandria NSW 1435
Tel:
Fax:
Web:
+ 61 2 8374 5600
+ 61 2 8374 5700
www.cancerinstitute.org.au
Email: [email protected]
Emails sent to this address are forwarded
to the appropriate person for action.
Cover Photo: Belinda Kendall, A/Nurse Unit Manager,
Cancer Care Centre, St George Hospital
CANCER ANNUAL REPORT COVER (12 spine).indd 2
7/11/2006 8:43:16 AM
Contents
Page
Letter to the Minister
4
Chief Cancer Officer’s Report
– Our Objectives
– Our Approach
– Our Guiding Principles
– Our Key Program Areas
– Measuring Our Progress
– Organisational Structure
– Organisational Functions
8
8
9
9
9
9
11
11
Our Achievements - The Year in Review
– Cancer Prevention
– Cancer Screening
– Cancer Services and Education
– Cancer Research
– Cancer Information and Registries
– Cancer Communication
– Corporate Development
22
22
27
33
39
44
47
49
The Way Forward
– Future Plans 2006-2007 and Beyond
52
52
Financial Statements
54
Appendices
– Accounts Payable Performance Report
– Agreements and Joint Programs
– Committees
– Consultants
– Credit Card Certification
– Electronic Service Delivery
– Energy Management
– Events
– Financial Overview 2005-2006
– Freedom of Information
– Guarantee of Service
– Media Releases
– Ministerial Representations Received
– Overseas Travel
– Privacy Management Plan
– Publications
– Risk Management
– Sponsorships and Community Grants
– Staffing
– Waste Reduction
96
97
98
100
136
136
136
137
137
138
139
139
139
140
141
141
141
142
143
144
151
Glossary
152
Index
155
Letter to the Minister
Hon. Mr Frank Sartor, MP
Minister for Planning
Minister for Science and Medical Research
Minister Assisting the Minister for Health (Cancer)
Level 34, Governor Macquarie Tower
1 Farrer Place
Sydney NSW 2000
Dear Minister
We have pleasure in submitting the Cancer Institute NSW Annual Report 2005-2006 for presentation to the
Parliament of New South Wales in accordance with the Annual Reports (Statutory Bodies) Act 1984.
This report contains information on the design and implementation of our major cancer control initiatives in the
six program areas and the further development of the Cancer Institute NSW to fulfil its objectives under the
Cancer Institute (NSW) Act 2003. It is also noteworthy that a five year agreement has been negotiated with The
Cancer Council NSW which allows a clear role differentiation with the Cancer Institute NSW.
We commend this report of the progress being achieved in cancer control in NSW to you.
The Hon. Peter Collins AM QC
Prof James F Bishop MD MMed
Chairperson
MBBS FRACP FRCPA
Board of the Cancer Institute NSW
Chief Cancer Officer
Chief Executive Officer
Cancer Institute NSW
4
Cancer Institute NSW: Annual Report 2005–2006
Chief Cancer Officer’s Report
This year is the third year of existence of the Cancer
We estimate around 30% more cancer cases in
Institute NSW. The Cancer Institute NSW was
NSW in the next decade compared to the last.
established by the NSW Government to improve
cancer survival, reduce cancer incidence, improve
the quality of life of those affected by cancer and
“One in two men and one in three women
provide information about cancer to the public,
are expected to be diagnosed with
health professionals, the Government and other
cancer in their lifetime.”
key stakeholders.
This year the Cancer Institute NSW consolidated its
role in cancer control, rolled out major programs and
The good news is that the majority of cancer
improved our ability to fulfil our obligations under the
patients are now expected to be cancer survivors
Cancer Institute (NSW) Act 2003.
with over 60% predicted to be alive five years after
their diagnosis. Death dates from cancer continue to
The Cancer Institute NSW has reported on the first
fall by over 20% in the top three cancers, prostate,
State Cancer Plan in a publication, NSW Cancer
bowel and breast cancer.
Plan 2004-2006, Lessening the Impact of Cancer:
A Two Year Progress Report. This report provides
While these results are as good as anywhere in the
detail on the progress of the 33 programs in
world, there is more urgent work still to be done to
the first State Cancer Plan. This report is
make cancer results better. The broad based cancer
available from the Cancer Institute NSW
control strategy developed by the Cancer Institute
or at www.cancerinstitute.org.au.
NSW with key parties, offers great hope of further
improvement since it is firmly based on evidence of
One of the greatest achievements in 2005-2006 has
what works.
been to facilitate meetings of around 500 health
professionals, patients, carers, members of the
Tobacco remains by far the commonest preventable
public, cancer charities and government officials
cause of cancer, responsible for 30% of cancer
to focus on the needs of cancer patients and
deaths in men and 13% in women. Cancer
opportunities for better cancer control in NSW. The
prevention using proven interventions to reduce
coordination of effort this brings will in turn bring
tobacco consumption remains a major focus of
tangible benefits of better cancer control as we
the Cancer Institute NSW program. In 2005-2006
move into 2007.
this included additional mass media anti-tobacco
campaigns run by the Cancer Institute NSW.
In March 2006, The Cancer Council NSW and
the Cancer Institute NSW signed a key Five Year
The smoking rate in NSW is now the lowest
Partnership Agreement. This important agreement
recorded with 20.1% of adults smoking but only
commits the major cancer charity and the NSW
14% of women and 17% of men smoking every day.
cancer agency to work in partnership in patient
Calls to the Quitline have more than doubled during
support and information services and in clinical
our campaigns. We have estimated that 100,000
trials. The patients and people of NSW should derive
smokers have reported quitting and two-thirds of
great benefit from this partnership and the focus it
current smokers have an intention to quit within
brings to these important areas.
six months.
Cancer remains an ongoing and difficult burden for
However, about 1.2 million adults in NSW continue
our society. One in two men and one in three women
to smoke with half of these destined to die of their
are expected to be diagnosed with cancer in their
smoking, losing an average of 10 years of productive
lifetime. The numbers of cancer cases are rising
life. One third of all smokers will die in middle age
mainly due to population ageing and growth.
losing around 22 years of life.
Cancer Institute NSW: Annual Report 2005–2006
5
Cancer screening was combined in the Cancer
Institute NSW to improve capacity in radiotherapy
Institute NSW in 2005-2006. The Cancer Institute
services and thus increase access
NSW has developed a high level strategic committee
of patients to radiotherapy.
to examine the structure, business practices,
workforce and customer service of breast screening,
Cancer information was made more accessible to
cervical and bowel screening.
the public and health professionals by developing a
searchable web-based module on cancer incidence
BreastScreen NSW has extended its hours of
and mortality. Over three hundred standard cancer
operation and developed additional screening
treatment programs are now available as a web-
capacity with a $4.2 million additional grant from
based resource. This can be accessed by patients,
the Cancer Institute NSW. The proportion of women
doctors, nurses and carers. Currently this site
aged 50-69 years who have had a mammogram
receives over 250,000 hits per month.
through BreastScreen NSW increased by nearly
4% in 2005-2006. There is evidence for considerable
The result of the work by dedicated health
private mammography in this age group so that the
professionals working in cancer are some of the best
great majority of women aged 50-69 years have had
results for cancer in the developed world. This high
a mammogram in the last two years. Screening has
level of achievement for the people of NSW allows
delivered great benefits to the women of NSW with a
areas of ongoing or unmet need to be the focus of
fall of 22% in breast cancer mortality rates and 52%
cancer services development in the next cancer
in cervical cancer over the last 10 years mainly due
plan. This plan will also need to address smarter
to screening.
models of delivering care with the increased number
of cancer cases expected as the population ages.
Cancer services throughout NSW have been
enhanced by the establishment of over 240 new
Cancer research has largely been responsible for
positions for cancer health professionals in Health
the large gains we have made in improving cancer
Services. Statewide cancer streams have been
results and will drive future improvement in cancer
established by the Cancer Institute NSW under the
and ultimately cure many cancer patients. The
NSW Oncology Group Program. This program allows
Cancer Institute NSW has substantially increased
specialists, consumers and specialist nurses from
the ability of cancer researchers in NSW to
across NSW to focus on a particular type of cancer
make important discoveries for the benefit of our
and work on ways to improve cancer outcomes.
community and the world at large.
Within Health Services, the Cancer Institute
The Cancer Institute NSW has established two new
NSW has provided a Director of Cancer Services
Chairs of Cancer Research, supported over 110
position, a Cancer Services Development Manager,
Data Managers, research nurses, doctors, nurse
coordinators, social workers and psychologists.
This structure has been supported by new funding
for over 110 multidisciplinary teams including
tele-health grants.
“...investment aims to deliver improved
therapy and accelerate our improving
cancer results.”
For rural areas the cancer nurse care coordinators
cancer researchers and increased patient access
and social workers have been supported by
to new cancer treatments in clinical trials. This
networking and cancer communications training.
investment aims to deliver improved therapy and
The Cancer Institute NSW is providing an additional
accelerate our improving cancer results.
$500,000 annually to improve the transport subsidy
of rural patients needing to travel over 100km for
The Cancer Institute NSW has consolidated its
cancer treatment.
corporate development with Divisional Heads
responsible for each major cancer control area.
6
Radiotherapy services have been improved with
It has continued to audit its internal activities using
new technology upgrades. A business improvement
the Internal Audit Bureau and has finalised its
process across NSW was initiated by the Cancer
policies, procedures and risk management activities.
Cancer Institute NSW: Annual Report 2005–2006
The Cancer Institute NSW has established an
We thank NSW Health, Health Services and
external, independent interstate Research Grants
non-government organisations, especially The
Review Committee and a similar Clinical Grants
Cancer Council NSW and The Cancer Council
Review Committee. These committees ensure
Australia, for their support on a number of levels.
that objective non-conflicted review of funding
Many volunteers have given freely of their time,
applications occurs. These committees are
expertise and perspectives, especially cancer
supported by 30 external, independent scientific
patients, their carers and health professionals
and clinical experts in the field from outside NSW in
throughout NSW, interstate and overseas.
Australia and overseas. This rigorous independent
review of the quality of applications for funds aims
Finally, I gratefully acknowledge the dedication of
to ensure that the applications receiving support
the Board and the staff of the Cancer Institute NSW
are based on evidence and are most likely to have a
and their commitment during a challenging year.
high impact on cancer control.
The Cancer Institute NSW has relied on key
partnerships and the goodwill of many also
dedicated to the defeat of cancer to implement
its programs. Special thanks go to the Minister
Assisting the Minister for Health (Cancer), the Hon.
Mr Frank Sartor and the Minister for Health, the Hon.
Mr John Hatzistergos for their support and guidance
Prof James F Bishop MD MMed
MBBS FRACP FRCPA
Chief Cancer Officer
Chief Executive Officer
Cancer Institute NSW
of this important government initiative.
Cancer Institute NSW: Annual Report 2005–2006
7
About the Cancer Institute NSW
The Cancer Institute NSW was established in July
2003 through the Cancer Institute (NSW) Act 2003
Our Objectives
as a response to the need to further decrease the
The objectives of the Cancer Institute NSW under
devastating impact of cancer on our society.
the Act are to:
•
increase the survival rates for cancer patients
At the time of its establishment, the Cancer Institute
NSW carried with it high expectations and the
•
good will of the NSW Government, the Parliament
and the people of NSW. The mandate given to
reduce the incidence rates of cancer in the
community
•
the Cancer Institute NSW under its Act is broad.
improve the quality of life for cancer patients and
their carers
This was to enable the Cancer Institute NSW to
develop programs across the complete cancer
control spectrum.
•
operate as a source of expertise on cancer
control for the government, health service
providers, medical researchers and the general
The other requirement is to focus such programs
where the impact on cancer will be greatest. Thus
all programs of the Cancer Institute NSW are tested
against its objectives under the Act.
8
Cancer Institute NSW: Annual Report 2005–2006
community.
All programs of the Cancer Institute NSW are
tested against its objectives under the Act.
Our Approach
Our Key Program Areas
•
The Cancer Institute NSW is Australia’s first
The Cancer Institute NSW has six key program
government supported cancer control agency.
areas:
•
We will save lives by promoting the best
prevention, early detection, treatment, research
and information.
•
We will drive innovation in partnership with other
leaders in our field to deliver the best cancer
results to the people of NSW.
Our Guiding Principles
•
Cancer Prevention
•
Cancer Screening
•
Cancer Services and Education
•
Cancer Research
•
Cancer Information and Registries
•
Cancer Communication
The Cancer Institute NSW is guided by the principles
Measuring Our Progress
that we will:
To achieve our goals the Cancer Institute NSW
developed in 2004 a two year strategic plan called
•
Develop partnerships with the public sector,
private sector and the general community.
•
Provide resources to benefit the greatest number
of people in an efficient and effective manner.
•
•
the NSW Cancer Plan 2004-2006, in collaboration
with key stakeholders. The three main objectives of
the NSW Cancer Plan 2004-2006 were to:
•
Define the strategic principles for the future
Promote the treatment of patients that is
development and acceleration of effective cancer
equitable, evidence based and patient centred.
control in NSW.
Promote cancer care that is accessible,
•
multidisciplinary and coordinated by the
appropriate networking of services.
•
Ensure public funds are fully accountable.
•
Promote collaboration between State, national
Develop goals for cancer control that will
substantially improve outcomes.
•
Develop high priority programs that will
achieve these goals and thereby accelerate
improvements in cancer survival, reduce cancer
and international cancer bodies.
•
Provide information about cancer control that is
incidence, better support patients and their
carers and better inform the community and
other important groups.
up-to-date and publicly available.
Thirty three goals were established under ten major
•
Promote cancer research that builds
strategic areas.
collaboration, depth and maximises the benefits
of research in a number of institutions in NSW.
Cancer Institute NSW: Annual Report 2005–2006
9
The implementation of the NSW Cancer Plan
In June 2006, a comprehensive review of the Plan
2004-2006 represents a remarkable achievement
was completed and key outcomes reported on in
in a short time.
NSW Cancer Plan 2004-2006 Lessening the Impact
of Cancer: A Two Year Progress Report. The report
One of the most important achievements was a
can be downloaded from our website
cohesive approach to cancer control, bringing
www.cancerinstitute.org.au or copies obtained
together many hundreds of patients, carers, health
by contacting the Cancer Institute NSW.
professionals, researchers, government officials,
charities and planners to combine their efforts to
reduce the effects of cancer.
10
Cancer Institute NSW: Annual Report 2005–2006
Organisational Structure*
Minister for Health
Hon. John Hatzistergos
Minister Assisting the
Minister for Health (Cancer)
Hon. Frank Sartor
Chief Cancer Officer
Chief Executive Officer
Prof Jim Bishop
Board of the
Cancer Institute NSW
Chief Operating Officer
Beth Macauley
Finance
David Sabanayagam
HR
Katherine
MacHutchison
IT
Michael Schmitz
Division of
Cancer Prevention
Trish Cotter
Division of
Cancer Screening
Denise Thomas
Division of
Cancer Services and
Education
Neville Board
Division of
Cancer Research
Carmel Edwards
Division of
Cancer Information
and Registries
Dr Paul Jelfs
Division of
Cancer Communication
Lancia Jordana
Tobacco
BreastScreen
Workforce
Grants and
Infrastructure
Central Cancer
Registry
Website
Skin, Melanoma
Cervical
Screening
Access
Clinical Trials
Monitoring
Reaearch and
Evaluation
Reports/
Communications
Bowel, Breast,
Other
Bowel
Screening
Education
Ethics
Epidemiological
Services
Conferences/
Events
Screening,
Marketing
GP
Program
Psychosocial
Standard Cancer
Treatments
Media
Collaboration and
Information
Information
Systems
Development
PTR/HCR
*at 30 June 2006
Cancer Institute NSW: Annual Report 2005–2006
11
Board of the Cancer Institute NSW
Back row (l to r): Dr Geoffrey Pritchard,
Prof Robert Sutherland, Dr Paul Moy
Centre row (l to r): Prof Sally Redman,
Ms Jill Boehm, Prof. John Simes
Front (l to r): The Hon. Peter Collins,
Prof Jim Bishop
Absent: Dr Patrick Cregan
Chairperson
Acting Chairperson
The Hon. Peter Collins AM RFD QC BA LLB
(June 2005 to November 2005)
(from November 2005)
Ms JilI Boehm RN CM C ORTH M Mgt FAICD
The Hon. Peter Collins served in the NSW Parliament
Ms Jill Boehm retired recently as the CEO of the
from 1981 until 2003 holding a number of portfolios
CanAssist (formerly the Cancer Patients Assistance
including Attorney-General, Minister for Consumer
Society of NSW), which runs the Jean Colvin
Affairs, Minister for the Arts, Minister for Health
Hospital in Darling Point, a facility for patients
and Minister for the Drug Offensive in 1988-1991.
travelling from rural areas to Sydney to receive
He initiated funding for the Rock Eisteddfod under
cancer treatment. She has been instrumental in
the Quit for Life program and expanded the event
developing additional rural branches of the Society
statewide for both government and non-government
and in improving communication links between
schools. Since 1988, this highly successful program
head office and rural branches. Ms Boehm is a
has gone Australia-wide and has been established
registered nurse and representative of the NSW
in the United States and the United Kingdom. As
Nurses Registration Board on Professional and
Opposition Leader (1995-1998) he built strong
Tribunal matters, a Fellow of the Australian Institute
working relationships with the Australian Hoteliers
of Company Directors and has been appointed to
Association, Clubs and the Restaurant and Catering
the Board of CanAssist.
Association to pioneer policies on outdoor dining
and passive smoking. He is a Commander in the
Royal Australian Navy Reserve. He is also Chair of
the Australian Institute of Health and Welfare and
served as a member of the interim Board of The
Cancer Council NSW now operating as a private
company limited by guarantee.
12
Cancer Institute NSW: Annual Report 2005–2006
Chief Cancer Officer
in the mathematical modelling of cancer, patient
Prof James Bishop
communication and the application of advanced
MD MMed MBBS FRACP FRCPA
technologies. Dr Cregan has served on a number
Prof Bishop became a Fellow of the Royal
of committees or Boards, including the Royal
Australasian College of Physicians (FRACP) and
Australian College of Surgeons, Wentworth Area
a Fellow of the Royal College of Pathologists of
Health Service, NSW Health Clinical Council and
Australasia (FRCPA) in haematology in 1979. He was
the Australasian Medical Simulation Society.
awarded a Fulbright Scholarship to study Medical
Dr Cregan is the Medical Director of a private
Oncology at the National Cancer Institute (NCI), USA
medical technology and research company,
from 1979 to 1981. At the Peter MacCallum Cancer
Medicvision.
Institute, Melbourne, he was a consultant medical
Dr Vivien Lane RN C Onc BA(Hons) PhD FCN
oncologist from 1981 to 1995, Head of Clinical
(August 2003 to October 2005)
Research from 1988 and Director of the Division
Dr Vivien Lane is Honorary Associate (Cancer),
of Haematology and Medical Oncology from 1990.
Sydney West Area Health Service (SWAHS) and has
From 1995 to 2003 Prof Bishop was the Director
been affiliated with the University of Technology
of the Sydney Cancer Centre at the Royal Prince
(UTS), Sydney. Dr Lane has 30 years cancer nursing
Alfred Hospital and Concord Repatriation General
experience with special interests in cervical cancer
Hospital in Sydney, and directed the Cancer Service
screening and theorising Nursical-Oncology utilising
for the Central Sydney Area Health Service. He is
nursing taxonomies. She developed postgraduate
the Professor of Cancer Medicine at the University
curricula for the College of Nursing, UTS and
of Sydney. Prof Bishop has been a practising
SWAHS. Dr Lane has experience with human
Oncologist for 25 years and his particular research
research ethics committees and was founding
interests are in clinical trials, new anti-cancer drug
chairwoman of the Western Sydney Area Health
development and new cancer therapies. He has
Service Bioethics Consultative Committee. Dr Lane
coordinated national clinical trials in leukaemia,
is also a Board member of CanAssist.
breast cancer and lung cancer. He has authored
more than 180 scientific papers on cancer, 150
abstracts and a textbook on cancer. He was
awarded a Doctorate of Medicine by research thesis
(Platelet Transfusion Therapy) in 1990 and a Master
of Medicine by research thesis (Induction Therapy
for Acute Myeloid Leukaemia) in 1999. Prof Bishop
was appointed CEO of the Cancer Institute NSW in
August 2003.
Dr Paul Moy BA (Hons Ec) Dip Ed PhD(Ec)
(from November 2005)
Dr Moy is Managing Director, UBS Global Asset
Management and has extensive experience in
investment banking, the energy, transport and
utility industries. Dr Moy’s previous positions
include Executive Director of UBS Warburg,
Deputy Secretary, NSW Treasury, Chairman of
the Innovation Investment Fund and Director of
Members
Dr Patrick Cregan MBBS FRACS
Dr Cregan is a specialist surgeon based at Nepean
Hospital, with a major interest in breast, endocrine
and endoscopic surgery. Dr Cregan has a particular
interest in surgical robotics, having performed
Australia’s first, and the world’s sixth, telesurgical
Western Power Corporation, the Commonwealth
Rehabilitation Service, the State Rail Authority
of NSW, Railcorp, and the Diversified Utility and
Energy Trust (DUET). He is also a former Member
of the National Competition Council and Australian
Statistics Advisory Council. Currently Dr Moy is
a Director of Centennial Coal, Austral Coal and
Transgrid Corporation.
procedure. Other areas include a research interest
Cancer Institute NSW: Annual Report 2005–2006
13
Prof John Simes
BSc MBBS VQE SM FRACP MD
Prof Simes is the Director, NHMRC Clinical Trials
Centre, University of Sydney; a Senior Principal
Research Fellow and Professor of Clinical
Epidemiology, School of Public Health, University
of Sydney; Medical Oncologist, Royal Prince Alfred
Hospital; Board Member, ANZ Breast Cancer Trials
Group Incorporated; and Board member, Australasian
Gastrointestinal Trial Group Incorporated.
Prof Simes has participated in a wide range of
scientific committees, including the Medicare
Services Advisory Committee, the Project Grants
Committee, NHMRC, and the International Breast
Cancer Intervention Study Steering Committee.
Prof Robert Sutherland
BAgrSc MAgrSc PhD
Dr Geoffrey Pritchard MBBS MSc FRACS
Prof Sutherland is the Director of the Cancer
Dr Pritchard, former Mayor of Tumut Shire Council
Research Program at the Garvan Institute of Medical
and former Clinical Director of the Southern Area
Research, a Senior Principal Research Fellow of
Health Service. Dr Pritchard has previously worked
the National Health and Medical Research Council
in the city and rural areas as a general surgeon.
and Professor, School of Medicine, University
During this time he established the palliative care
of New South Wales. Prof Sutherland has been
unit at the Prince Henry and Prince of Wales
responsible for the development of Garvan’s basic
Hospitals in Sydney and was a member of the Peer
and translational cancer research programs aimed at
Review Committee for the NSW Medical Board
identifying new genes involved in the development
(Surgery).The last 13 years of his practice were
and progression of diverse cancers, and their use
spent as a surgeon and general practitioner in rural
as diagnostic and prognostic markers and as novel
practice. Dr Pritchard is also a cancer survivor,
therapeutic targets for treatment and prevention.
having had radical surgery for melanoma.
Prof Sally Redman BA (Hons) PhD
Prof Redman is the Chief Executive Officer of
The Sax Institute (formerly the Institute for Health
Research) and has academic appointments at the
University of Newcastle, the University of Sydney
and the University of New South Wales.
Prof Redman is a member of the Board of the
National Institute for Clinical Studies and was
formerly the CEO of the National Breast Cancer
Centre.
14
Cancer Institute NSW: Annual Report 2005–2006
Prof John Zalcberg MBBS PhD FRACP (August
2003 to October 2005)
Board Meetings
Prof John Zalcberg is the Director of the Division of
Haematology and Medical Oncology at the Peter
During the year, the Board met on six occasions.
MacCallum Institute in Melbourne. Prof Zalcberg
Attendance of Board members was as follows:
helped establish the Cancer Alliance Network, a
national cancer consumer network, and is Executive
No. of
No. of
meetings
meetings
eligible
attended
Secretary and co-founder of the Lorne Cancer
Name
Conference. Prof Zalcberg is a member of the
The Hon. Peter Collins
4
4
Standing Research Sub-Committee of The Cancer
Prof James Bishop
6
6
Council Victoria, and grant reviewer for The Cancer
Ms Jill Boehm
6
6
Councils of other states, the NHMRC and other
Dr Patrick Cregan
6
4
granting agencies. Prof Zalcberg’s Board experience
Dr Vivien Lane
2
2
includes the Chairmanship of the Australasian
Dr Paul Moy
4
3
Gastrointestinal Trials Group and membership of the
Dr Geoffrey Pritchard
6
4
Board of Cancer Trials Australia.
Prof Sally Redman
6
6
Prof John Simes
6
6
Prof Robert Sutherland
6
4
Prof John Zalcberg
2
2
The Board has adopted a Code of Conduct,
consistent with best practice.
Cancer Institute NSW: Annual Report 2005–2006
15
Our Executive Team
(l to r): Ms Denise Thomas, Mr Michael Schmitz, Ms Carmel Edwards, Prof Jim Bishop,
Mr David Sabanagayam, Ms Beth Macauley, Mr Charles Latimer, Ms Trish Cotter,
Dr Paul Jelfs, Ms Katherine MacHutchinson. Absent: Mr Neville Board,
Ms Lancia Jordana, Dr David Manning.
Prof James F Bishop
Divisional Directors
MD MMed MBBS FRACP FRCPA
Chief Cancer Officer and CEO,
Mr Neville Board RN BA(Syd) MPH (UNSW)
Cancer Institute NSW
Acting Director, Cancer Services and Education
Professor of Cancer Medicine,
Division (March – June 2006)
University of Sydney
Mr Neville Board commenced at the Cancer Institute
Ms Beth Macauley BA GCHSM RN
Chief Operating Officer
Ms Beth Macauley was appointed as the Chief
Operating Officer, Cancer Institute NSW in
September 2003. Ms Macauley has extensive
professional experience in strategic health services
management, medical relations management and
administration in the private hospital sector. In
late 2000, Ms Macauley was appointed by Mayne
Health as Director of Hospitals in Nepean, North
Western Sydney and, the National Capital Private
Hospital in the ACT. During this period, she also
worked for Mayne as Medical Relations Manager for
NSW, coordinating and facilitating Mayne Hospital
business development initiatives throughout the
State. Other experiences include the commissioning
of co-located tertiary level health services,
decommissioning of several private hospitals and
the divestment of non-performing assets.
16
Cancer Institute NSW: Annual Report 2005–2006
NSW in October 2003. He holds a degree in history
and politics, is a registered nurse and has a Masters
in Public Health. After four years nursing at Prince of
Wales Hospital, Sydney, Mr Board spent nine years
abroad, mostly running primary health projects in
Brazil. Returning to Australia, he worked in clinical
and hospital management roles in public and private
hospitals, and worked on trials of short-stay and
hospital in the home care pathways. At NSW Health
he developed ambulatory information projects, and
managed the roll-out of radiotherapy information
systems. At the Cancer Institute NSW he manages
cancer information projects, and was Acting
Director, Cancer Services and Education between
March and June 2006.
Ms Trish Cotter BSc MPH
Director, Cancer Prevention Division
Ms Trish Cotter has 20 years experience in tobacco
control, specialising in communications and
social marketing campaigns. Ms Cotter started
her career at Quit Victoria, responsible for annual
quit campaigns centred on TV advertising but
incorporating PR and support for smokers. Ms
Cotter spent a year at the Massachusetts Tobacco
Dr Paul Jelfs BSc (Hons) PhD
Control Program’s advertising agency to develop
Director, Cancer Information and
their media campaigns. Ms Cotter was a key
Registries Division
organiser of Australia’s National Tobacco Campaign,
Dr Paul Jelfs manages the Central Cancer Registry,
and in 1999 became the Deputy Marketing Director
the Clinical Cancer Registry, cancer epidemiology,
at The Age newspaper. As Communications
the Pap Test Register and has an advisory role in
and Marketing Director for the Victorian Health
the breast, cervix and bowel screening programs.
Promotion Foundation (VicHealth), she developed
Dr Jelfs was formerly Director of the Epidemiology
Australia’s first campaign for mental health
Branch in the South Australian Department of
promotion in 2000-2001. She joined the Cancer
Health and headed the Population Health and
Institute NSW in 2004.
Health Registers and Cancer Monitoring Units at the
Ms Carmel Edwards BSc Mqual Path
Australian Institute of Health and Welfare. Dr Jelfs
Director, Cancer Research Division
has been responsible for the development of a large
Ms Carmel Edwards commenced at the Cancer
number of public health information systems such
Institute NSW in March 2004. Ms Edwards holds a
as the National Death Index, the National Cancer
science degree majoring in genetics and physiology
Statistics Clearing House and the National Diabetes
and Masters qualifying in pathology. Ms Edwards’
Register. He has an interest in cancer epidemiology,
immediate postgraduate years were spent as
public health information development, spatial
a researcher in the disciplines of genetics and
epidemiology, health inequalities and veterans’
immunology followed by a short period of time in
health. Dr Jelfs is currently the Chair of the Clinical
the pharmaceutical industry. Ms Edwards’ research
Oncological Society of Australia Epidemiology
administration and management experience has
Group, Chair of the Australasian Association of
been gained over the past 15 years, with senior
Cancer Registries and the Oceania representative to
positions held at St Vincent’s Health Care Campus,
the International Association of Cancer Registries.
MBF Australia and NSW Health.
Cancer Institute NSW: Annual Report 2005–2006
17
Ms Denise Thomas BHM AC Cert RN
Director, Cancer Services and Education
(July 2005 – March 2006)
Director, Cancer Screening (March – June 2006)
Ms Denise Thomas was appointed to the Cancer
Institute NSW in March 2005. Ms Thomas has
worked in health care for more than 25 years in
both public and private sectors holding numerous
management and Executive roles. In the private
sector Ms Thomas has managed large-scale
national and international projects and has worked
in hospital, pathology and radiology businesses.
Prior to joining the Cancer Institute NSW Ms Thomas
held the role of Director, Nepean Private Hospital.
In March 2006 Ms Thomas moved into the role of
Director Cancer Screening.
Executive Office and
Administration
Ms Lancia Jordana
BA Dip Film and Television Production
Mr Charles Latimer BA BEc GAICD
Director, Cancer Communication Division
Policy Adviser/Executive Officer to the Chief Cancer
(from May 2006)
Officer and CEO
Ms Lancia Jordana has over twenty years
Mr Charles Latimer has held senior policy
experience in communications as an adviser
adviser positions in a range of public and private
to government ministers as well as extensive
organisations for more than 17 years. For the past
corporate communications exposure within a range
six years Mr Latimer has worked in the health sector,
of organisations. Ms Jordana’s career includes
mainly in cancer control policy. Together with the
journalist and communications specialist roles with
Chief Cancer Officer, Mr Latimer is responsible for
ABC radio and television, the Australian National
Government liaison, stakeholder management for
Council on AIDS, the Department of Community
health consumers and the NSW cancer charities
Services and the Australia Council. Before joining
sector. Mr Latimer is also secretary to the Board of
the Cancer Institute NSW Ms Jordana worked for the
the Cancer Institute NSW.
RTA as Manager Business and Information Services.
Ms Katherine MacHutchison
Dr David Manning BSc PhD PGCE
BA Grad Dip Business (Human Resource
Director, Cancer Communication Division
Management and Industrial Relations)
(to December 2005)
Human Resource Manager
Dr David Manning has a PhD in cancer genetics
Ms Katherine MacHutchison was appointed as the
from the University of Wales College of Medicine
Human Resource Manager in February 2004. Ms
and has worked on genes involved in breast cancer
MacHutchison has extensive experience in human
metastasis. He has studied Science Journalism
resource management, organisational development,
and Health Communications at Birkbeck College,
change management and employee relations. Ms
University of London and has written and produced
MacHutchison has worked in the health sector for
health programmes for the broadcast media. He
the past five years and has experience in consulting
has managed communications for several cancer
in both the public and private sector.
organisations in Australia and the UK and has been
a communications consultant for the NHS Cancer
Networks Patient Partnership Programme and
Macmillan Cancer Relief’s Patient Information and
Support Programme.
18
Cancer Institute NSW: Annual Report 2005–2006
Mr David Sabanayagam MBA PNA
across a broad range of issues and functions to
Finance Administration Manager
ensure the provision of high quality, coordinated
Mr David Sabanayagam was appointed as Finance
advice and information to the Cancer Institute NSW
and Administration Manager in September 2004.
Board and the NSW Government.
Mr Sabanayagam has 17 years experience in
finance roles in Communications, Information
Finance and Administration
Technology, Publishing and Advertising industries in
Provides financial management, reporting and
the private sector. David has a Masters in Business
budgetary services and administrative services for
Administration from Macquarie University and is a
the Cancer Institute NSW, including financial policy,
member of National Institute of Accountants. Just
financial analysis, insurance and risk management,
prior to joining the Cancer Institute NSW, he was the
GST/tax advice.
Finance Manager for the Buspak Advertising Group
of companies, and previously was the Financial
Controller for Thomson Education Direct.
Human Resources
The Human Resources department at the Cancer
Mr Michael Schmitz MPD
Institute NSW provides strategic advice and
Information Technology Manager
services that facilitate the attraction, maintenance
Mr Michael Schmitz commenced as Information
and development of high performance staff. The
Technology Manager in July 2004 and has been
department provides operational solutions that
involved in the Information Technology and
support line management accountability for staff.
Communications industry for more than 25 years.
Mr Schmitz has an Advanced Diploma in Project
The key Human Resource activities at the Cancer
Management, is a Master Project Director and
Institute NSW include recruitment, job evaluation
is a member of the Australian Institute of Project
and establishment, coaching and advice to
Management. Prior to joining the public sector,
line management, remuneration management,
Michael held senior positions with several major
organisational development, change management,
information technology organisations and niche
employee relations, and learning and development.
consultancies primarily focusing on project
management and methodologies. He has a vast
Information Technology
range of experience and has successfully managed
The Information Technology department provides
a variety of projects including information technology
Information Communication and Telecommunication
infrastructure and systems implementations, data
(ICT) strategic planning, maintenance and support
centre and relocation projects, primarily in the, legal,
of information systems and a high level of client
banking and finance, pharmaceutical and essential
focused customer service to ensure all business
service arena.
areas are provided with the most appropriate
Organisational
Functions
technology solutions and services.
Executive Office and
Administration
The key Information Technology activities at the
Cancer Institute NSW include the operational
support of information systems which include
the Pap Test Register, Central Cancer Registry,
The Executive Office provides high-level executive
BreastScreen Information System and other cancer
and coordinated administrative support to the Chief
related systems. In addition to these operational
Cancer Officer and the Chief Operating Officer
duties the Information technology department is
Cancer Institute NSW: Annual Report 2005–2006
19
currently in the process of providing a number of
•
through tumour streams
new initiatives which will significantly benefit the staff
of the Cancer Institute NSW and its stakeholders.
•
Institute NSW. The Cancer Prevention Division
develops and implements strategies to:
•
educate the community about the consequences
of smoking and promote cancer risk reduction
behaviour
•
promote NSW Government legislation and policy
•
assist in developing and implementing national
and state cancer prevention comprehensive
•
enabling skilled health professionals.
Cancer Research Division
The key role of the Cancer Research Division is to
drive improvements in cancer control by accelerating
the translation of research discoveries directly
into clinical practice. To achieve this, the Division
implements programs and competitive funding
opportunities specifically designed to:
•
provide a unified, independent peer review
process for cancer research funding in NSW
strategies.
Cancer Screening Division
fostering patient-centred care coordination and
structured validated psychosocial support
Cancer Prevention Division
Cancer prevention is a key priority for the Cancer
establishing lead clinicians and specialisation
•
connect research discoveries to patient care
improvements
The Cancer Screening Division aims to reduce the
morbidity and mortality associated with cancer
increase the capacity of cancer research in
through the provision of population based screening
NSW by supporting researchers and developing
programs. The Division develops and implements
infrastructure
strategies to:
•
•
screening programs including hard to reach and
relevance.
improve the quality of cancer screening services
Cancer Services and Education
Division
The Cancer Services and Education Division
develops and implements strategies to strengthen
Area Cancer Services, including:
supporting integrated, Area-based cancer
services with a named Director
•
encourage scientific collaboration and
amalgamation to enhance research capacity and
in NSW.
•
•
increase participation of target populations in
disadvantaged groups
developing multidisciplinary team care plans for
each patient
20
•
Cancer Institute NSW: Annual Report 2005–2006
Cancer Information and
Registries Division
The Cancer Information and Registries Division
draws together population based and patient based
cancer information, synthesises and delivers the
Cancer Communication
Division
information through a range of reports, advice and
The Cancer Communication Division supports the
electronic delivery systems. The Division has a role
Cancer Institute NSW objectives through provision
in setting standards for data collection, influencing
of key cancer messages to the public, cancer
existing information systems to collect cancer
awareness and program messages to health
related information and where necessary building
professionals, the NSW Parliament and to the
new information systems. The Division also plays a
general community through targeted campaigns,
role in influencing clinical decision making through
publications, the internet and the media. The
its establishment of treatment protocols.
Division also provides strategic communications
support and services to other Cancer Institute NSW
The Division has five major activities:
•
Cancer registration
–
Central Cancer Registry
–
Clinical Cancer Registry
•
Pap Test Register
•
Epidemiological analysis and study support
•
Information systems development
•
Divisions.
Standard Cancer Treatment Protocol
development
The Division also plays an advisory role for the
other Cancer Institute NSW Divisions by providing
information or technical support for programs such
as screening, prevention and program evaluation.
Cancer Institute NSW: Annual Report 2005–2006
21
The Year in Review
Cancer Prevention
A major focus of the NSW Cancer Plan 2004-2006
is the public anti-tobacco campaigns aimed at
reinforcing quitting behaviours amongst smokers.
Highlights
The nine successful campaigns and other initiatives
have changed our community’s attitude to smoking.
•
Smoking prevalence reduced to the lowest
recorded in NSW with only 15.7% of adults
Overall smoking rates have fallen by 2.2% from
22.3% to 20.1% in the last two years.
smoking every day.
•
Calls to the Quitline have more than doubled
The number of adults in NSW who smoke every
since 2003.
day is now only 15.7%. The fall has been greatest
in women where only 14.3% of adult women now
•
Seven new language-specific Quitline phone
smoke everyday compared to 17% of adult men.
numbers established in 2006.
Calls to the Quitline have more than doubled from
21,135 in 2004-2005 to 45,199 in 2005-2006. More
Tobacco smoking remains the largest preventable
than half the calls to the service were from women.
cause of disease in NSW, responsible for 30% of
cancer deaths in men and 13% of cancer deaths in
Smoking is disappearing from pubs and clubs, with
women. One in two smokers will die from smoking
expected health benefits for staff and patrons.
and smokers on average lose 10 years of productive
22
life. About one third of smokers die in middle age,
It is estimated that around 100,000 smokers (or
losing over 20 years of life. Currently tobacco
10%) have reported quitting in the last two years.
smoking kills around 6,600 people each year
There are now more people in NSW who have quit
in NSW.
smoking than are currently smoking.
Cancer Institute NSW: Annual Report 2005–2006
One in two smokers will die from smoking and smokers
on average lose 10 years of productive life.
This decline will have a substantial impact on the
•
$6.6 billion smoking costs in NSW each year. The
Health remains the most prominent reason for
thinking about quitting smoking (77%).
reduction in smoking rates of 2.2% is estimated to
save NSW between $1-2.5 billion over the next
•
that dying from a smoking related illness is
20 years. However, there remains around 1.2 million
usually slow and painful (80% agreement up
adults in NSW who smoke and are at risk of dire
5% from 2005).
effects on their health.
Programs in 2005-2006
Among smokers there was greater recognition
Parents Quit Smoking Campaign
The Cancer Institute NSW launched the Parents Quit
2006 Smoking and Health Survey
Smoking Campaign in September 2005, coinciding
Building on its inaugural Smoking and Health Survey
with Father’s Day. The campaign developed and
in 2005, the Cancer Institute NSW ran a follow-up
implemented in Victoria, targeted parents who
survey in 2006. The purpose of the research was to
smoke, highlighting the impact smoking has on
gain a better understanding of patterns of tobacco
the health of the smoker and the wellbeing of
use, quit attempts and barriers to quitting among
loved ones.
NSW smokers. Furthermore the survey offered
an opportunity to understand smokers’ and nonsmokers’ knowledge about the health consequences
of smoking, attitudes towards current smoking
issues and look at shifts that have occurred
The campaign achieved:
•
At its peak, 72% recognition among smokers.
•
59% found the television commercial attention
since 2005.
Key findings include:
grabbing.
•
Among smokers, 45% believed the ad was
worth watching.
•
51% of respondents nominated stopping
smoking as most likely to improve someone’s
•
believable.
health.
•
56% of respondents believed tobacco smoking
was the leading cause of premature death in
NSW.
•
65% of smokers found the advertisement
•
Respondents (38%) found the television
commercial personally relevant.
Lung Disease Quit Smoking Campaign
Almost two thirds (63%) of smokers indicated
Sufferers of the disease emphysema describe it as a
that they were considering quitting smoking in
living breathing hell or like they are suffocating
the next six months (up from 59% in 2005).
24 hours a day, seven days a week.
Cancer Institute NSW: Annual Report 2005–2006
23
The program aimed to:
•
Reinforce campaign key messages at a
community level.
•
Complement a ‘whole of community’ approach
to address the issue of tobacco smoking.
•
Strengthen community networks and
relationships.
•
Provide opportunities for educating, empowering
and enabling change within communities.
Eligible community groups were invited to apply
for two rounds of small grant funding as part of the
Parents and Lung Disease Quit Smoking Campaigns.
A total of 11 projects were funded, many working with
priority groups.
Melanoma Awareness Campaign
The Cancer Institute NSW launched the Lung
Disease Quit Smoking Campaign, developed and
implemented in Victoria, on 3 November 2005.
The campaign ran for six weeks and demonstrated
to smokers what lies ahead if they don’t quit
smoking now. It warned not to ignore the early
warnings signs of lung damage caused by their
smoking.
Campaign tracking found:
•
Using lifesavers to deliver the message, the Cancer
Institute NSW launched its new Melanoma Information
Campaign at Bondi Beach on 15 January 2006.
Fourteen shirtless Bondi lifesavers stood on the beach
with the message ‘Melanoma Kills’ painted on their
backs, before then putting on shirts with the words
‘Slip! Slop! Slap!’ spelt out.
The Melanoma Campaign was aimed at reawakening
Australians to the dangers of skin cancers and
At its peak, 80% of smokers had seen the
providing them with important information about how
‘Bubblewrap’ television commercial.
to assess their risk of getting a melanoma. People
living in NSW have among the highest rates of skin
•
Among smokers, 49% found the television
cancer in the world.
commercial attention grabbing.
•
36% of respondents felt the commercial was
Quitline Services Campaign
worth watching.
The NSW Minister for Health John Hatzistergos and
Chief Cancer Officer Prof Jim Bishop teamed up with
•
•
46% of smokers felt that it was personally
the Sydney Swans on Wednesday 19 April 2006 to
relevant.
launch a new Quitline Services Campaign.
Smokers (16%) were more likely to stop smoking
immediately as a result of seeing the ad.
commercials, radio, press and outdoor media
Community Grants Program
commenced in April and will air through to
To support the Cancer Institute NSW’s investment
October 2006.
in campaigns, a community grants program was
established in August 2005.
24
The campaign is comprised of six 15-second TV
Cancer Institute NSW: Annual Report 2005–2006
The campaign aims to provide smokers with better
The campaign ran on television, outdoor media,
understanding of the range of services and support
press and radio and preliminary evaluation of the
available just by picking up the phone and calling
amputation ad found:
13 7848 (13 QUIT).
•
By participating in the Quitline’s free callback
service a smoker can double their chances of
At its peak and after four weeks, 78%
recognition among smokers.
•
successfully quitting.
After three weeks, half of all smokers could
describe the gangrene ad when asked about
smoking ads on television.
Research undertaken by the Cancer Institute NSW
in 2005 found that while there was generally high
•
65% of smokers find it attention grabbing, the
awareness of the Quitline among smokers there
highest of any of the Cancer Institute NSW’s
was poor understanding of the services provided.
campaign run yet.
National Health Warnings Campaign
The NSW Minister for Health John Hatzistergos
and Chief Cancer Officer Prof Jim Bishop launched
•
64% of smokers found the ad confronting.
•
Among smokers, 44% found it better than the
other quit smoking ads.
the new National Health Warnings Campaign on
Monday 8 May 2006.
Excuses Campaign – Re-Run in 2006
Due to its success in 2005, the Cancer Institute NSW
The collaboration, initiated by the Cancer Institute
re-implemented its highly recognisable Excuses
NSW with Quit Victoria as a key partner, includes
(Echo) Campaign. The campaign aimed to motivate
State and Territory smoking and health programs.
smokers to quit now rather than leave it until it is
The first phase of the collaboration was to launch
too late. It confronts people who smoke with the
the new national campaign featuring the gangrene
excuses they often use to delay trying to quit and
graphic health warning.
provides them with a strong, honest portrayal of the
consequences of smoking. The campaign was re-
The campaign aims to encourage smokers to quit
run from May to June 2006.
by providing them with new health information and
make a connection between the graphic health
Language-Specific Quitline Phone Numbers
warnings on cigarette packs. The advertisement
On 15 May 2006, the Cancer Institute NSW,
focuses on preparation for amputation of a
Multicultural Health Communication Service and the
gangrenous foot caused by peripheral arterial
Quitline launched seven new dedicated language-
disease (PAD).
specific smokers’ telephone lines, for smokers
wishing to seek support from Quitline but for whom
From 1 March 2006, all tobacco products
English is not their first language. In this pilot phase
manufactured or imported to Australia have pictorial
smokers call their language line and leave their
warning labels on packages. Each pack has a
name, telephone number and the preferred days and
warning message covering
times that they can be reached. A Quitline adviser
30 per cent of the front and 90 per cent of the back
with the same graphic, a corresponding explanatory
and interpreter phones them back to provide advice,
support and information to help them stop smoking.
message, and for the first time the Quitline logo
and phone number. Seven new warnings were
introduced from March 2006 and a second set will
be introduced from 1 November 2006.
Cancer Institute NSW: Annual Report 2005–2006
25
In addition to the English Quitline (13 7848), there
NSW implemented a second wave in June 2006 to
are now seven dedicated lines for the following
announce the next stage of restrictions to smoking
groups:
in licensed venues.
Arabic
1300 7848 03
Chinese (Cantonese
and Mandarin)
1300 7848 36
Italian
1300 7848 61
which will see licensed venues go smoke free
Vietnamese
1300 7848 65
indoors in July 2007.
Korean
1300 7848 23
Greek
1300 7848 59
restrictions. The 2006 Smoking and Health Survey
Spanish
1300 7848 25
found:
From 3 July 2006, smoking will be further restricted
to one part of NSW pubs, clubs and the casino. The
restriction is the second step in a series of changes
In NSW, these language groups have higher
The campaign builds on public support for smoking
•
‘bothered’ when exposed to other people’s
smoking prevalence and lower English language
smoke in public places.
proficiency. A new Quitline service where individuals
will be able to speak directly with an adviser who
90% of non-smokers and 42% of smokers are
•
90% of respondents ‘strongly agreed’ that all
can fluently speak their language is in development
workers have the right to work in a smoke free
for the latter part of 2006.
environment.
In their first month of operation the lines have
•
Three quarters of non-smokers and one quarter
attracted unprecedented numbers of calls from non-
of smokers try to avoid situations that are likely
English speaking background smokers.
to be smoky.
•
88% of respondents agreed that going smoke
free will make pubs and clubs safer for them to
be in.
Pubs and Clubs Campaign
‘Change is in the Air’ 2006
Building on the first wave of the ‘Change is in the
Air’ Campaign’ from 2005, the Cancer Institute
26
Cancer Institute NSW: Annual Report 2005–2006
Screening and better treatments have resulted in better
survival outcomes in NSW …
Cancer Screening
A meta-analysis of breast screening clinical trials has
concluded that mammography screening reduces
breast cancer mortality by 16%-35% among women
Highlights
50-69 years of age. Screening and better treatments
•
Breast screening participation rates for women
with over 85% of women in NSW now surviving five
50-69 years increased by approximately 4%.
years post diagnosis. In the past 10 years the age
have resulted in better survival outcomes in NSW
standardised mortality rate has declined by 22%.
•
An additional $4.2 million funding provided
to Area Health Services for breast screening
These excellent results can be largely attributed to
the screening program.
services to make services more accessible.
•
Implementation of National Health and Medical
Improving the sensitivity and specificity of current
Research Council (NHMRC) guidelines for
mammography is likely to further reduce the chance
cervical screening.
of false positive tests which has been identified as
one of the barriers to attendance to the program. It
•
Bowel Screen NSW program established and
is also shown that non-attenders have a higher risk
National Bowel Cancer Screening Program due
of more advanced breast cancer compared to those
to commence in August 2006.
that attend breast screening services.
BreastScreen Australia, established in 1991, is
BreastScreen NSW
a nationwide screening program which provides
fixed or mobile mammography services biennially
Breast cancer is the most common cancer in women
for asymptomatic women aged 50-69 years who
and the most common cause of cancer death in
are actively recruited to the program. Women aged
women in NSW and Australia (AIHW 2004, CIM
40-49 and 70 years and older may also attend the
Report NSW 2003). Breast cancer is a risk for one
program free of charge.
in eight women during their lifetime. Breast cancer
incidence increased by 7% over the last decade.
Since its introduction in 1988 and its statewide rollout by 1995, population-based mammography has
contributed to a substantial increase in the detection
of breast cancer. Adherence to recommended
mammography guidelines has been suggested to
help identify smaller and more treatable tumours
resulting in better survival outcomes.
Cancer Institute NSW: Annual Report 2005–2006
27
Achievements
Following the program transfer to the Cancer Institute
NSW from July 2005:
NSW Cervical
Screening Program
Cervical cancer accounts for 1.7% of all cancers in
•
Increase in participation rate by approximately
4% since 1 July 2005
females in NSW. Cervical cancer ranks fourteenth for
•
increase of 24,152 in number of women aged
50-69 years screened biennially since 1 July 2005
Incidence and Mortality Report 2003).
•
provisional accreditation of Hunter Screening and
Assessment Service
Cervical screening has been available to Australian
•
incidence and twentieth for mortality in NSW (Cancer
women since the 1960s. In 1991 the Commonwealth
in conjunction with state and territory governments
increased appointments available with the
introduction of extended hours of screening at
major sites
established the Organised Approach to the Prevention
of Cancer of the Cervix, later renamed the National
Cervical Screening Program in 1995.
•
survey of women in NSW aged 50-69 years
revealed around 30% had a private mammogram
in the last two years.
Number of Women Screened
NSW BreastScreen Participation Rate by Month
400,000
July 2005 – June 2006
Woman
WomenScreened
ScreenedBiennially (50-69 years)
380,000
360,000
340,000
320,000
300,000
Jul
05
Aug Sep
05
05
Oct
05
Nov
05
Dec
05
Jan
06
Feb
06
Mar
06
Apr
06
May
06
Jun
06
Month ended
NSW BreastScreen Biennial Participation of
Women Aged 50 – 69 years
July 2005 – June 2006
™ÊäääÊÊÊÊÊÊ
näää
Çäää
Èäää
xäää
{äää
Îäää
Óäää
£äää
ä
Տ‡äx
28
Õ}‡äx
-i«‡äx
"V̇äx
œÛ‡äx
iV‡äx
>˜‡äÈ
՘ÌiÀÊ,i}ˆœ˜Ê
EÊ7ޜ˜}Ê-…ˆÀi
i˜ÌÀ>ÊEÊ
>ÃÌiÀ˜Ê-Þ`˜iÞ
Ài>ÌiÀÊ7i>ÌiÀ˜
-Þ`˜iÞ
-œÕ̅Ê7iÃÌÊ
-7
-œÕ̅iÀ˜Ê-Þ`˜iÞ
Eʏ>Ü>ÀÀ>
-œÕ̅Ê>ÃÌiÀ˜Ê
-7
iL‡äÈ
>À‡äÈ
œÀ̅iÀ˜Ê-Þ`˜iÞ
EʜÜiÀÊ
œÀ̅Ê7iÃÌÊ
-7
«À‡äÈ
>އäÈ
՘‡äÈ
œÀ̅Ê
œ>ÃÌÊ
i˜ÌÀ>ÊEÊ7iÃÌiÀ˜Ê
-7
Cancer Institute NSW: Annual Report 2005–2006
38425 Cancer Inst AR 2005-06_051006.indd 28
12/03/2007 4:07:08 PM
In NSW in the 10 years from 1994-2003, the
in NSW in the near future. Current NSW program
incidence rate of cervical cancer has fallen by
performance is below that of most other states
46% and mortality has fallen by 52%. Recent data
and currently sits at 57.5 %. A target participation
indicates that the survival from cervical cancer five
increase for 2006-2007 has been established at 3%
years post diagnosis is 73%.
aimed specifically at late screeners, those who do
not screen and hard to reach populations.
The reduction in cervical cancer incidence and
mortality is largely attributable to the treatment of
Implementation of New Cervical Screening
pre-cancerous abnormalities and early detection
(NHMRC) Guidelines
through population based screening programs.
Revised cervical screening guidelines Screening
General practitioners are the main providers of Pap
to Prevent Cervical Cancer: Guidelines for the
tests in NSW.
Management of Asymptomatic Women with Screen
Detected Abnormalities were endorsed by the
Improvement of Cervical Cancer
NHMRC in July 2005 and come into effect on
Screening Rates
3 July 2006.
The Cancer Institute NSW is examining the most
efficient method to improve the biennial
NHMRC Guideline Education Seminars
participation rate for women aged 20-69 years and
Education seminars for GPs, practice nurses,
will be commissioning a review of the program
gynaecologists, laboratory staff and women’s health
Biennial Participation in Cervical Screening of
NSW Women Aged 20 – 69 years (1)
Number of Women Screened
July 2005 – June 2006
Women Screened
1,093,000
1,088,000
1,083,000
1,078,000
1,073,000
1,068,000
Jul
05
Aug Sep
05
05
Oct
05
Nov
05
Dec
05
Jan
06
Feb
06
Mar
06
Apr
06
May
06
Jun
06
Month ended
(1) Monthly screening numbers and rates are of women who screened at least once in the 24 months
up to the end of the given month
Source: NSW Pap Test Register data
Cancer Institute NSW: Annual Report 2005–2006
29
nurses informing them of the NHMRC changes are
The efficacy of a bowel cancer screening program
progressing well across NSW in urban, regional
in Australia by testing for blood in bowel motions
and rural locations. These key seminars have been
has now been proven by the Australian Bowel
taught by Dr Gerry Wain. The Cancer Institute NSW
Cancer Screening Pilot conducted in 2002-2004.
is grateful for his dedication in this important task.
The Australian Government has recently announced
a National Bowel Cancer Screening program to
Bowel Screening
be rolled out in August 2006. In NSW the Program
Bowel cancer is the second most common cause
will be supported by NSW Health and the Cancer
of cancer in both men and women in NSW. There
Institute NSW.
is a higher incidence of bowel cancer in Australia
and NSW than in most developed countries. In 2003
Screening Achievements
bowel cancer accounted for 13% of all cancers
Division of Cancer Screening Established
diagnosed in NSW. In total there were 4262 new
Responsibility for the breast and cervical screening
cases of bowel cancer, 2306 males and 1956
programs in NSW was transferred to the Cancer
females.
Institute NSW in July 2005. A Cancer Screen
Advisory Committee was then established to assist
NSW annual incidence rates per 100,000 from
1993-1997 of 47.9 for males and 32.2 for females
were among the highest in the world. This was
similar to Canada’s rates of 41.8 for males and 28.8
for females, higher than the United States rates of
38.4 for males and 27.6 for females and lower than
in New Zealand rates of 52.0 for males and 40.6 for
females.
In 2003 bowel cancer was the second most
common cause of cancer death after lung cancer in
NSW. In total 1637 people died from bowel cancer
related death; 888 males and 749 females. The five
year relative survival experienced in 1994-2000 was
60% for both males and females.
The risk of bowel cancer increases from the age of
40, with a sharp rise after the age of 50 (AIHW 2005).
Survival rates can significantly improve if treated
early, thus making screening for this cancer highly
beneficial.
Clinical trials show that organised population-based
screening can reduce mortality and morbidity
from bowel cancer using a test for blood in bowel
motions.
30
Cancer Institute NSW: Annual Report 2005–2006
in determining key strategic priorities for cancer
screening programs. The Committee commissioned
a review of BreastScreen NSW and further to
the findings of that review the Division of Cancer
Screening was established. The establishment
of this Division will enable a more focussed and
synergistic approach to population screening
programs in NSW.
The Division of Cancer Screening is supported
by the Cancer Information and Registries, Cancer
Prevention and Cancer Communication Divisions of
the Cancer Institute NSW, which provide expertise
and cross-divisional support to the cancer
screening programs. Administration of the breast
and cervical programs has been relocated to the
Cancer Institute NSW at Australia Technology Park,
bringing all programs to a centralised location
alongside the other Divisions of the Cancer Institute
NSW.
… new technology and improved business practices
have made screening programs more accessible.
Breast Imaging Fellowship Program
the introduction of extended operating hours at
In 2005, Cancer Institute NSW commenced a Breast
major screening sites. Work has started to review
Imaging Fellowship Program for radiologists and
business practices, freeing up additional capacity
senior radiology registrars. Two Fellowships, each
for additional screening and making the service
valued at $120,000, were awarded during the first
more client focused. Preliminary work has begun
round. A second round of Fellowships will be offered
to change the breast screening boundaries to Area
in late 2006.
Health Service boundaries so that infrastructure can
be shared, allowing for greater screening capacity.
Implementation of New Digital Technologies for
BreastScreen NSW
Implementation of National Health and Medical
During early 2006, Cancer Institute NSW
Research Council (NHMRC) Guidelines for
commenced the staged implementation of digital
Cervical Screening
mammography (full field or computed) in a number
Cervical Screening has carriage of the
of BreastScreen NSW screening and assessment
implementation of the revised NHMRC guidelines
services.
Screening to Prevent Cervical Cancer: Guidelines
for the Management of Asymptomatic Women with
In January 2006, a full field digital mammography
Screen Detected Abnormalities and have presented
system commenced operation at The Rose Clinic
educational seminars for GPs, GP registrars,
BreastScreen centre within the Sydney CBD
gynaecologists, practice nurses, women’s health
David Jones Elizabeth Street store. In June 2006,
nurses and laboratory staff across NSW. These
a computed mammography system commenced
guidelines are designed to give medical practitioners
operations at the newly established Croydon
evidence based recommendations to better manage
BreastScreen centre.
patients with abnormal results.
Further implementation of digital mammography
systems is planned for 2006-2007.
Additional Funding to Area Health Services for
BreastScreen NSW
In 2005-2006 the Cancer Institute NSW allocated
an additional $4.2 million to Area Health Services
to assist in delivering breast screening services and
increasing participation in the target age group.
This resulted in an increase of 24,152 women in
the target age group screened since 1 July 2005.
Initiatives included additional clinical staff and
Cancer Institute NSW: Annual Report 2005–2006
31
Bowel Cancer Screening in NSW
The National Bowel Cancer Screening Program will
be launched in August 2006 and will be supported in
NSW by the Cancer Institute NSW and NSW Health.
The Bowel Cancer Screening Program in NSW
aims to ensure a safe, efficient and sustainable
bowel cancer screening process is introduced and
rolled out in NSW that actively contributes to the
prevention and early diagnosis of bowel cancer.
In early 2006 the Cancer Institute NSW has
undertaken a workforce capacity review of
colonoscopy services to inform the development
of the program and is formulating monitoring
and review processes to assess the impact of
implementation.
32
Cancer Institute NSW: Annual Report 2005–2006
Developing a highly educated and trained profession is
essential …
Cancer Services and
Education
psychologists. Additional positions were funded to
enhance genetic and palliative care services and
nurse education in NSW.
The funding of Technology Grants for radiotherapy
Highlights
and medical equipment was designed to introduce
innovative technology for cancer detection and
•
A Director of Area Cancer Services with
treatment which will result in enhanced quality
dedicated Cancer Service Development
of care and access to care for the patient, and
Managers funded in seven of the eight Area
improved cancer treatment and patient outcomes.
Health Services and 56 Care Coordinators,
21 Lead Clinicians and 29 Psycho-Oncology
support positions were created or strengthened.
•
$1.5 million allocated in Multidisciplinary Team
Development Grants to establish or enhance 118
multidisciplinary teams.
•
Provided 22 clinical and Psycho-Oncology
fellowships, 13 Nurse Education Scholarships
and 17 travel grants to medical meetings.
Training for Cancer Health Professionals
Developing a highly educated and trained profession
is essential to ensure the best possible outcomes
for cancer patients and attract and retain personnel.
The Cancer Institute NSW professional development
program aims to provide a range of education and
training opportunities to further support and develop
health care professionals working in cancer. Funding
supported the clinical workforce through specialist
fellowships, nursing scholarships, grants to attend
medical meetings and communications training.
General Overview 2005-2006
A workshop was convened in late June for the Cancer
Clinical Enhancements
Services Development Managers (CSDMs) who are
The budget allocation for the Clinical Enhancement
funded by the Cancer Institute NSW. Their key role is
Program which was an ongoing program from
to support the development of cancer services in each
2004-2005 was $11.5 million for 2005-2006. The
Area Health Service. The workshop, while providing a
Program provided funding for leadership positions
professional development opportunity, also enabled
such as Directors of Cancer Services, to ensure
each CSDM to provide a profile of their achievements
Area Cancer Services are structured to implement
to date and share their common challenges. An
improved cancer care. Funding was also allocated
ongoing monthly meeting has further enhanced the
to clinical positions to ensure that patients
establishment and networking of these key positions
received well coordinated care through new nurse
and provided tangible support to them by the
coordinators and that their psychosocial needs
Cancer Institute NSW.
were addressed through new social workers and
Cancer Institute NSW: Annual Report 2005–2006
33
General Practice Liaison Programs
The Radiotherapy Workforce Program
The Cancer Institute NSW worked in partnership
Two rounds of funding have been provided to fund
with the Alliance of NSW Divisions to delivery
supernumerary professional development year (PDY)
key general practice cancer projects within NSW
training positions for radiation therapists through
Divisions of General Practice. These are detailed
collaboration between the Cancer Institute NSW and
in the NSW Cancer Plan 2004-2006 Lessening the
NSW Health.
Impact of Cancer: A Two Year Progress Report.
In 2005 calendar year 24 positions were funded
Participating Divisions implemented specific projects
and a further 41 positions were funded in the 2006
at a local level addressing cancer prevention, early
calendar year.
detection or ongoing management in an innovative
and sustainable manner. The project resulted in
Four Academic Chairs have been created in
Cancer Lead positions being established in ten
Radiation Oncology to increase the academic
NSW Divisions of General Practice. In addition, the
involvement and academic profile of Radiation
Cancer Institute NSW worked in partnership with
Oncology and the radiation sciences in NSW. The
the Southern Highlands Division of General Practice
positions are at the University of Sydney (Chair
to implement a pilot Cancer Liaison Officer project
in Radiation Oncology and a Chair in Radiation
to focus on a smoking cessation project within
Therapy), University of Wollongong (Chair in
the local area including education in best practice
Radiation Oncology Medical Physics) and the
smoking cessation activities to GPs and practice
University of New South Wales (Chair in Radiation
nurses, practice visits and the dissemination of
Oncology).
resources.
Ambulatory Cancer Care Centres Review
Training for General Practice
In 2005, the Cancer Institute NSW commissioned
The Cancer Institute NSW worked collaboratively
a review of Medical Oncology and Haematology
with NSW Health and national cancer and general
outpatient treatment delivery in NSW across public
practice organisations to support the provision
and private sectors. This review presents data
education to general practitioners.
on outpatient chemotherapy and haematology
activity, physical resources, staffing, and access
In partnership with the National Cancer Control
to associated services within NSW and the ACT.
Initiative (NCCI), the Cancer Institute NSW facilitated
The outcomes will inform an upcoming project
Train the Trainer workshops in informed decision
focused on business process improvement in the
making regarding testing for prostate cancer. These
administration of chemotherapy across the State.
workshops were attended by staff from Divisions
This review will provide the basis to plan future
of General Practice who have been provided with
services to ensure improved quality and access
support to provide training for general practitioners
to services.
locally.
Working with NSW Health and the Australian
Chinese Medical Association, the Cancer Institute
NSW supported a workshop on evidence based
smoking cessation for health professionals working
with Chinese populations. This was delivered by
expert trainers and was tailored to meet the needs of
this specific group of health professionals.
34
Cancer Institute NSW: Annual Report 2005–2006
Professional development opportunities enhanced …
The Psychosocial Support Program
Clinical Fellowships in Cancer Specialities
The Psychosocial Support Program continued in
To continue to increase the depth and expertise of
2005-2006 to work across a number of themes
Oncology disciplines in NSW and to further train the
in the Cancer Services and Education Division.
next generation of cancer specialists, the Cancer
The Program supported the newly appointed
Institute NSW established 24 Clinical Fellowship
workforce in Psycho-Oncology, with 29 new clinical
positions for 2006.
psychologists and social workers across AHS.
Travel Grants for Cancer Health Professionals
Professional development opportunities for the
The Cancer Institute NSW is supporting the ongoing
workforce were enhanced by two workshops
professional development of health professionals
and travel grants for national and international
working in cancer in NSW through the Cancer
conference participation.
Institute NSW Travel Grant Program. These grants
enable participation at national and international
The Cancer Institute NSW initiated the inaugural
conferences, seminars and workshops. The
round of Psycho-Oncology clinical fellowships in
interstate Travel Grant Review Panel met four times
January 2006. This is the first time in Australia that
over the year to evaluate applications. Seventeen
such an opportunity has been made available to
applicants have attended international and national
build capacity by supporting high quality clinicians
conferences relevant to their area of expertise.
to conduct relevant research projects.
Education Scholarships for Nurses
A clinical pathway for screening, assessment
Working in Cancer
and referral of cancer patients with psychosocial
The Cancer Institute NSW Nurse Education
distress was developed by the Patient Support
Scholarship Program has been established through
Sub-Committee. This pathway will be pilot tested in
a competitive application process to provide nurses
late 2006 and will further contribute to developing
working in Oncology an opportunity to access a
resources, pathways and protocols to assist
range of study options available through universities,
Psycho-Oncology and multidisciplinary team
tertiary institutions and Area Health Services. The
development.
2006 program supported 13 nurses to complete
New Initiatives in 2005-2006
higher education programs.
Professional Development
A number of initiatives were developed in 2005-2006
to support ongoing professional development for
cancer health professionals.
Cancer Institute NSW: Annual Report 2005–2006
35
Psychosocial Support Program
The following new initiatives were developed under
the Psychosocial Support Program during
2005-2006:
•
Psycho-Oncology clinical fellowship program
funded five new positions for clinical
psychologists to undertake clinical work and a
research project for 12 months.
•
Two professional education workshops were
delivered to Cancer Institute NSW funded
Psycho-Oncology staff (clinical psychologists
and social workers). The first workshop
addressed issues of role delineation and
establishing a Psycho-Oncology service. The
second workshop focused on communication
skills training.
•
The Patient Support Sub-Committee initiated
work on developing a clinical pathway about
Communication Skills Training for Cancer Nurse
the screening, assessment and referral of
Coordinators and Psychosocial Support Staff
cancer patients for psychosocial distress.
During the year, the Cancer Institute NSW
The Sub-Committee also endorsed the use of a
coordinated four rounds of communication skills
previously validated screening tool for measure
training for Cancer Nurse Coordinators (CNCs) and
psychosocial distress, which is the Distress
one round for psychosocial support staff across the
Thermometer.
State. Following formal evaluation, most participants
agreed or strongly agreed that the new skills gained
Quality Improvement in Radiotherapy
were useful and that they would recommend
The business process improvement firm LSI
the training.
Australia Pty Ltd has been contracted to work with
Multidisciplinary Team Development
In 2005, the Cancer Institute NSW provided
public Radiation Oncology departments to:
•
identify opportunities for improvement in
competitive grants to establish or enhance
business practices and best practice in
multidisciplinary teams in cancer services. In total,
service delivery;
23 grants have been approved and funding is to
continue into 2007. There are 118 teams across all
•
eight Area Health Services including some in private
services currently supporting this program.
facilitate processes to implement changes in
these practices; and
•
develop generic business models to improve
business efficiency statewide.
Funding has provided teleconferencing, other
equipment, and administrative support to run
Phase 1 of this project began in late May 2006 and
multidisciplinary meetings and to keep logs of
includes radiotherapy centres at Royal Prince Alfred
activity. This support for multidisciplinary teams
Hospital, Liverpool and Macarthur Cancer Therapy
has also enabled IT access to data from the Cancer
Centres.
Institute NSW. Web-based resources available
include Standard Cancer Treatments and cancer
results in their region.
36
Cancer Institute NSW: Annual Report 2005–2006
Findings to date have indicated genuine process
It will consolidate current Cancer Institute NSW
improvements that will increase patient access to
initiatives for rural cancer patients such as support
treatment and that can be implemented even in
for the transport of cancer patients over 100
centres where benchmarks for treatment are
kilometres, cancer nurse coordinators and Psycho-
being met.
Oncology health workers.
Academic Palliative Care Chair NSW
Ongoing Work from 2004-2005
During the year the Cancer Institute NSW funded an
academic position in palliative care that will foster
improvement in the clinical practice of palliative
care, workforce and research in palliative care in
NSW. A Chair was awarded to a consortium headed
by the University of New South Wales bringing
together a multidisciplinary group of significant NSW
palliative care stakeholders.
Palliative Radiotherapy Review
The aims of this review, which will continue into
2006-2007, are to:
•
•
During 2005-2006, the Cancer Institute NSW
continued to coordinate the BSOC. In 2006, 31
cancer health professionals registered to the course.
Two scholarships were awarded.
Accreditation Program
An important part of the Cancer Institute NSW’s
quality program is the development of an
accreditation framework for cancer services in NSW.
A Quality and Clinical Effectiveness Committee was
Review the proportion of patients who receive
established to, in part, oversee the quality program.
palliative radiotherapy
The Committee was Chaired by Professor Clifford
Determine the total proportion of cancer
patients who should receive radiotherapy
•
Basic Sciences in Oncology Course (BSOC)
Hughes, Chief Executive Officer of the Clinical
Excellence Commission.
of palliative intent
The Nous Group were contracted to prepare two
Identify the gap between above 2 groups and
action plans, a one year plan and a three year plan,
make recommendations on mechanisms to
for progressing the accreditation framework and
address any gap.
standards program.
The Rural Access Review
This Program will continue in 2007 to further develop
The Rural Access Review was undertaken by Health
the accreditation framework.
Outcomes International Pty Ltd. It gives a snapshot
of cancer services in rural and remote NSW and
includes outcomes of qualitative research covering
patients and service providers. The outcomes of the
review will inform the Cancer Institute NSW Rural
Oncology Committee and upcoming Cancer Institute
NSW projects and enable initiatives to improve
access to cancer services for people in rural and
remote NSW.
Complementary Therapies Program
Complementary therapies are often used by people
with cancer to try to cure their disease or improve
their quality of life, often without the full knowledge
of the medical team caring for the patient. The
Cancer Institute NSW has defined complementary
therapies and provided comprehensive information
to support the appropriate use of complementary
therapies that improve the quality of life of people
with cancer.
Cancer Institute NSW: Annual Report 2005–2006
37
Links to high quality evidence based information and
Patient Support Program
other resources have been made available through
The Patient Support Sub-Committee was
the Cancer Institute NSW website.
established in 2004 and met during 2005-2006 on a
bimonthly basis.
A workshop to start to address the evidence for
complementary therapies was held in March 2006 to
The Sub-Committee was disbanded in June 2006 and
further guide the development of the program and
will be replaced by the Joint Patient Support Advisory
information about complementary therapies.
Committee with The Cancer Council NSW.
The Cancer Institute NSW has conducted a review
The Area Psycho-Oncology Teams Program
of access to complementary approaches available
(Program 11.2 of the NSW Cancer Plan 2004-2006)
to patients using cancer services. The results of this
continued to be supported through the funding of 29
survey will be used to develop new initiatives for the
positions for Psycho-Oncology professionals.
NSW Cancer Plan 2007-2010.
38
Cancer Institute NSW: Annual Report 2005–2006
… promoting activity and participation in cancer
clinical trials …
Cancer Research
encourage the very best researchers to choose
cancer research as their selected field of research
endeavour and to continue research that is nationally
Highlights
and internationally competitive.
•
Research Scholarships granted over two calendar
•
•
Funding of 1 Health Services Research
Fellowship, 3 International Collaboration Grants,
9 Research Equipment Grants, 10 Career
Development and Support Fellowships, and 26
new PhD Student Scholarships.
Inaugural Cancer Research Awards held 25 May
2006.
Establishment of the NSW Cancer Trials Group
(NSWCTG) to promote activity and participation
in cancer clinical trials, and to support the
activities of national cancer trials groups.
years currently support 38 outstanding PhD
students, including 26 new students in 2005-2006,
who have the potential to develop highly significant
careers in cancer research in NSW.
Translating Research Discoveries into
Clinical Practice
Translational Program Grants support bench to
bedside research that enables multidisciplinary
approaches to cancer research that will translate
new research discoveries made in the laboratory
directly into clinical programs or policy to benefit
Programs Undertaken in
2005-2006
cancer patients.
Supporting Cancer Researchers
The NSW Clinical Trials program accelerates the
The Cancer Research Leaders program strengthens
translation of clinical trials into practice, and the
cancer research capacity by funding new high
improvement of cancer control through research.
level academic posts and supporting outstanding
The key aims of the program are to increase the
research teams at NSW, hospitals, universities
quality of cancer clinical trials being conducted in
and/or other institutions. The program is directed
NSW as well as increasing the number of patients
to attracting outstanding research leaders from
being offered clinical trial participation.
Supporting Cancer Clinical Trials
interstate and/or overseas, and their core team of
researchers.
These aims are being achieved through the
implementation of various grants, partnerships and
The Research Fellowships are currently supporting
collaborations.
28 Cancer Research Fellows across various
disciplines of cancer research. These Fellowships
Cancer Institute NSW: Annual Report 2005–2006
39
A total of twenty-nine full time clinical trial nurses
Streamlining Ethical Review of
and data managers have been funded across the
Cancer Research in NSW
state, who are dedicated to the co-ordination and
This Program is being established to achieve a
support of cancer clinical trials in hospital units.
high quality single scientific and ethical review of
These positions cover well established clinical trial
multi-site NSW cancer research, meet international
sites as well as smaller units with the potential to
benchmarks for review timelines and to assure
expand the number of trials conducted.
a coordinated approach to research governance
administration. It is anticipated that a key outcome
A five year agreement between The Cancer Council
of this program will be improved access by patients
NSW and the Cancer Institute NSW will result in the
to ethically approved new cancer therapies.
integration of the cancer clinical trials programs of
the two organisations to provide a single streamlined
Supporting Population and Health
funding program for clinical trials nurses and data
Services Research
managers across the state.
This program focuses on the impact of cancer, its
treatment and its costs on the NSW community.
The Cancer Institute NSW is facilitating the further
The results of research will be used to improve care,
development of the NSW Cancer Trials Group
service delivery and economic burden.
(NSWCTG). The NSWCTG provides a forum for
clinical cancer researchers across all specialties
The Cancer Institute NSW is funding patterns of care
and tumour types, to exchange ideas, pursue
studies in lung cancer, colorectal cancer, prostate
collaborations, develop trial protocols and contribute
cancer and melanoma. These studies will document
to cancer clinical research in NSW.
current practice which can then be compared to
best practice based on agreed cancer treatment
In support of the newly established NSWCTG, the
guidelines.
Cancer Institute NSW has developed Partnerships
to support clinical trial activity. The Partnership
Building Infrastructure
with NHMRC Clinical Trials Centre for clinical trials
The program provides substantial financial support
operations and statistics includes developing
for key research platforms and core equipment.
two new national clinical trial cooperative groups
Innovative sharing arrangements to optimise use of
supporting genitor-urinary trials and lung trials in
key equipment have been specifically supported.
addition to building on existing expertise.
Despite the short duration of this program, its
impact on research output is evidenced by 25
The Partnership with Kendle Pty Ltd is providing
journal articles (16 published, five accepted, four
audit of clinical trials and clinical trials units.
submitted) and 10 conference presentations based
on research directly related to the provision funded
The Cancer Institute NSW is supporting the national
clinical trials groups based in NSW. The South
Eastern Area and Illawarra Consortium for Rational
Cancer Therapeutics is coordinating clinical trials
and enhancing collaboration between basic research
and clinical trials with support from the Cancer
Institute NSW.
40
Cancer Institute NSW: Annual Report 2005–2006
infrastructure.
An effective business liaison program is being
established …
New Initiatives Undertaken in
2005-2006
As part of the Epidemiology and Services Research
The Cancer Institute NSW International Collaboration
patterns of care studies. These studies collect
Grants are aimed at facilitating new and existing
information about cancer care practices used to
collaborative research between NSW based cancer
manage cancer patients over the course of their
researchers and teams and internationally based
disease, report various outcomes associated with
cancer researchers and teams located at centres
these practices, and provide information about
of cancer research excellence. In 2005-2006 three
patient and provider behaviours and perceptions. In
grants were awarded with $90,000 committed.
2005-2006 $457,000 was committed for patterns of
The Health Services Research Fellowships
Program, the Cancer Institute NSW has established
Patterns of Care Partnerships to further develop
care studies.
strengthen and support health services research
The Clinical Trial Units Establishment Grants have
(including health economics) in hospitals, universities
funded the placement of one full time equivalent
and institutions by providing opportunities for health
Clinical Trials Nurse or Clinical Trials Data Manager
service researchers to develop and sustain long-
in new or smaller clinical trials units. Successful
term careers in health service research.
recipients received an award of up to $84,900 per
In 2005-2006 one fellowship was awarded with
annum for salary, over 18 months, plus $10,000
$634,956 funding committed over three years.
start-up allowance. The total funding committed for
Research Equipment Grants provide funding
the 2005-2006 financial year was $726,750.
for essential research equipment. These grants
The NSW Cancer Trials Group, a cooperative group
were awarded on the basis of the international
providing a forum for clinical cancer research across
competitiveness of the research and the ability to
all specialities and tumour types, was established.
share or network the equipment with other groups.
The NSWCTG enables clinical researchers to
In 2005-2006 nine grants totalling $1.96 million were
exchange ideas, pursue collaborations, develop trial
awarded.
protocols and contribute to cancer clinical research
Clinical Research Fellowships are designed to
in NSW.
support clinicians by providing funding to ensure
An effective business liaison program is being
protected time from clinical duties for high quality
established to encourage interaction between
clinical research. In 2005-2006 five fellowships were
researchers and the business community engaged in
awarded with funding of $3.4 million committed over
medical research.
three years.
Cancer Institute NSW: Annual Report 2005–2006
41
The Clinical Trials Nurses and Data Managers Grant
was established in 2004, and awarded funding to 20
hospital based clinical trial units to employ a full time
clinical trials nurse or data manager. These positions
are dedicated to the conduct of cancer clinical trials
in NSW. In 2005-2006, $1,698,000 was provided in
funding for these positions.
The Cancer Institute NSW supported scientific and
ethical review of new and ongoing cancer research
proposals requiring access to the NSW Central
Cancer Registry and the Pap Test Register.
Through a process of broad consultation involving
cancer researchers, consumers, industry and Area
Health Service ethics committees in 2005-2006, the
Cancer Institute NSW has played a leading role in
advancing initiatives to streamline ethical review in
NSW.
Ongoing Projects and Program
Work from 2004-2005
The scene is now set to commence operations
of both the Clinical Cancer Research Ethics
In 2004-2005 a number of programs were ongoing
Committee, to focus on review of cancer clinical
including those listed below.
trials, and the Population and Health Services
Research Ethics Committee, to review research
Twenty-two Fellows supported under the Career
proposals involving large administrative health
Development and Support Fellowship Program.
datasets in 2006-2007.
These fellowships provide funding to develop and
support researchers who have substantial ability
Ongoing evaluation of the market with respect to an
and potential as future cancer research leaders.
online application for research ethics administration
Fellowships valued at up to $197,500 per annum for
software has been ongoing. With a preferred
3 years were awarded. Total funding of $13 million is
provider selected, the activities of both the Clinical
committed until October 2008.
Cancer Research and Population and Health
Services Ethics Committee’s will be supported
One Translational Program Grant awarded early
through electronic application and scientific review,
2005 supports a multidisciplinary approach to
and documentation management.
translate research discoveries into clinical programs,
specifically looking at prostate cancer risk and
screening. Funding of $3.75 million is committed for
this project over five years.
Ten Research Scholars were ongoing with grants
of $25,000 per year for up to 3 years. Funding of
$425,000 is committed for these scholarships.
Twenty six Research Infrastructure Grants totalling
$2.37 million continued during 2005-2006. These
grants provide funding for key research platforms,
core equipment and capacities to enhance the
cancer research effort in NSW. Funding is continuing
to March 2008.
42
Cancer Institute NSW: Annual Report 2005–2006
Research and Development
Grants Provided
Program
No.
Program Title
Number
Awarded
25.1
Research Leaders
Program
2
25.2
Clinical Research
Fellowship Program
5
25.3
Research Scholarship
Program
26
27
Research Equipment
Grants
9
27.2
Patterns of Care
Partnerships
2
29.2
Health Services Research
Fellowships
1
30.2
International Collaboration
Grants
3
Clinical Trial Units Establishment Grants
These grants provide funding of up to $84,900
per annum with an additional $10,000 start up
allowance, to fund the placement of a full time
clinical trials nurse or data manager in a clinical trial
unit. The grant was set up to fund sites who did
not meet the criteria for the Clinical Trials Nurses
and Data Managers Grant as they were not well
established trail units. The grant has been awarded
to nine clinical trial sites to expand the clinical trial
activities in these units.
Cancer Institute NSW: Annual Report 2005–2006
43
which will allow for improved geographical display
of cancer information for areas and assist in
investigating potential cancer clusters.
A significant amount of energy has been invested
in the electronic scanning of paper based historical
cancer notifications. This process will not only
remove the storage of the paper but will provide a
more accessible mechanism for retrieving data. This
project is expected to be finalised in mid 2007.
A project has been commissioned to build the
user requirements for the development of a new
cancer registry. The existing registry is built on
technology in excess of 20 years old which is unable
to meet the demands of the users and provide
the timeliness of data and is difficult to support.
A consultant has been engaged to assess these
requirements, working with the registry stakeholders
Cancer Information and
Registries
and is expected to report in August 2006. It is then
anticipated that procurement of a new registry
system will commence.
Clinical Cancer Registry and
Highlights
Information Systems
This program has focussed on the establishment
•
•
Establishment of the Monitoring, Evaluation and
of the NSW Clinical Cancer Registry Pilot project
Research Unit to undertake data analysis and
(Program 22.2). The primary purpose of the Registry
reporting and to support external researchers.
is to collate the agreed Minimum Data Set for
The establishment of the CI-SCaT program
website, that is now attracting 250,000 hits per
month from clinical and other users.
•
all cancers treated in NSW so as to provide a
high-quality database for Area Health Services to
monitor patterns, quality and timeliness of care, as
well as capturing detailed caseload and casemix
Production of the NSW Cancer Incidence and
information. The pilot has been established in five
Mortality report for 2003 and the supporting
Area Health Services, covering 249 hospitals and
web-based information module.
employing over 30 cancer data managers. The
program has been successful in delivering a web-
Central Cancer Registry
The Registry monitors cancer incidence, mortality
and survival to support the work of clinicians, policy
makers and planners, researchers and to provide
information to the public and cancer sufferers.
The Registry has undertaken significant work to
improve the data capture and quality through
improving operational practices and working with
data providers. It has also improved consistency
in coding of cancer information to International
guidelines through the development of nine cancer
site specific manuals and training staff to implement
these guides. The Registry has been augmented
through the addition of geocoded information
44
Cancer Institute NSW: Annual Report 2005–2006
based data collection module that connects with
existing information systems in hospital settings and
is also testing an alternative commercial option. An
evaluation is expected to commence in 2007.
The Cancer Institute NSW has also worked with
Area Health Services to develop information systems
to support clinicians to deliver chemotherapy. This
work has been jointly funded and has delivered a
series of systems assessment and implementation
plans which will result in installation of systems
in 2006-2007. The Cancer Institute NSW has also
commissioned work with NSW Health to build the
same functionality into the existing Cerner hospital
information system to make it available to Areas
Health Services.
A pilot program of electronic transfer of pathology
NSW Pap Test Register
results to the Central Cancer Registry was
The NSW Pap Test Register supports the
also commissioned with joint funding from the
CervicalScreen NSW program by operating a
Cancer Institute NSW and the Department of
reminder system for women to have regular
Communications, Information Technology and
Pap smears and by providing data to estimate
the Arts under the Information Technology Online
participation rates for program planning and
(ITOL) Program. This program successfully
evaluation. The quality of the smears, and resulting
established file transfer mechanisms from two major
health outcomes, are monitored and information
pathology laboratories using both existing and new
is provided to pathology laboratories and doctors
technologies and investigated the improvement
to support clinical management. The Register
in efficiency, accuracy and timeliness of these
maintains Pap test histories for more than 2.2 million
notifications. This work will is expected to be
women.
transferred to ongoing operations for the Cancer
Registry in 2006-2007.
In 2005 the NHMRC released new guidelines for
the management of asymptomatic women with
CI-SCaT - The Cancer Institute NSW Standard
screen-detected cervical abnormalities and as
Cancer Treatments Program
a consequence changed the manner in which
During the reporting period this program
the Register managed reminders to women and
developed more than 300 protocols that provide
clinicians. This included the introduction of a new
information on evidence-based cancer treatments
National Cervical Cytology Coding System, replacing
for clinicians, patients and carers. Each protocol
the state-based system.
and its accompanying patient support information
is presented in a standardised format on the
This opportunity for change also allowed NSW
website. The program draws together the best
to align itself with other States in a number of
available evidence on the use of these treatments,
operational and policy issues to ensure more
evaluates this evidence in the context of the clinical
consistency across Australia. The implementation of
environment, and then presents it to its clinical
the new guidelines was due to commence on the 3
reference groups to reach a consensus position.
July 2006 and had already proven to be successful
These protocols are then endorsed and promoted
in its trial over the previous months.
through the clinical network via education sessions,
conference presentations, and other clinical groups.
The program has been highly successful with more
than 250,000 hits per month on the website, the
establishment of six clinical reference groups, and
presentations to in excess of 1,200 clinicians. The
New Initiatives Undertaken
in 2005-2006
New initiatives undertaken during the reporting
period include:
•
Commissioned the first phase of the NSW
program will seek to review and update the current
Cancer Registry Redesign Project to specify
protocols and extend its work into the areas of bone
detailed user requirements for the design,
marrow transplantation, Radiation Oncology, and
procurement and implementation of a new
palliative care protocols.
cancer registry for NSW.
Cancer Institute NSW: Annual Report 2005–2006
45
•
Pilot program for testing electronic notification of
pathology results to the Central Cancer Registry
– improve the efficiency, timeliness and security
of results transfer.
Ongoing Projects and Program
Work from 2004-2005
Central Cancer Registry
The Registry continued its work on managing the
•
Support and develop Medical Oncology and
Haematology information systems to meet
the needs of the Medical Oncology and
Haematology clinical communities in Newcastle
Mater Misericordiae, St George, Liverpool and
Macarthur (Campbelltown) cancer centres
notifications of cancer. Its work focused on the
registration of cases for 2004 and 2005. The registry
was transferred from The Cancer Council NSW
during this period and committed resources to
manage this transition and to re-establish operations
at the Cancer Institute NSW.
using information systems built onto existing
•
radiotherapy systems. Develop the same
Clinical Cancer Registry (ClinCR) Pilot
functionality in Cerner eMR to support clinicians
The Clinical Cancer Registry Pilot was established in
in other areas and extend an existing Medical
order to capture additional clinical cancer data. Cancer
Oncology system in Albury. Planning and
incidence and mortality data is collected centrally
assessment studies have been completed in
in the Central Cancer Registry, whereas the ClinCR
Newcastle and St George with some systems
project collects cancer stage at diagnosis, treatment
due for implementation in 2006-2007.
and quality of care items for each cancer patient. Five
Support the development of an Information
Management Strategy for palliative care across
the NSW. This work included developing
standards for information management in
palliative care – with key performance indicators/
clinical indicators, standardised definitions and
•
Area-based pilots have been funded and established
during 2004-2005. The Pilot went ‘live’ in April 2006
and data is now being captured both electronically and
manually. Quality checks are now being undertaken
by all sites and system change requests are being
managed for future version enhancements.
clinical assessment methods, and better practice
NSW Pap Test Register
pathways for palliative care - a detailed gap
The Register continued to manage the functions of
analysis has been produced which outlines the
the registry, sending out reminder letters to clients,
precise information requirements for extending/
managing the delivery of history files to pathology
modifying existing information systems to
laboratories and working with laboratories to monitor
support palliative care.
quality issues. The Register also continued to deliver
Support of Biostatistical trainees – improve
the capacity of the health system to undertake
information to support the policy and promotional
work of the Cervical Screening Program.
analyses of public health information and
Research and Development Grants
to support cancer research. Projects on the
Funding Agreements were developed with
protective effects of cervical screening and
15 pathology laboratories for up to $5,000 each to
examination of age specific trends in cancer
assist their work on implementing the new National
will result.
cervical cytology coding system to support the NSW
Pap Test Register operations.
46
Cancer Institute NSW: Annual Report 2005–2006
… useful information that contributes to the effective
treatment and care of those affected by cancer.
Cancer Communication
Website
The Cancer Institute NSW website
www.cancerinstitute.org.au has been upgraded
Highlights
and was launched on 15 June 2006. The layout of
the website has been changed to improve its visual
•
Development of resources for people affected
by cancer, health professionals and the general
public.
•
Construction of an updated Cancer Institute
appeal and more importantly, to improve navigation
so that users can easily locate information and
access downloadable documents including research
reports, publications and campaign material.
NSW website.
During 2006-2007, a new website will be launched
•
Strengthening the Cancer Institute NSW profile
which will include the development of a robust
through a wider network of media contacts,
intranet and extranet to encourage collaborative
announcements and events.
work via the sharing of documents and information,
and to enable all advisory groups to participate in
interactive on-line discussions.
Publications
Cancer is an extremely complex disease to
The Cancer Institute NSW is also responsible for the
understand. Over the past year, the Communication
following sites:
Division has focused on providing useful information
•
BreastScreen NSW (www.bsnsw.org.au)
•
NSW Cervical Screening Program
that contribute to the effective treatment and care of
those affected by cancer.
(www.csp.nsw.gov.au)
The 2005 Cancer Institute NSW Patient Survey
showed that 71% of people affected by cancer
Media on Cancer Messages
wanted to receive information about support groups.
Between 1 July 2005 and 30 June 2006, there
Three directories were developed to provide up-to-
were forty-five media releases from the Cancer
date information for cancer patients to ensure that
Institute NSW on all aspects of cancer including
everyone benefits from the best cancer treatment
reinforcement of cancer avoidance behaviour. This
and care. In October 2005, the Cancer Institute NSW
generated stories in metropolitan and suburban/
published the following directories:
regional print, television and regional/national radio.
The Division will continue to raise public awareness
•
A-Z Directory of Support Groups 2005
•
A-Z Directory of Cancer Publications 2005
•
Accommodation Guide 2005
of key cancer health messages and Cancer Institute
NSW programs, initiatives and campaigns in the
areas of cancer prevention, cancer screening, and
cancer education and research.
Cancer Institute NSW: Annual Report 2005–2006
47
Committee assesses a wide range of potential
opportunities to foster proactive health messages to
the people of NSW. Additionally, sponsorships assist
in the establishment of partnerships and enhanced
professional relationships with organisations that
support the objectives of the Cancer Institute NSW.
Cancer Charities in NSW
Cancer fundraising by not-for-profit foundations
and charities is an essential and critical part of the
cancer control effort in NSW. The cancer charities
sector raises in excess of $100 million per annum
and is a mix of national charities with a NSW
presence, not-for-profit foundations established to
support a single facility, charities for specific cancer
types, general cancer charities and patient support
organisations.
The Cancer Institute NSW commissioned an opinion
A list of all 2005-2006 media releases is available in
the Appendices of this Report. The full text of these
media releases are available at the Cancer Institute
NSW website www.cancerinstitute.org.au
cancer research ranked first amongst the public as
a cause which is considered the most important
for donations. The poll also found that almost two
thirds of those polled would like to know more
Events
about cancer charities. A large segment (41%) of
Events are a highly visible and effective way to
the polling sample had concerns that money given
raise awareness of key cancer health messages
to a charity may not be used in the way in which the
and programs of the Cancer Institute NSW among
cause is promoted.
stakeholders and the general public. The media
exposure generated by key events aids in the
delivery of targeted messages to the community on
cancer.
The Cancer Institute NSW has sought to engage
the NSW cancer charities in discussions on non
intrusive ways in which the Cancer Institute NSW
can facilitate and assist them in strengthening their
Events also work to ensure the Cancer Institute
positions in the public fund-raising market. A Cancer
NSW’s public messages continue to gain
Charities Fundraising Round Table was held on
momentum and credibility. A total of 18 events were
10 May 2006 as part of this process. Possible
held over the last financial year. Highlights included
initiatives under discussion include a voluntary
the successful launch of the inaugural Premier’s
cancer charities register which will be publicly
Awards for Excellence in Cancer Research, 2006
accessible and a statement of principles or code
and the launch of the Melanoma Print campaign on
of conduct to underpin the voluntary register.
Sydney’s Bondi Beach.
A list of all 2005-2006 events is available in the
Appendices of this Report.
Sponsorships
An important component of the Cancer Institute
NSW’s communication of health messages and
education strategies focuses on identifying and
supporting external events and activities that
influence behaviours and lead to better health
outcomes. The Cancer Institute NSW Sponsorship
48
poll of over 4,000 people in May 2006 which found
Cancer Institute NSW: Annual Report 2005–2006
Corporate Development
Finance and Administration
During 2005-2006, the Cancer Institute NSW further
developed a lean corporate structure to enable the
Highlights
Cancer Institute NSW to deliver its obligations under
the Act.
•
Screening Programs effectively transferred to the
Cancer Institute NSW in July 2005, and related
The Internal Audit Bureau (IAB) continued its role
finance and administrative functions transferred
as the Cancer Institute NSW’s internal auditor. IAB
during the year.
wrote policies on all aspects of the Cancer Institute
•
NSW’s operations and conducted a detailed
risk management audit and workplan which was
financial year 2004-2005 with an unqualified
overseen by the Audit Committee.
A Board Strategic Retreat set the Cancer Institute
First set of audited financial statements
produced for the Cancer Institute NSW for the
audit report.
•
Financial and Administrative policies developed
NSW’s overall strategic direction and the broad
during the year, of which some have been
parameters for the second State Cancer Plan. This
finalised and others in draft format currently
process was facilitated by the McKinsey Group who
undergoing review and will be released
provided services pro-bono for which the Cancer
subsequently.
Institute NSW expresses its gratitude.
•
Effective budget tracking systems implemented
These strategic directions were further developed
in the financial systems, with regular reports
in detail by Deloittes. In consultation with the
being provided for Cancer Institute NSW
Executive team, Deloittes developed a strategic plan
Executive, and the Audit Committee.
for the Cancer Institute NSW linked to Divisional
Operational Plans for the work for 2006-2007. These
plans have been linked to an ongoing performance
management framework being developed by the
Human Resources Department.
The transfer of the screening programs from
Cumberland Hospital required additional fit-out
of accommodation and information technology
services at the Australian Technology Park,
Eveleigh. During 2005-2006 accommodation was
also established for the Centre for Health Records
Linkage and additional analytical capacity in the
Division of Cancer Information and Registries.
The Finance and Administration Department at the
Cancer Institute NSW provides support and services
in relation to developing and monitoring budgets,
meeting statutory financial reporting obligations
and ensuring compliance with relevant policies and
directives.
The key Finance and Administration activities
at the Cancer Institute NSW include payables,
receivables, managements and financial reporting,
and coordinating the preparation of tax obligations
for the organisation. The Central Corporate Services
Unit (CCSU) provides the Cancer Institute NSW with
third party financial services support.
Cancer Institute NSW: Annual Report 2005–2006
49
The majority of staff at the Cancer Institute NSW
respond to the Health Employees Condition of
Employment (State) Award. Industrial relations and
Human Resource policies and practices within the
Cancer Institute NSW accord with Government
policies and those of the NSW Health. In March
2006, the Government Service of New South Wales
was established. Employees are now employed
in The Cancer Institute NSW Division of the NSW
Government Service under Chapter 1A of the Public
Sector Employment and Management Act 2002.
During the reporting period:
•
average sick leave taken was 4.1 days per
employee
•
two claims were lodged for workers
compensation, several days were recorded as
being lost for one of the claims
Human Resources
•
Highlights
•
BreastScreen NSW and the Cervical Screen
and several Award changes were implemented
•
•
disruption to service provision.
•
The Cancer Screening organisational structure
as at 30 June 2006 the value of untaken
recreation leave was $842,000
Program were effectively transferred to the
Cancer Institute NSW in July 2005 without any
in July 2005, staff received a 4% salary increase
as at 30 June 2006 the value of untaken long
service leave was $773,000
•
was established and key positions were
there were no industrial disputes involving the
Cancer Institute NSW during the year
appointed, including the Director of Cancer
Screen, BreastScreen NSW Clinical Operations
Manager and Program Manager Bowel Screen.
•
staff turnover at the Cancer Institute NSW was
15.5% - below accepted benchmarks for start up
organisations.
•
BreastScreen NSW and the NSW Cervical
Screen Program were reorganised and integrated
into the new Cancer Screen Organisation to
facilitate enhanced performance and greater
efficiency.
•
Greater human resource depth and capability
has been achieved in the key Divisions of Cancer
Prevention, Cancer Services and Education,
Cancer Research, Cancer Information and
Registries and Cancer Communication.
•
A tailored performance development process
has been developed to underpin performance
excellence, staff development and retention.
•
Individual ergonomic workplace assessments
and training have been offered to all staff
resulting in improved safety and productivity.
50
Cancer Institute NSW: Annual Report 2005–2006
Information Technology
Highlights
•
The successful relocation of staff and technology
from BreastScreen NSW, Cervical Screen
Program and the Hereditary Cancer Registry.
These projects were completed on time with no
impact to the business.
•
The information system used by the NSW Pap
Test Register was successfully revised in order to
support the 2006 NHMRC Screening Guidelines.
This represented a major, evidence-based
revision of the ways in which cervical screening
is carried out in Australia. It required each State
and Territory’s Pap Test Register to implement
the first national standard for coding Pap test
results, and also required a complete revision of
the ways in which women with different types
of cervical abnormality are followed up by those
Registers. In NSW, this significant project was
successfully completed on time and with minimal
disruption to normal operations.
•
Significant changes and upgrades to the
Cancer Institute NSW’s Information Technology
architecture and infrastructure including a
total redesign and implementation of our
Standard Operating Environment and further
enhancements to our information security
systems.
Cancer Institute NSW: Annual Report 2005–2006
51
The Way Forward
Future Plans 2006-2007
and Beyond
The process for developing the NSW Cancer Plan
2007-2010 will allow wide consultation and invite
substantial input. A Discussion Paper entitled NSW
Cancer Plan 2007-2010 Accelerating the Control of
The major work of the Cancer Institute NSW in
Cancer has been published by the Cancer Institute
2005-2006 was to implement and report on the first
NSW and widely distributed.
State Cancer Plan. This was achieved with the report
NSW Cancer Plan 2004-2006: Lessening the Impact
A number of workshops will provide feedback on the
of Cancer: A Two Year Progress Report.
first State Cancer Plan and on the above Discussion
Paper. This feedback will provide the content of the
For 2006-2007, the Cancer Institute NSW will further
next NSW Cancer Plan.
consolidate and continue to evaluate programs
initiated over the last two years. In addition, the
Since many of the successful programs established
Cancer Institute NSW has embarked on a major
will be enhanced in the next planning cycle, the
consultation process to formulate the second State
Discussion Paper has grouped programs into a
Cancer Plan.
number of obvious categories for discussion and
listed them below in Summary of Programs. Ways to
The NSW Cancer Plan 2007-2010 will rely heavily on
specifically address rural issues will be incorporated
the many reviews and the feedback received over
into all major cancer services programs.
the last two years on all aspects of cancer control
in NSW. These reviews and feedback give clear
direction and identify the needs and the relevance of
cancer programs.
52
Cancer Institute NSW: Annual Report 2005–2006
For 2006-2007, the Cancer Institute NSW will further
consolidate and continue to evaluate programs initiated
over the last two years.
NSW Cancer Plan 2007-2010:
Summary of Programs
Cancer Prevention
•
Tobacco control program
•
Melanoma and skin cancer program
•
Cancer screening awareness programs
•
Lifestyle cancer avoidance programs
Cancer Screening
Cancer Information
•
NSW Cancer Registry program
•
Cancer screening data
•
Centre for Health Record Linkage
•
Accessible cancer information program
The NSW Cancer Plan 2007-2010 will also
emphasise the importance of constructive
•
Breast cancer screening program
•
Cervical cancer screening program
In particular enhanced working relationships will
•
Bowel cancer screening program
be sought between the Cancer Institute NSW and
•
Screening other cancers
NSW Health, Area Health Services, cancer charities
partnerships between key stakeholders in cancer.
and consumer groups, research organisations,
Cancer Services and Education
universities and public groups.
•
Better coordination of care program
•
Smarter models of care program
developed evaluation framework embedded in
•
Skilled cancer professionals program
each of its major programs. This will enable
•
Comprehensive patient support program
ongoing monitoring and measurement of
The second state Cancer Plan will have a well
outcomes.
Cancer Research
A series of workshops will occur in August and
•
Translational research program
•
Clinical trials program
•
Research careers program
key stakeholders will have input into the new
•
Cancer research infrastructure program
Cancer Plan. This plan will be published before
September 2006 to discuss all aspects of cancer
control in NSW. It is anticipated that around 500
the end of 2006.
Cancer Institute NSW: Annual Report 2005–2006
53
Financial Statements
Cancer Institute NSW - Financial Report
for the Year Ended 30 June 2006
54
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
55
56
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
57
58
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
59
60
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
61
62
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
63
64
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
65
66
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
67
68
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
69
70
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
71
72
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
73
74
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
75
76
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
77
78
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
79
Financial Statements
Cancer Institute Division - Financial Report
for the period 17 March 2006 to 30 June 2006
80
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
81
82
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
83
84
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
85
86
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
87
88
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
89
90
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
91
92
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
93
94
Cancer Institute NSW: Annual Report 2005–2006
Cancer Institute NSW: Annual Report 2005–2006
95
Appendices
96
Cancer Institute NSW: Annual Report 2005–2006
Accounts Payable Performance Report
Aged Analysis at the End of Each Quarter
Quarter
Current
(i.e. within
due date)
$
Less than
30 days overdue
$
Between 30 days
and 60 days
overdue
$
Between 60 days
and 90 days
overdue
$
More than
90 days overdue
$
September Quarter
149,008
0
0
0
0
December
Quarter
316,822
0
0
0
0
March
Quarter
2,994,022
0
0
0
0
June
Quarter
3,394,902
0
0
0
0
Accounts Paid on Time Within Each Quarter
Quarter
Total
Amount Paid ($)
Total Accounts Paid on Time
Target
Actual
$
September Quarter
88%
93%
10,974,565
11,480,530
December
Quarter
88%
97%
14,862,207
15,012,423
March
Quarter
88%
92%
14,438,303
15,945,227
June
Quarter
88%
96%
23,221,914
24,151,526
During 2005-2006 there were no instances where
penalty interest was paid in accordance with
section 18 of the Public Finance and Audit (General)
Regulation 1995.
There were no significant events that affected payment
performance during the reporting period.
To improve future performance greater emphasis
will be placed on enhancing electronic processing of
accounts together with increased use of Purchase
Orders for recurring purchases.
Cancer Institute NSW: Annual Report 2005–2006
97
Agreements and Joint Programs
Agreements and
Memorandums of
Understanding
•
Memorandum of Understanding between Cancer
Institute NSW, NSW Health and The Cancer
Council NSW for the review of the NSW Skin
Cancer Prevention Strategic Plan 2001-2005
and the development of the NSW Skin Cancer
Prevention Strategic Plan 2006-2010.
•
The BreastScreen NSW program is delivered
Joint Programs
The Cancer Institute NSW has entered into an
agreement with the Sydney Melanoma Unit to
identify all new melanoma notifications relating
to NSW residents over a one year index period.
Information will the be gathered and analysed about
the nature, utilisation and access to, diagnostic and
pathology services, the quality of pathology services,
the adherence to guidelines or best practice
recommendations for treatment and psychosocial
services, family history and referral patterns
through Performance and Funding Agreements
between Cancer Institute NSW and Area Health
A partnership with the Cancer Epidemiology
Services.
Research Unit at The Cancer Council NSW has been
established to analyse data collected for patterns of
•
A Memorandum of Understanding between
Cancer Institute NSW and Sydney West
care studies on the management and treatment of
colorectal, lung and prostate cancers.
Area Health Service for the operation of the
•
BreastScreen NSW Central Screen Reading
Statewide Cancer Networking and
Facility (CRF) is under consideration following
Mentorship Project
the relocation of the CRF to Jeffrey House in
In accordance with the NSW Cancer Plan 2004-2006
Parramatta.
(Program 1.1) implementation of the NSW Oncology
The Cancer Institute NSW has entered into a
Memorandum of Understanding with The Sax
Institute to develop a Costing and Economic
Evaluation Unit (CEEU).
•
•
doctors and nurses, consumers, patients and
planners.
Five year partnership agreement between The
Funding of $250 000 has been received from the
Commonwealth Department of Health and Ageing
NSW.
to support rural participation in NSWOG through
Memorandum of Understanding between NSW
a Statewide Cancer Networking and Mentorship
Project.
partners for the establishment of a Centre for
Project Objectives:
Health Record Linkage.
•
Twenty statewide expert groups will meet four
Memorandum of understanding with NSW Health
times per annum with meetings organised and
for the operations of the Pap Test Register and
facilitated by the Cancer Institute NSW
the NSW Central Cancer Registry.
•
bring together approximately 500 cancer specialist
Cancer Council NSW and the Cancer Institute
Health, the Cancer Institute NSW and other
•
Groups (NSWOG) commenced in August 2005 to
•
Rural members from each group will be
Memorandum of understanding with ACT Health
encouraged and funded to attend meetings in
for the management of ACT cancer registrations.
person or by teleconference or videoconference
•
NSWOG committees will work on major issues in
each type of cancer.
•
Provide a grant to each committee to move
forward high priority projects for NSW.
98
Cancer Institute NSW: Annual Report 2005–2006
Key Outcomes:
Cancer Clinical Trials
•
Increased representation of rural and remote
The Cancer Institute NSW has entered into a
cancer services staff at the NSW Oncology
collaborative partnership with the NHMRC Clinical
Group meetings
Trials Centre. This partnership has been established
•
Production of rural specific referral pathways and
treatment protocols incorporating the views and
experience or rural/remote practitioners
•
Increased skills and knowledge through the
to provide operational and statistical services for
cancer clinical trials that gain support through the
NSW Cancer Trials Group (NSWCTG). A total of
$643,765 was spent on this partnership in
2005-2006.
education and professional development
opportunities
The Cancer Institute NSW has also entered a
partnership with Kendle Australia to assist in the
NSW Specialist Palliative Care
development and implementation of Standard
Services Inventory
Operating Procedures, and undertake audits of
This project is a joint initiative between the Cancer
clinical trial units. This partnership will ensure clinical
Institute NSW and NSW Health. Its aim is to gain an
trial activity undertaken in NSW meets the highest
understanding of specialist palliative care service
international standards.
across the State. The findings of the review will
inform subsequent projects in palliative care.
Streamlined Ethical Review
The Cancer Institute NSW entered into an
Health Services Research Partnerships
arrangement with the NSW Department of Health
These services, together with existing services, need
to jointly support the Population and Health
to be evaluated in terms of their impact, cost and
Services Ethics Committee, with executive and
acceptability to ensure appropriate and adequate
secretariat services to be managed from the
information is available on which to base critical
Cancer Institute NSW.
decisions about optimal cancer services in the
future.
Payment of funds under Research Programs is
made to the relevant Administering Institution. All
Three partnerships have been established with:
•
The Sax Institute and NSW Health – $300,000
Administering Institutions enter into a standard Deed
of Agreement with the Cancer Institute NSW.
over 18 months to develop a Costing and
Economic Evaluation Unit (CEEU).
•
The University of Sydney - $100,000 over
12 months to implement strategies to improve
doctor-patient communication and increase
patient involvement in decision making.
•
Sydney South West Area Health Service
Collaboration for Cancer Outcomes Research
and Evaluation (CCORE) - $225,000 over
15 months to estimate the proportion of
new cases of cancer that should receive
chemotherapy, thus providing an evidencebased target for chemotherapy services.
Cancer Institute NSW: Annual Report 2005–2006
99
Committees, Working Parties and
Community Consultation
All committees of the Cancer Institute NSW are multidisciplinary and have a high level of consumer involvement.
Minutes of all committees are available for Cancer Institute NSW Board meetings. All Committees have a Code
of Conduct and Conflict of Interest Policy.
Audit Committee
Member
Position
Institution / Location
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Dr Patrick Cregan (Chair)
Clinical Director Surgery /
Board Member
Greater Western Area Health Service /
Cancer Institute NSW
Mr David Jones
Director Financial Audit Service
The Audit Office of NSW
Ms Beth Macauley
Chief Operating Officer
Cancer Institute NSW
Dr Paul Moy
Managing Director / Board Member
UBS Global Asset Management / Cancer
Institute NSW
Mr Phil O’Toole
Director Risk Management Services
Internal Audit Bureau
Prof Sally Redman
Chief Executive Officer /
Board Member
The Sax Institute / Cancer
Institute NSW
Mr David Sabanayagam
Finance and Administration Manager
Cancer Institute NSW
Bowel Cancer Screening Implementation Advisory Committee
100
Member
Position
Institution / Location
Prof Jim Bishop
Chief Cancer Officer and
Chief Executive Officer
Cancer Institute NSW
Dr Michael Bourke
Director of Gastrointestinal Endoscopy
Westmead Hospital
Ms Tara Bowman
Project Officer Bowel Screen NSW
Cancer Institute NSW
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Dr John Crimmins
General Practitioner Representative
Alliance of NSW Divisions
Ms Mary Crum
Senior Analyst
NSW Health
Ms Maeve Eikli
Network Manager
Greater Metropolitan Clinical Taskforce
Dr Katie Ellard
Chairperson
Gastroenterological Society of Australia
Dr Tony Eyers
Colorectal Surgeon
Royal Prince Alfred Hospital
Prof Kerry Goulston
Chairperson
Greater Metropolitan Clinical Taskforce
Ms Michelle Hughes
Program Manager Bowel Screen NSW
Cancer Institute NSW
Dr Paul Jelfs
Director Cancer Information and
Registries
Cancer Institute NSW
Dr Andrew Keegan
Gastroenterologist
Nepean Hospital
A/Prof James Kench
Senior Staff Specialist
Institute of Clinical Pathology and
Medical Research
A/Prof Judy Kirk
Director Familial Cancer Services
Westmead Hospital
A/Prof Anne Kricker
Epidemiologist
University of Sydney
Mr John Newsom
Consumer Representative
n/a
Dr Ian Norton
Gastroenterologist
Concord Repatriation
General Hospital
Dr Les Rae
Consumer Representative
Rotary
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Ms Lynn Rapley
Director of Education
Gastroenterological Nurses College of
Australia
A/Prof Glenn Salkeld
Health Economist
University of Sydney
A/Prof Michael Solomon
Surgeon
Royal Prince Alfred Hospital
A/Prof James St John (Chair)
Senior Clinical Consultant
National Cancer Control Initiative
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
BreastScreen NSW Service Management Advisory Committee
Member
Position
Institution / Location
Mr Maurice Ahern
A/Director
BreastScreen South West
Ms Judy Bursle
A/Director
BreastScreen Greater
Western Sydney
Mr Mark Costello (Chair)
Operations Manager
BreastScreen NSW
Cancer Institute NSW
Dr Robyn Godding
Director Screening and Assessment
Services
BreastScreen Northern Sydney
and Lower Central Coast
Ms Fran Hartman
Senior Project Officer
Cancer Institute NSW
Ms Connie Ho
Senior Data Manager
Cancer Institute NSW
Mr Paul Hopkins
Director Screening and Assessment
Services
BreastScreen North West
Mr John McCleery
Director Screening and Assessment
Services
BreastScreen Central and Western
Ms Maureen McGovern
Area Manager Cancer and Palliative Care
and BreastScreen Services
North Coast Cancer Institute / North
Coast Area Health Service
Mr Scott Maunder
Manager Statewide Corporate Services
Cancer Institute NSW
Mr Warwick May
Accreditation Coordinator BreastScreen
NSW
Cancer Institute NSW
Ms Jill Miller
State Radiographer
Cancer Institute NSW
Ms Jodie Partridge
Director Screening and Assessment
Services
BreastScreen Central and
Eastern Sydney
Ms Helen Sutherland
Director Screening and Assessment
Services
BreastScreen ACT and
South Eastern NSW
Mr Michael Symonds
Director Screening and Assessment
Services
BreastScreen Hunter Region
and Wyong Shire
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Jane Vallentine
Director Screening and Assessment
Services
BreastScreen Southern
Sydney and Illawarra
Cancer Institute NSW: Annual Report 2005–2006
101
BreastScreen NSW Data Management Meetings
Member
Position
Institution / Location
Mr Ken Bruderlin
Data Manager
BreastScreen Northern Sydney
and Lower Central Coast
Mr Philip Crawford
Data Manager
BreastScreen ACT and South Eastern
NSW
Ms Bec Delaporte
Data Manager
BreastScreen Greater
Western Sydney
Mr Arturo Diaz-Ugarte
Acting Data Manager
BreastScreen Hunter Region
and Wyong Shire
Ms Jane Estoesta (Chair)
State Data and Evaluation Manager
Cancer Institute NSW
Mr Mohammed Fazli
Data Manager
BreastScreen Central and
Eastern Sydney
Ms Connie Ho
Senior Data Manager State Data and
Evaluation Team
Cancer Institute NSW
Ms Kim Kena
Acting Data Manager
BreastScreen North Coast
Mr Kojo Odoom
Data Manager State Data and
Evaluation Team
Cancer Institute NSW
Ms Jill Sternfeld
Business / Data Manager
BreastScreen Southern Sydney
and Illawarra
Mr Graham Thompson
Data Manager
BreastScreen North West
Mr Andrew Vogt
Business / Data Manager
BreastScreen South West
Mr Barry Waser
Data Manager
BreastScreen Central and Western
BreastScreen NSW State Accreditation and
Quality Improvement Committee
102
Member
Position
Institution / Location
A/Prof Michael Bilous
Pathologist
Royal College of Pathologists of Australia
(RCPA) / Institute of Clinical Pathology and
Medical Research
Mr Mark Costello
Operations Manager
BreastScreen NSW
Cancer Institute NSW
Ms Betty Johnson
Consumer Representative
Australian Pensioners and Superannuates
Federation
Mr Warwick May
Accreditation Coordinator
BreastScreen NSW
Cancer Institute NSW
Dr Dominic Moon
Surgical Oncologist
Royal Australasian College of Surgeons
(RACS) / NSW Breast Cancer Institute
Westmead Hospital
Dr Ann Poulos
Senior Lecturer
Australian Institute of Radiography (AIR)
/ Faculty of Health Sciences Cumberland
Campus
Ms Dianne Priestly
Counsellor
BreastScreen Central and Western NSW
Dr Andrew Scott
Radiologist
Royal Australian and New Zealand College
of Radiologists (RANZCR) / Wagga
Medical Imaging / BreastScreen South
West NSW
Dr Denis Smith (Chair)
Quality Consultant
n/a
Dr Jane Vallentine
Director Screening and
Assessment Services
BreastScreen Southern Sydney and
Illawarra
Cancer Institute NSW: Annual Report 2005–2006
BreastScreen NSW Capital Advisory Committee
Member
Position
Institution / Location
Mr John Bedford
Southern Director
NSW Health
Ms Lee Collins
Medical Physicist
BreastScreen NSW
Mr Mark Costello (Chair)
Operations Manager
BreastScreen NSW
Cancer Institute NSW
Ms Mary Crum
Senior Analyst
NSW Health
Mr Ravinder Grewal
Medical Physicist
BreastScreen NSW
Ms Jacqui Grossmith
Manager Infrastructure and Business
Services
South Eastern Sydney Illawarra Area
Health Service
Ms Nevine Iskander
Acting Business Manager
BreastScreen NSW
Mr Scott Maunder
Manager Statewide
Corporate Services
Cancer Institute NSW
Mr Bill Rock
Probity Adviser
Internal Audit Bureau
Mr David Sabanayagam
Finance and Administration Manager
Cancer Institute NSW
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
BreastScreen NSW Designated Radiologist Group Meeting
Member
Position
Institution / Location
Dr Stephen Cahill
Radiologist
BreastScreen NSW Greater Western
Sydney
Mr Mark Costello (Chair)
Operations Manager
BreastScreen NSW
Cancer Institute NSW
Dr Nita Durham
Radiologist
BreastScreen NSW Central and Eastern
Sydney
Dr Georges Hazan
Radiologist
BreastScreen ACT and South Eastern
NSW
Dr Jim Lai
Radiologist
BreastScreen NSW Hunter and Wyong /
BreastScreen NSW North West
Dr Marjorie Kossoff
Designated Radiologist
BreastScreen NSW Northern Sydney and
Lower Central Coast
Dr Amanda Palmer
Radiologist
BreastScreen NSW Southern Sydney
and Illawarra
Dr Andrew Scott
Radiologist
BreastScreen NSW South West
Dr Jo Sommerfeld
Radiologist
BreastScreen NSW North Coast
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
103
Cancer Information and Registries Advisory Committee
Member
Position
Institution / Location
Prof Stephen Ackland
Director Medical Oncology
Newcastle Mater Misericordiae Hospital
Prof Bruce Armstrong
Head School of Public Health
University of Sydney
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Prof Richard Chye
Director Palliative Care
Sacred Heart Palliative Care St Vincent’s
Hospital
Ms Nari Clarke
Project Officer Clinical Cancer Registry
Cancer Institute NSW
Mr Michael Coley
Consumer Representative
n/a
A/Prof Geoff Delany
Director Radiation Oncology
Western ZoneSydney South West Area
Health Service
Dr Tony Eyers
Colorectal Surgeon
Royal Prince Alfred Hospital
Mr Stuart Greenham
Manager
North Coast Cancer Institute
Mr John Haswell
Chief Information Officer
Sydney West Area Health Service
Ms Sally Hodgkinson
Consumer Representative
Cancer Voices NSW
Dr Paul Jelfs
Director Cancer Information and
Registries
Cancer Institute NSW
Dr Louisa Jorm
Director Epidemiology and Research
NSW Health
Ms Christine Packer
Cancer Services Development Manager
Greater Southern Area Health Service
Prof David Roder
Group Executive Research Development
and Statistics
The Cancer Council South Australia
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Ms Elizabeth Tracey
Strategic Manager NSW Central Cancer
Registry
Cancer Institute NSW
A/Prof Owen Ung (Chair)
Director Clinical Services
NSW Breast Cancer Institute
Cancer Research Advisory Committee
104
Member
Position
Institution / Location
Prof Stephen Ackland
Director Medical Oncology
Newcastle Mater Misericordiae Hospital
A/Prof Michael Barton
Research Director Collaboration for
Cancer Outcomes Research and
Evaluation (CCORE)
Liverpool Hospital
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Ms Mercia Bush
Community Representative
n/a
A/Prof Christine Clarke
Research Group Leader
Westmead Institute for
Cancer Research
Prof Enrico Coiera
Foundation Chair in Medical Informatics
University of New South Wales
Prof Roger Daly
Head Signal Transduction
Group
Garvan Institute of Medical Research
Ms Carmel Edwards
Director Cancer Research
Cancer Institute NSW
Prof Afaf Girgis
Director Centre for Health Research and
Psycho-Oncology
University of Newcastle
Prof Maree Gleeson
Director Medical Research
Office for Science and
Medical Research
Ms Cheryl Grant
Community Representative
Cancer Voices NSW
Prof Peter Gunning (Chair)
Chair Division of Research and Head
Oncology Research Unit
The Children’s Hospital at Westmead
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Dr Anne Hamilton
Staff Specialist
Sydney Cancer Centre Royal Prince
Alfred Hospital
Prof Philip Hogg
NHMRC Senior Principal
Research Fellow
University of New South Wales
Ms Judith Hudson
Research Grants and
Infrastructure Manager
Cancer Institute NSW
Prof Douglas Joshua
Director
The Institute of Haematology Royal
Prince Alfred Hospital
Dr Deborah Marsh
Cancer Institute NSW Fellow / Principal
Research Fellow
University of Sydney
A/Prof Murray Norris
Executive Director
Children’s Cancer Institute Australia
Prof John Rasko
Head Gene Therapy Unit
Centenary Institute
Prof Rodney Scott
Head Discipline of Medical Genetics
John Hunter Hospital
Prof Robyn Ward
Medical Oncologist
St Vincent’s Hospital
Cancer Screen Advisory Committee
Member
Position
Institution / Location
A/Prof Michael Bilous
Director Department of Tissue Pathology
Institute of Clinical Pathology
and Medical Research
Prof John Boyages
Director
NSW Breast Cancer Institute
Dr Kerry Chant
Director Health Protection / Deputy Chief
Health Officer
NSW Health
Ms Mary Crum
Project Officer Population Health
NSW Health
Prof David Gillett
Breast Surgeon
The Strathfield Breast Centre
Ms Roberta Higginson
Consumer Representative
Breast Cancer Action Group NSW
Dr Elizabeth Hindmarsh
General Practitioner
Alliance of NSW Divisions (Metropolitan)
Dr Anne Kricker
ResearcherSchool of Public Health
University of Sydney
Mr Scott Maunder
Manager Statewide Corporate Services
Cancer Institute NSW
Ms Jennifer Muller
Director Women’s Cancer Screening
Services
Queensland Health
Mr John Newsom
Consumer Representative
n/a
Mr Jonathon Osborne
State Radiologist
BreastScreen Queensland
Dr Carole Pinnock
Principal Research Scientist Urology Unit
Repatriation General Hospital (South
Australia)
Dr Ann Poulos
Senior LecturerSchool of Medical
Radiation Sciences
Faculty of Health Sciences Cumberland
Campus
Ms Julianne Quaine
Director Screening Section
Department of Health and
Ageing
Prof David Roder (Chair)
Group Executive Research Development
and Statistics
The Cancer Council
South Australia
Dr Marion Saville
Director
Victorian Cytology Service
Prof Jim St John
Senior Clinical Consultant
National Cancer Control
Initiative
Ms Onella Stagoll
Chief Executive Officer
BreastScreen Victoria
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Gerry Wain
Scientific Director Cervical Screening
NSW
Cancer Institute NSW
Dr Todd Walker
School of Biomedical Sciences
Charles Sturt University
Dr Helen Zorbas
Director
National Breast
Cancer Centre
Cancer Institute NSW: Annual Report 2005–2006
105
Clinical Cancer Registry Project Steering Committee
106
Member
Position
Institution / Location
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
A/Prof Geoff Delaney (Chair)
Director Radiation Oncology
Western Zone
Sydney South West
Area Health Service
Ms Cathy Doran
Project Manager
South Eastern Sydney Illawarra Area
Health Service
Mr Neil Heron
Project Manager
Northern Sydney Central Coast Area
Health Service
Dr Tony Jones
Director of Pathology
North Coast Area Health Service
Mr John Marshall
Project Manager
North Coast Area Health Service
Ms Jeanne Mitchell
Project Officer
Hunter New England
Area Health Service
Ms Deb Oong
A/DirectorClient Partnerships
NSW Health
Dr Val Poxon
Project Manager
Sydney South West
Area Health Service
Prof David Roder
Group Executive Research Development
and Statistics
The Cancer Council
South Australia
Dr Tony Sara
Director Clinical Information Systems
South Eastern Sydney Illawarra Area
Health Service
Ms Michelle Stern
Senior IT Consultant
Quality Assurance
IAB Services
Dr Paul Sved
Urologist
Sydney West Area Health Service
Dr Campbell Tiley
Staff Specialist in Haematology
Northern Sydney Central Coast Area
Health Service
Ms Elizabeth Tracey
Strategic Manager NSW Central Cancer
Registry
Cancer Institute NSW
Mr George Truman
Project Manager
Sydney West Area Health Service
Cancer Institute NSW: Annual Report 2005–2006
Clinical Services Advisory Committee
Member
Position
Institution / Location
Dr Fiona Abell
A/Director Area Cancer Services
Hunter New England
Area Health Service
Dr Christopher Arthur
Director Area Cancer Services
Northern Sydney Central Coast Area
Health Service
Prof Bruce Barraclough
Chairman
Australian Council for Safety and Quality
in Health Care
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Ms Philippa Cahill
Manager Clinical Workforce
Cancer Institute NSW
Prof Phillip Clingan
Lead Clinician
Wollongong Hospital
Ms Kerry Cooke
Community Representative
Cancer Voices NSW
Ms Sally Crossing
Chair
Cancer Voices NSW
Ms Mary Foley
Executive Officer
St Vincent’s and Mater Health Sydney
A/Prof Paul Harnett (Chair)
Director Area Cancer Services
Sydney West Area Health Service
A/Prof Robin Stuart Harris
Director Capital Region Cancer Service
Medical Oncology Unit
The Canberra Hospital
Prof John Kearsley
Director Area Cancer Services
South Eastern Sydney Illawarra Area
Health Service
Prof Michael Kidd
Head Department of
General Practice
University of Sydney
Ms Tish Lancaster
Clinical Nurse Consultant
Westmead Hospital
A/Prof Glen Marshall
Director Centre for Children’s Cancer
and Blood Disorders
Sydney Children’s Hospital
Ms Kathy Meleady
Director Statewide Services
Development Branch
NSW Health
Prof Christopher O’Brien (Deputy
Chair)
Director Sydney Cancer Centre and
Director Area Cancer Services
Sydney South West
Area Health Service
Dr Denise Robinson
Chief Health Officer and Deputy DirectorGeneral
NSW Health
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Prof Allan Spigelman
Director Cancer Services
St Vincent’s and Mater Health Sydney
Prof Bernard Stewart
Head of Cancer Control Program
South Eastern Sydney Illawarra Area
Health Service
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
107
Designated Radiographers Meeting
Member
Position
Institution / Location
Ms Rhonda Brown
Chief Medical Radiation Scientist
BreastScreen NSW Hunter Region and
Wyong Shire
Ms Anna Cossetto
Radiographer
BreastScreen NSW Greater Western
Sydney
Ms Sue Cross
Radiographer
BreastScreen NSW North Coast
Ms Pam Gins
Chief Radiographer
BreastScreen NSW Central and Eastern
Sydney
Ms Trish Green
A/Chief Radiographer
BreastScreen NSW Southern Sydney
and Illawarra
Ms Roxanne Mason
Radiographer
BreastScreen NSW Central
and Western
Ms Jill Miller (Chair)
State Radiographer
BreastScreen NSW
Coordination Unit
Ms Janine O’Neil
Radiographer
BreastScreen NSW North West
Ms Jennie Polkinghorne
Designated Radiographer
BreastScreen NSW South West
Ms Beverlee MacDonald Scott
Chief Radiographer
BreastScreen NSW Northern Sydney and
Lower Central Coast
Ms Sue Richardson
Senior Radiographer
BreastScreen ACT and South Eastern
NSW
Education and Workforce Advisory Committee
108
Member
Position
Institution / Location
Dr Fiona Abell
Senior Staff Specialist Medical Oncology
Newcastle Mater
Misericordiae Hospital
A/Prof Michael Barton (Deputy Chair)
Research Director Collaboration for
Cancer Outcomes Research and
Evaluation (CCORE)
Liverpool Hospital
Prof Martin Berry
Director Cancer Services
Sydney South West
Area Health Service
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Ms Philippa Cahill
Manager Clinical Workforce
Cancer Institute NSW
Mr Keith Cox
Clinical Nurse Practitioner Chemotherapy
Royal Prince Alfred Hospital
Prof Philip Crowe
Surgeon
University of New South Wales / Prince
of Wales Hospital
Ms Annette Dahler
Clinical Nurse Coordinator Oncology
Greater Southern
Area Health Service
Dr Joanne Doran
Palliative Care Physician
St Vincent’s Hospital Lismore
Prof Don Iverson
Dean of Health and Behavioural Sciences
University of Wollongong
Ms Ruth Jones
Cancer Service Development Manager
Greater Western
Area Health Service
Ms Elisabeth Kochman
Community Representative
Cancer Voices NSW
Dr Katrina Moore
Breast Surgeon
Royal North Shore Hospital
Dr Sue Shanley
Familial Cancer Service
Royal North Shore Hospital
Ms Fiona Shipman
Manager Cancer Education
and Training
Cancer Institute NSW
Prof Bernard Stewart (Chair)
Head of Cancer Control Program
South Eastern Sydney Illawarra Area
Health Service
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Dr Kendra Sundquist
Manager Supportive Care Development
Unit
The Cancer Council NSW
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Prof Kate White
Director Research
Faculty of Nursing and Midwifery
University of Sydney
Dr Nicholas Wilcken
Staff Specialist
Medical Oncology Westmead Hospital
Dr Jennifer Wiltshire
Director of Palliative Care
Sydney South West Area Health Service
Position
Institution / Location
Ethics Committee
Member
Mr Rodney Ecclestone
Ethics Manager
Cancer Institute NSW
Prof Paul Glare
Staff Specialist Palliative Care
Royal Prince Alfred Hospital
Mrs Lois Grassi
Community Representative
n/a
Ms Rhonda Gray
Community Representative
n/a
Ms Julie Hamblin
Lawyer
Ebsworth and Ebsworth
Lawyers
Dr Lisa Horvath
Medical Oncologist / Researcher
Royal Prince Alfred Hospital
Dr Paul Jelfs
Director Cancer Information and
Registries
Cancer Institute NSW
Ms Rada Kusic
Clinical Trials Manager
Westmead Hospital
Prof Stephen Leeder (Chair)
Director Australian Health Policy Institute
University of Sydney
Ms Kirsten Legione
Project Officer Ethics
Cancer Institute NSW
Dr Winston Liauw (Deputy Chair)
Medical Oncologist / Clinical
Pharmacologist / Researcher
St George Cancer Care Centre
Ms Soraya Mir
Lawyer
Ebsworth and Ebsworth
Lawyers
Mr Norman Neill
Community Representative
n/a
Cancer Institute NSW: Annual Report 2005–2006
109
Grants Review Committee
Member
Position
Institution / Location
Ms Carmel Edwards
Director Cancer Research
Cancer Institute NSW
A/Prof Lin Fritschi
Head of Laboratory for Cancer Medicine
Western Australian Institute for Medical
Research
Prof John Funder (Chair)
Professor of Medicine /
Senior Fellow
Monash University / Prince Henry’s
Institute of Medical Research
Prof John Hopper
Director
Centre for Genetic Epidemiology
University of Melbourne
Ms Judith Hudson
Research Grants and Infrastructure
Manager
Cancer Institute NSW
Prof Michael Millward
The Cancer Council NSW Professor of
Clinical Cancer Research
Sir Charles Gairdner Hospital
Dr Richard Pestell
Director Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia
A/Prof Andrew Scott
Director Ludwig Institute for Cancer
Research
Melbourne Centre for
Clinical Sciences
Prof Robert Thomas
Director Surgical Oncology
Peter MacCallum Cancer Centre
Mr Garry Way
Project Officer Research
Cancer Institute NSW
Prof Wayne Tilley
Dame Roma Mitchell Chair in Cancer
Research
University of Adelaide
Medical Oncology and Haematology Information Systems
Strategy Working Party
110
Member
Position
Institution / Location
A/Prof Stephen Ackland
Director Medical Oncology
Newcastle Mater Misericordiae Hospital
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Ms Nari Clarke
Project Officer Clinical Cancer Registry
Cancer Institute NSW
Mr Keith Cox
Clinical Nurse Consultant
Sydney Cancer Care Centre
Dr Ilona Cunningham
Haematologist
Concord Repatriation
General Hospital
Dr Stephen Della Fiorentina
Director
Macarthur Cancer
Therapy Centre
Ms Siobhan Finnerty
Project Consultant
Cancer Institute NSW
Mr Stuart Greenham
Chief Radiation Therapist
North Coast Cancer Institute
Dr Howard Gurney
Medical Oncologist
Westmead Hospital
Dr Ralph Hanson (Co-Convenor)
Chief Information Officer
The Children’s Hospital at Westmead
Mr Neil Heron
Project Manager Clinical Cancer Registry
Northern Sydney Central Coast Area
Health Service
Dr Paul Jelfs (Co-Convenor)
Director Cancer Information and
Registries Division
Cancer Institute NSW
Ms Rada Kusic
Clinical Trials Manager
Westmead Hospital
Mr Toby Mathieson
Assistant Director Business Planning
NSW Health
Dr Geoffrey McCowage
Paediatric Oncologist
The Children’s Hospital
at Westmead
Ms Megan Montgomery
Manager Electronic Medical Records
State Based Build
NSW Health
Mr Michael Schmitz
Information Technology Manager
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Dr Campbell Tiley
Haematologist
Gosford Hospital
Dr Craig Underhill
Medical Oncologist
Border Medical Oncology
Ms Linda Watson
Project Manager
Gosford Hospital
Mr Andrew Young
Manager Client Partnerships
NSW Health
National Health Warnings Steering Committee
Member
Position
Institution / Location
Ms Joan Bartlett
Executive Officer
The Cancer Council ACT
Mr James Brohier
Tobacco Enforcement Officer
Northern Territory Government
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Ms Anita Dessaix
Program Manager Cancer Prevention
Cancer Institute NSW
Mr Todd Harper
Executive Director
Quit Victoria
Ms Caroline Miller
Manager
The Cancer Council South Australia
Ms Lyn Roberts (Chair)
Executive Officer
National Heart Foundation (VIC)
Mr Maurice Swanson
Chief Executive
National Heart Foundation (WA)
Ms Helen Taylor
Senior Project Officer
Queensland Health
Prof Melanie Wakefield
Director
Centre for Behavioural Research
in Cancer
Mr Michael Wilson
Executive Director
Quit Tasmania
NHMRC Implementation GP Working Group
Member
Position
Institution / Location
Dr Katherine Brown
General Practitioner
Illawarra Sexual Health Clinic
Dr Michael Edwards
Chief Executive Officer
Nepean Division of General Practice
Dr Elizabeth Hindmarsh
General Practitioner
Alliance of NSW Divisions (Metropolitan)
Dr Jenny May
General Practitioner
Peel Health Care Tamworth
Dr Amanda McBride
General Practitioner
Northern Sydney Central Coast Area
Health Service
Ms Jane McQueen
Manager Clinical Services Cervical
Screening NSW
Cancer Institute NSW
Dr Con Paleologos
General Practitioner
Western Sydney Division of General
Practice
Dr Marion Reeves (Chair)
General Practitioner
Murrumbidgee Division of
General Practice
Dr David Sanders
General Practitioner
Hunter Rural Division of
General Practice
Dr Rebecca South
General Practitioner
Family Planning NSW
Dr Gerry Wain (Chair)
Scientific Director Cervical
Screening NSW
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
111
NSW Cancer Trials Group Executive Committee
Member
Position
Institution / Location
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Ms Angelina Catanzariti
Clinical Trials Manager
Cancer Institute NSW
Ms Carmel Edwards
Director Cancer Research
Cancer Institute NSW
Prof Michael Friedlander
Professor of Medicine
Prince of Wales Hospital
Dr Howard Gurney
Director
Sydney West Cancer Trials Centre
Dr Anne Hamilton (Chair)
Staff Specialist
Sydney Cancer Centre Royal Prince
Alfred Hospital
Ms Rada Kusic
Clinical Trials Manager
Westmead Hospital
Ms Marie Malica
Manager Research Strategy Unit
The Cancer Council NSW
Dr Peter O’Brien
Radiation Oncologist
Newcastle Mater Misericordiae Hospital
Dr Nick Pavlakis
Medical Oncologist
Royal North Shore Hospital
Prof John Simes
Director NHMRC Clinical Trials Centre /
Board Member
University of Sydney /
Cancer Institute NSW
Dr Paul de Souza
Medical Oncologist
St George Hospital
A/Prof Martin Stockler
Medical Oncologist
Sydney Cancer Centre Royal Prince
Alfred Hospital
Prof John Thompson
Director
Sydney Melanoma Unit
NSW Central Cancer Registry Advisory Committee
112
Member
Position
Institution / Location
Prof Bruce Armstrong (Chair)
Head School of Public Health
University of Sydney
Dr Michael Bilous
Director Department of Tissue Pathology
Institute of Clinical Pathology and
Medical Research Westmead Hospital
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Ms Stephanie Callaghan
Assistant Director
Health and Vital Statistics Unit Australian
Bureau of Statistics
Ms Joanne Chicco
Clinical Coding Consultant
NSW Health
Ms Sally Crossing
Consumer Representative
Cancer Voices NSW
Ms Beth Macauley
Chief Operating Officer
Cancer Institute NSW
Mr Scott Maunder
Manager Statewide Corporate Services
Cancer Institute NSW
Dr Helen Moore
Epidemiology Branch Representative
NSW Health
Prof David Roder
Group Executive Research Development
and Statistics
The Cancer Council South Australia
Dr Narelle Shadbolt
General Practitioner
Royal Australasian College of General
Practitioners
Prof Bernard Stewart
Head of Cancer Control Program
South Eastern Sydney Illawarra Area
Health Service
Ms Elizabeth Tracey
Strategic Manager NSW Central Cancer
Registry
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
NSW Oncology Groups (NSWOG)
NSWOG Bone and Soft Tissue Sarcoma
Member
Position
Institution / Location
Dr Peter Barry
Surgeon
ACT
Dr Stephen Cooper
Radiation Oncologist
St Vincent’s Hospital
Prof Philip Crowe (Chair)
Professor of Surgery
Prince of Wales Hospital
Prof Michael Friedlander
Professor of Medicine
Prince of Wales Hospital
Prof Joe Ghabrial
Surgeon
Hunter New England Area Health Service
Dr Warren Hargreaves
Oncological Surgeon
St Vincent’s Clinic / St Vincent’s Hospital
Dr Michael Hughes
Surgeon
Westmead Hospital
Dr Michael Jensen
Surgeon
St Vincent’s Clinic / St Vincent’s Hospital
Dr Cynthia Lean
Manager Collaboration and Information
Cancer Institute NSW
Dr Peter O’Brien
Radiation Oncologist
Newcastle Mater Misericordiae Hospital
Dr Andrew Parasyn
Oncological Surgeon
Prince of Wales Hospital
Dr Paul Stalley (Deputy Chair)
Surgeon
Royal Prince Alfred Hospital
Dr Ian Woodgate
Orthopaedic Surgeon
St Vincent’s Clinic / St Vincent’s
Public and Private Hospitals / Sydney
Children’s Hospital
Ms Leanne Watson
Clinical Nurse Consultant for Cancer
Services and Surgical Oncology
Westmead Hospital
Member
Position
Institution / Location
Dr Rosemary Balleine
Translational Oncology
Sydney West Area Health Service /
Westmead Institute for Cancer Research
Prof Bruce Barraclough
Chairman
Australian Council for Safety and Quality
in Health Care
Dr Stephen Begbie
Director of Oncology
Port Macquarie Base Hospital
A/Prof Michael Bilous
Pathologist and Director
Institute of Clinical Pathology and
Medical Research
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Ms Elisabeth Black
Clinical Nurse Consultant Specialist
Breast Nurse
Westmead Hospital
A/Prof John Boyages
Radiation Oncology
Westmead Hospital
Dr Fran Boyle
Medical Oncologist
Royal North Shore Hospital
Dr Meagan Brennan
Breast Physician
NSW Breast Cancer Institute Westmead
Hospital
Dr Gail Bryson
Acting Director
BreastScreen NSW North Coast
Dr Catherine Clark
Radiation Oncologist
St George Hospital
Ms Kay Collett
Chief Radiologist
Royal North Shore Hospital
Dr Allen-John Collins
Surgeon
Greater Southern
Area Health Service
Ms Margie Collins
BreastScreen Nurse
Women’s Health Service
Mr Mark Costello
Operations Manager BreastScreen NSW
Cancer Institute NSW
Dr Pat Cregan
Surgeon
Nepean Hospital
Ms Sally Crossing
Consumer Representative
Cancer Voices NSW
A/Prof Geoff Delaney
Director Radiation Oncology
Western Zone
Sydney South West
Area Health Service
NSWOG Breast
Dr Alison Evans
Acting Deputy Director
National Breast Cancer Centre
Ms Louise Farrell
Project Officer
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
113
114
Member
Position
Institution / Location
Prof John Forbes
Surgeon
Hunter New England
Area Health Service
Prof Michael Friedlander
Professor of Medicine
Prince of Wales Hospital
A/Prof David Gillett (Chair)
Surgeon
Concord Repatriation
General Hospital
Dr Paul Glare
Palliative Care
Sydney South West
Area Health Service
Ms Janet Green
Consumer Representative
Breast Cancer Action Group NSW
Ms Ann Marie Griffin
Breast Cancer Care Coordinator
Sydney West Area Health Service
Dr Anne Hamilton
Medical Oncologist
Royal Prince Alfred Hospital
Dr Stephen Hayes
Breast Endocrine and General Surgeon
Dudley Private Hospital / Orange Base
Hospital / Parks District Hospital
Ms Roberta Higginson
Consumer Representative
Breast Cancer Action Group NSW
Dr Jane Hill
Medical Oncologist
Riverina Cancer Care Centre
Dr Nabeel Ibrahim
Surgeon
Westmead Private Hospital / Hunters Hill
Private Hospital
Ms Marie Janik
Database Manager / Research Nurse
Royal Prince Alfred Hospital
Ms Kathy Kennedy
Database Manager
Sydney South West
Area Health Service
A/Prof Judy Kirk
Director Familial Cancer Services
Westmead Hospital
Dr Cynthia Lean
Manager Collaboration and Information
Cancer Institute NSW
Dr David Littlejohn
Surgeon
Greater Southern
Area Health Service
Dr Amanda McBride
General Practitioner
Northern Sydney Central Coast Area
Health Service
Ms Merren McKessar
Radiologist
Northern Sydney Central Coast Area
Health Service
Dr Pip Middleton
Surgeon
Northern Sydney Central Coast Area
Health Service
Dr Katrina Moore (Deputy Chair)
Surgeon
Royal North Shore Hospital
Dr Marianne Morgan
Medical Oncologist
Gosford Hospital
Ms Amanda O’Reilly
Manager Cancer Support
Royal North Shore Hospital
Ms Alison Pryor
Senior Social Worker
Liverpool Hospital
Dr Andrew Spillane
Surgeon
Royal Prince Alfred Hospital
Dr John Stewart
Medical Oncologist
Newcastle Mater Misericordiae Hospital
Dr Martin Stockler
Medical Oncologist
Royal Prince Alfred Hospital
A/Prof Robin Stuart-Harris
Medical Oncologist
The Canberra Hospital
Prof Rob Sutherland
Director Cancer Research Program
Garvan Institute of Medical Research
Ms Alison Szwajcer
Clinical Breastcare Nurse
St George Hospital
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr David Townend
Surgeon
Lismore
A/Prof Roger Uren
Nuclear Medicine Physician
Royal Prince Alfred Hospital
A/Prof Richard West
Surgeon
Royal Prince Alfred Hospital
Dr Nicholas Wilcken
Medical Oncologist
Westmead Hospital
Ms Joanne Woodlands
Breast Cancer Nurse Specialist
Port Macquarie Base Hospital
Dr Helen Zorbas
Director
National Breast Cancer Centre
Cancer Institute NSW: Annual Report 2005–2006
NSWOG Cancer Genetics
Member
Position
Institution / Location
Prof Bruce Barraclough
Chairman
Australian Council for Safety and Quality
in Health Care
Ms Jennifer Blackwell
Senior Policy and Project Officer
NSW Health
Dr Michael Buckley
Molecular Genetics
South Eastern Sydney Illawarra Area
Health Service
Ms Belinda Creighton
Genetic Counsellor
St George Hospital
Dr Tracey Dudding
Geneticist
Hunter Genetics
Ms Kate Dunlop
Education
Royal North Shore Hospital
Mr Rodney Ecclestone
Ethics Manager
Cancer Institute NSW
A/Prof Matthew Edwards
Director
Hunter Genetics
Dr Mike Field
Geneticist
Hunter Genetics
Dr John Forbes
Breast Surgeon
Newcastle Mater Misercordiae Hospital
Prof Michael Friedlander
Professor of Medicine
Prince of Wales Hospital
Ms Margaret Gleeson
Genetic Counsellor
Hunter Genetics
Ms Claire Groombridge
Genetic Counsellor
Hunter Genetics
A/Prof Nick Hawkins
Pathologist
University of New South Wales
A/Prof Judy Kirk (Deputy Chair)
Director Familial Cancer Services
Westmead Hospital
Ms Jessica Koehler
Genetic Counsellor
Prince of Wales Hospital
Dr Anne Kricker
ResearcherSchool of Public Health
University of Sydney
Dr Jenny Leary
Molecular Genetics
Westmead Hospital
Dr Cliff Meldrum
Molecular Genetics
John Hunter Hospital
Ms Glenda Mullan
Molecular Genetics
Prince of Wales Hospital
Ms Sheridan O’Donnell
Genetic Counsellor
Hunter Genetics
Prof Rodney Scott
Genetics
Hunter New England
Area Health Service
Dr Allan Spigelman
Surgeon
St Vincent’s Hospital
Prof Ron Trent
Molecular Genetics
Royal Prince Alfred Hospital / University
of Sydney
Dr Kathy Tucker
Geneticist
Prince of Wales Hospital
Prof Robyn Ward (Chair)
Medical Oncologist
St Vincent’s Hospital
Ms Linda Warwick
Genetic Counsellor
The Canberra Hospital
Ms Rachel Williams
Genetics Counsellor
St Vincent’s Hospital
Cancer Institute NSW: Annual Report 2005–2006
115
NSWOG Child and Adolescent Cancer Network
Member
Position
Institution / Location
Dr Frank Alvaro
Paediatric Oncologist
Hunter New England Area Health Service
Ms Cathy Banks
Parent
Hunter New England Area Health Service
Ms Jacqueline Blanche
Social Worker
The Children’s Hospital at Westmead
Ms Debbie Carr
Clinical Coordinator
The Children’s Hospital at Westmead
Dr Susan Carroll
Radiation Oncologist
Prince of Wales Hospital
Ms Dianne Cotterell
Registered Nurse
John Hunter Hospital
Dr Luciano Dalla-Pozza (Deputy
Chair)
Paediatric Oncologist
The Children’s Hospital at Westmead
Ms Genevieve Daly
Pharmacist
Sydney Children’s Hospital
Ms Helen Knox
Registered Nurse
Sydney Children’s Hospital
Dr Cynthia Lean
Manager Collaboration and Information
Cancer Institute NSW
Mr Michael Maher
Parent
Sydney Children’s Hospital
Prof Glenn Marshall (Chair)
Paediatric Oncologist
Sydney Children’s Hospital
Member
Position
Institution / Location
Dr Ned Abrahams
Surgeon
Coffs Harbour
Dr Steve Ackland
Medical Oncologist
Hunter New England
Area Health Service
Dr Ghauri Aggarwal
Palliative Medicine
Sydney South West
Area Health Service
Prof Bruce Armstrong
Head School of Public Health
University of Sydney
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Ms Sonia Bisson
Cancer Nurse Coordinator
Port Macquarie Base Hospital
Prof Leslie Bokey
Surgeon
Concord
Dr Tony Bonaventura
Medical Oncologist
Hunter New England
Area Health Service
NSWOG Colorectal
116
Prof John Cartmill
Surgeon
Nepean Hospital
A/Prof Pierre Chapuis
Surgeon
Concord Repatriation General Hospital
Dr Philip Clingan
Medical Oncologist
Wollongong
Dr Phil Douglas
Surgeon
Prince of Wales Hospital
Dr Brian Draganic
Surgeon
Hunter New England
Area Health Service
A/Prof Haney Elsie
Director Radiation Oncology
The Canberra Hospital
Ms Maria Emerton-Bell
Stomal Therapy Clinical Nurse
Consultant
Kempsey / Port Macquarie
Dr Justin Evans
Surgeon
Royal North Shore Hospital
Dr Anthony Eyers (Chair)
Surgeon
Royal Prince Alfred Hospital
Ms Louise Farrell
Project Officer
Cancer Institute NSW
Dr Andrew Gilmore
Surgeon
Orange
A/Prof David Goldstein
Medical Oncologist
Prince of Wales Hospital
Ms Karen Gorzynska
Clinical Nurse Consultant and Cancer
Nurse Coordinator
Coffs Harbour Health Campus
A/Prof Nicholas Hawkins
Anatomical Pathologist
University of New South Wales
Dr Christopher Henderson
Senior Staff Specialist
South Western Area
Pathology Service
Dr Henry Hicks
Surgeon
Wagga Wagga
Dr Bruce Hodge
Surgeon
Port Macquarie
Ms Fran Hofstee
Nurse Unit Manager Surgical Ward
Tweed Hospital
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Ms Michelle Hughes
Program Manager Bowel Screen NSW
Cancer Institute NSW
Dr Jayasingham Jayamohan
Radiation Oncologist
Westmead
Dr Paul Jelfs
Director Cancer Information and
Registries
Cancer Institute NSW
Ms Jackie Johnston
Cancer Nurse Coordinator
Northern Sydney Central Coast Area
Health Service
A/Prof James Kench
Senior Staff Specialist Department of
Tissue Pathology
Institute of Clinical Pathology and
Medical Research Westmead Hospital
Prof Denis King
Surgeon
St George Hospital
Dr Andrew Kneebone (Deputy Chair)
Staff Specialist in Radiation Oncology
Liverpool Hospital
Dr Matthew Morgan
Surgeon
Sydney South West
Area Health Service
Prof David Morris
Surgeon
St George Hospital
Mr Sian Munro
Project Manager
Garvan Institute of Medical Research
Mr Quoc Nguyen
Project Manager
South Eastern Sydney Illawarra Area
Health Service
Dr Nim Pathma-Nathan
Surgeon
Westmead Hospital
Dr John Percy
Surgeon
Royal North Shore Hospital
Dr Stephen Pillinger
Colorectal Surgeon
Royal North Shore Hospital
Dr Val Poxon
Project Manager
Liverpool Hospital
Ms Sue Quayle
Colorectal Cancer Care Coordinator
The Canberra Hospital
Dr Jane Read
Accredited Practising Dietitian
Fresh Nutrition Solution
Dr Margaret Schnitzler
Surgeon
Royal North Shore Hospital
Dr Jenny Shannon
Medical Oncologist
Nepean Hospital
Dr Richard Simpson
Colorectal Surgeon
Gosford Hospital
Ms Helen Snodgrass
Clinical Nurse Consultant
Oncology / Executive
Bloomfield Hospital / NSW Institute of
Rural Clinical Services and Teaching
A/Prof Michael Solomon
Surgeon
Royal Prince Alfred Hospital
Prof Allan Spigelman
Surgeon
Hunter New England
Area Health Service
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Stephen Thompson
Colorectal Surgeon
Prince of Wales Hospital
Prof Robyn Ward
Medical Oncologist
St Vincent’s Hospital
Dr Robert Wilson
Surgeon
Liverpool Hospital
A/Prof Cyril Wong
Surgeon
Bankstown
Cancer Institute NSW: Annual Report 2005–2006
117
NSWOG Complementary Therapies
Member
Position
Institution / Location
Prof Alan Bensoussan
Director
Centre for Complementary Medicine
Research
Ms Jennifer Carter
Psychologist
Broken Hill Hospital
Prof Stephen Clarke (Chair)
Professor of Medicine
Concord Repatriation
General Hospital
A/Prof John Eden
Reproductive Endocrinology
Royal Hospital for Women
Dr Peter Graham
Radiation Oncologist
Cancer Care Centre
St George Hospital
Mr Christopher Harris
Community Representative
Ms Petrea King
Chief Executive Officer
Quest for Life
Dr Ramesh Manocha
Complementary Therapist / Researcher
Barry Wren Fellow Natural Therapies Unit
Royal Hospital for Women
Dr Andrew McLachlan
Director Clinical Studies
Herbal Medicines Research and
Education Centre / University
of Sydney
Prof Stephen Myer
Director
Australian Centre for Complementary
Medicine
Ms Annette Polizois
Social Worker
The Children’s Hospital
at Westmead
Ms Jane Read
Dietitian
Sydney Cancer Centre
Ms Lorraine Rodden
Manager
Calvary Holistic Healing Centre
Mr John Stubbs
Community Representative
Cancer Voices Australia
Ms Robyn Thomas
Project Officer
Cancer Institute NSW
NSWOG General Practice Committee
118
Member
Position
Institution / Location
Ms Karen Eaton
Cancer Care Coordinator
Prince of Wales Hospital
Prof John Gullotta
General Practitioner
Australian Medical
Association (NSW)
Prof Mark Harris
Executive Director Centre for Primary
Health Care and Equity
University of New South Wales
Dr Elizabeth Hindmarsh
General Practitioner
Alliance of NSW Divisions (Metropolitan)
Ms Sally Hodgkinson
Secretary
Cancer Voices NSW
Prof Michael Kidd (Chair)
Head Department of
General Practice
University of Sydney
Dr Vlad Matic
Board Member
Alliance of NSW Divisions
Dr Peter McInerney
President
Rural Doctors Association NSW
Ms Jane McQueen
Manager Clinical Services Cervical
Screening NSW
Cancer Institute NSW
Ms Jan Newland
Education and Support Manager
Alliance of NSW Divisions
Dr Glen Periera
General Practitioner
Harold Street Medical Centre
Mr Gary Smith
Vice President NSW Branch
Australian Association of
Practice Managers
Mr Richard Tewson
Manager Population Health Strategy
BreastScreen NSW
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Julie Thompson
General Practice Liaison Officer
National Breast Cancer Centre
Cancer Institute NSW: Annual Report 2005–2006
NSWOG Gynae-Oncology
Member
Position
Institution / Location
Dr Phillip Beale
Medical Oncologist
Royal Prince Alfred Hospital
Dr Colin Bull
Radiation oncologist
Westmead Hospital
A/Prof Johnathan Carter
Surgeon
Royal Prince Alfred Hospital
Dr Felix Chan
Surgeon
Liverpool Hospital
Dr Gregory Gard
Surgeon
Royal North Shore Hospital
A/Prof Neville Hacker
Surgeon
Royal Hospital for Women
A/Prof Paul Harnett
Medical Oncologist
Westmead Hospital
Ms Annie Hutton
Network Manager
Greater Metropolitan Clinical Taskforce
Prof Don Marsden (Chair)
Gynaecologist
Royal Hospital for Women / Greater
Metropolitan Clinical Taskforce
Dr Chris Millross
Radiation Oncologist
Royal Prince Alfred Hospital
Ms Kathryn Nattress (Deputy Chair)
Cancer Nurse Coordinator
Gynaecological Cancer
Royal Prince Alfred Hospital
Dr Tony Proietto
Surgeon
Hunter New England Area Health Service
Ms Roslyn Robertson
Psychologist
Royal Hospital for Women
Dr Greg Robertson
Surgeon
Royal Hospital for Women
Dr Stephen Thompson
Radiation Oncologist
Prince of Wales Hospital
Dr Gerry Wain
Scientific Director Cervical Screening
NSW
Cancer Institute NSW
Dr Yeqin Zuo
Manager Pap Test Register
Cancer Institute NSW
NSWOG Head and Neck
Member
Position
Institution / Location
Dr Peter Aquilina
Consultant Oral and
Maxillofacial Surgeon
Hunter New England
Area Health Service
Dr Lyn Austen
Radiation Oncologist
The Canberra Hospital
Dr Peter Barry
Consultant Surgeon
The Canberra Hospital
Dr Ronaldo Bova
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Michael Boyer
Medical Oncologist
Sydney South West
Area Health Service
Dr Stephen Braye
Anatomical Pathologist
Newcastle Mater Misericordiae Hospital
Dr Andrew Bridger (Deputy Chair)
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Joseph Bucci
Radiation Oncologist
St George Hospital
Dr Peter Campbell
Head and Neck Surgeon
Liverpool Hospital
Mr Andrew Chicco
Senior Data Manager
Sydney South West
Area Health Service
Dr Jonathan Clark
Head and Neck Surgeon
Sydney South West
Area Health Service
Dr Anthony Clifford
Surgeon
Sydney South West
Area Health Service
Dr Ian Cole
Surgeon
Primary Health Care
Dr Ann Collins
Maxillofacial Surgeon
Sydney South West
Area Health Service
Dr Michael Cooper
Maxillofacial Surgeon
The Canberra Hospital
Dr Peter Corlette
Ear Nose and Throat Surgeon
Sydney South West
Area Health Service
Dr Paul Craft
Director Medical Oncology
The Canberra Hospital
Cancer Institute NSW: Annual Report 2005–2006
119
120
Member
Position
Institution / Location
Dr Ramesh Cuganesan
Radiologist
Sydney South West
Area Health Service
Dr Jane Dahlstrom
Anatomical Pathologist
The Canberra Hospital
Ms Luci Dall’Armi
Care Coordinator
Sydney South West
Area Health Service
Dr David Dalley
Medical Oncologist
St Vincent’s Hospital
Dr Anand Deva
Plastic surgeon
Sydney South West
Area Health Service
Ms Amanda Doherty
Speech Pathologist
John Hunter Hospital
Dr Jenny Donovan
Radiation Oncologist
Royal North Shore Hospital
Dr Rob Eisenberg
Ear Nose and Throat Surgeon
Newcastle Mater Misericordiae Hospital
Dr Vanessa Estall
Radiation Oncologist
Sydney South West
Area Health Service
Dr Michael Farrell
Surgeon
St George Hospital
Ms Sandra Farrugia
Head and Neck Data Manager
Liverpool Hospital
Dr Linda Fenton
Head and Neck Surgeon
Newcastle Mater Misericordiae Hospital
Mrs Merran Findlay
Dietitian
Royal Prince Alfred Hospital
Ms Camille Formston
Cancer Nurse Coordinator
Royal North Shore Hospital
Dr Dion Forstner
Radiation Oncologist
Liverpool Hospital
Dr Richard Foster
Radiation Oncologist
Gosford Hospital
Dr Allan Fowler
Radiation Oncologist
Sydney South West
Area Health Service
Dr Richard Gallagher
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Evan Godfrey
Oral Surgeon
Royal North Shore Hospital
Dr Amanda Goldrick
Medical Oncologist
Sydney South West
Area Health Service
Dr Nicole Gorddard
Oncologist
The Canberra Hospital
Dr Peter Graham
Radiation Oncologist
St George Hospital
Ms Julie Greer
Social Worker
South Eastern Sydney Illawarra Area
Health Service
Dr Gary Hoffman
Oral Maxillofacial Surgeon
Newcastle Mater Misericordiae Hospital
Dr Christopher Hughes
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Michael Jackson
Radiation Oncologist
Sydney South West
Area Health Service
Dr George Jacob
Radiation Oncologist
The Canberra Hospital
Dr Ian Jacobson
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Michael Jensen
Surgeon
South Eastern Sydney Illawarra Area
Health Service
Dr Craig Johnston
Surgeon
Gosford Hospital
Dr Inars Kalnins
Surgeon
Sydney West Area Health Service
Dr Patricia Kho
Medical Oncologist
Sydney South West
Area Health Service
Dr Mahesh Kumar
Radiation Oncologist
Hunter New England
Area Health Service
Dr Cynthia Lean
Manager Collaboration and Information
Cancer Institute NSW
Dr Mark Lee
Radiation Oncologist
Sydney South West
Area Health Service
Dr Peter Lin
Staff Specialist Nuclear Medicine
Sydney South West
Area Health Service
Dr Christine Loo
Pathologist
Sydney South West
Area Health Service
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Ms Kellie McCarthy
Speech Pathologist
Sydney South West
Area Health Service
Dr Christopher Milross
Radiation Oncologist
Sydney South West
Area Health Service
Dr Gary Morgan (Chair)
Surgeon
Westmead Hospital
Dr Yuresh Naidoo
Consultant
Sydney South West
Area Health Service
Dr Richard North
Medical Oncologist
Newcastle Mater Misericordiae Hospital
Ms Megan Nutt
Head and Neck Cancer Care Coordinator
The Canberra Hospital
Prof Chris O’Brien
Surgeon
Royal Prince Alfred Hospital
Ms Cathy O’Delli
Dietitian
Newcastle Mater Misericordiae Hospital
Dr Yishay Orr
Centre for Vascular Research
Representative
University of New South Wales
Dr Carsten Palme
Surgeon
Sydney West Area Health Service
Dr Chundra Patel
Plastic and Reconstructive Surgeon
The Canberra Hospital
Dr T Pham
Radiation Oncologist
Gosford Hospital
Dr Rebecca Phillips
Dietitian
Macarthur Cancer Therapy Centre
Ms Tricia Potter
Speech Pathologist
Newcastle Mater Misericordiae Hospital
Dr Gane Pranavan
Trainee Oncologist
The Canberra Hospital
Dr Barry Reed
Oral Maxillofacial Surgeon
Newcastle Mater Misericordiae Hospital
Dr Colin Reid
Ear Nose and Throat Surgeon
Newcastle Mater Misericordiae Hospital
Ms Joan Ryan
Clinical Nurse Consultant Palliative Care
Royal Prince Alfred Hospital
Dr Mark Schifter
Oral Medicine Specialist
Westmead Hospital
Dr Jenny Shannon
Medical Oncologist
Nepean Hospital
Dr Kerwin Shannon
Surgeon
Sydney South West
Area Health Service
Dr Brian Sheridan
Surgeon
Sydney West Area Health Service
Dr Mark Sidhom
Radiation Oncologist Registrar
Sydney South West
Area Health Service
Mrs Teresa Simpson
Social Worker
Liverpool Hospital
Dr Stuart Slater
Radiologist
Newcastle Mater Misericordiae Hospital
Dr Robert Smee
Radiation Oncologist
Prince of Wales Hospital
Ms Kate Starick
Speech Pathologist
The Canberra Hospital
Dr Edward Sun
Radiation Oncologist
Gosford Hospital
Dr Kenneth Sunderland
Radiation Oncologist
ACT Breast Care Nursing Service
Dr Mo Mo Tin
Radiation Oncologist
Royal Prince Alfred Hospital
Dr Kenneth Tiver
Radiation Oncologist
Sydney West Area Health Service
Dr David Veivers
Surgeon
Royal North Shore Hospital
Dr Michael Veness
Radiation Oncologist
Westmead Hospital
Dr Peter Vickers
Oral Maxillofacial Surgeon
Canberra Surgicentre
Ms Beverley Vine
Consumer Representative
Cancer Voices NSW
Dr Andrew Wignall
Surgeon
Northern Sydney Central Coast Area
Health Service
Dr Ian Wilson Oral
Oral Maxillofacial Surgeon
Hunter New England
Area Health Service
Dr Karen Wong
Radiation Oncologist
Sydney South West
Area Health Service
Ms Wendy Woodman
Radiation Oncologist
The Canberra Hospital
Dr Chris Wratten
Radiation Oncologist
Newcastle Mater Misericordiae Hospital
Dr Desmond Yip
Medical Oncologist
The Canberra Hospital
Ms Debbie Zaslona
Data Manager
Newcastle Mater Misericordiae Hospital
Dr Khaled Zoud
Senior Registrar Maxillofacial Surgery
Westmead Hospital
Cancer Institute NSW: Annual Report 2005–2006
121
NSWOG Lung
Member
122
Position
Institution / Location
Dr Fiona Abell
Medical Oncologist
Newcastle Mater Misericordiae Hospital
Dr Anthony Aouad
Physician
Campbelltown Hospital
A/Prof David Barnes
Physician
Royal Prince Alfred Hospital
Dr Matthew Bayfield
Surgeon
Royal Prince Alfred Hospital
Dr Stephen Begbie
Director of Oncology
Port Macquarie Base Hospital
Dr Michael Boyer (Chair)
Medical Oncologist
Royal Prince Alfred Hospital
Dr Karen Briscoe
Medical Oncologist
Coffs Harbour and
District Hospital
A/Prof David Bryant
Surgeon
St Vincent’s Hospital
Ms Linda Christenson
Consumer Representative
Cancer Voices NSW
Ms Julie Clowry
Lung and Mesothelioma Cancer Care
Coordinator
The Canberra Hospital
Ms Debra Cook
Nurse Coordinator Cancer Care Centre
Wollongong Hospital
Dr Stephen Cooper
Radiation Oncologist
St Vincent’s Hospital
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Dr Cathy Crombie
Medical Oncologist
Nepean Hospital
Ms Doris Dadic
Lung Cancer Coordinator
South Western Sydney
Cancer Service
Dr Paul De Souza
Medical Oncologist
St George Hospital
Dr Christoper Dennis
Physician
Royal North Shore Hospital
Dr Paul Despas
Physician
Westmead Hospital
Ms Anita Dessaix
Program Manager Cancer Prevention
Cancer Institute NSW
Dr Gary Fermanis
Supervisor of Training
St George Hospital
Dr Peter Flynn
Cardio-thoracic Surgeon
Bondi / Nepean Hospital
A/Prof Michael Fulham
Director Positron Emission Tomography
(PET) and Nuclear Medicine Unit
Royal Prince Alfred Hospital
Dr Jane Hill
Medical Oncologist
Wagga Wagga Base Hospital
Dr Ivan HoShon
Chief Nuclear Medicine Technologist
Liverpool Hospital /
Royal North Shore Hospital
Dr Rina Hui
Senior Staff Specialist in Medical
Oncology
Westmead Hospital
Dr Alan James
Surgeon
John Hunter Hospital
Dr Philip Lee
Palliative Physician
Westmead Hospital
Dr Craig Lewis
Staff Specialist Medical Oncologist
Prince of Wales Hospital
Dr Matthew Links
Medical Oncologist
The Centenary Institute
Dr Jane Ludbrook
Radiation Oncologist
Newcastle Mater Misericordiae Hospital
Prof Brian McCaughan
Physician
Royal Prince Alfred Hospital
Ms Sue McCullough
Consumer Representative
Dr Jocelyn McLean
Case Manager Thoracic Surgery
Royal Prince Alfred Hospital
Dr Steve McNamara
Staff Specialist in Respiratory Medicine
Royal Prince Alfred Hospital
A/Prof Dianne O’Connell
Researcher
The Cancer Council NSW
Dr Nick Pavlakis
Medical Oncologist
Royal North Shore Hospital
Dr Matthew Peters
Physician
Concord Repatriation General Hospital
Dr Nicholas Saltos
Respiratory Department
John Hunter Hospital
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Prof Bernard Stewart
Head of Cancer Control Program
South Eastern Sydney Illawarra Area
Health Service
Dr Mo Mo Tin
Radiation Oncologist
Royal Prince Alfred Hospital
Ms Elizabeth Tracey
Strategic Manager NSW Central Cancer
Registry
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Dr Craig Underhill
Oncologist
Border Medical Oncology
Dr Shalini Vinod (Deputy Chair)
Staff Specialist Radiation Oncologist
South Western Sydney Cancer Service
NSWOG Malignant Haematology
Member
Position
Institution / Location
Mr Ray Araullo
Social Worker
Royal North Shore Hospital
Dr Christopher Arthur
Haematologist
Royal North Shore Hospital
Ms Deborah Baker
Manager Monitoring Evaluation
and Research
Cancer Institute NSW
Prof Ken Bradstock (Chair)
Haematologist
Westmead Hospital
Mr Peter Brown
Community Representative
Cancer Voices NSW
Mr David Collins
Clinical Nurse Consultant
Westmead Hospital
Dr Ilona Cunningham
Haematologist
Concord Repatriation General Hospital
Dr Tony Dodds
Haematologist
St Vincent’s Hospital
Dr Arno Enno
Haematologist
Newcastle Mater Misericordiae Hospital
Dr John Gallo
Haematologist
Liverpool Hospital
Ms Yvonne Gonet
Clinical Nurse Consultant
Royal North Shore Hospital
A/Prof David Gottlieb
Haematologist
Westmead Hospital
Dr Matthew Greenwood
Staff Specialist
Liverpool Hospital
Dr Margot Harris
Haematologist
Hornsby
A/Prof Mark Hertzberg
Haematologist
Westmead Hospital / Nepean Hospital
Dr Jayasingham Jayamohan
Radiation Oncologist
Westmead Hospital
Dr Paul Jelfs
Director Cancer Information
and Registries
Cancer Institute NSW
Prof Doug Joshua
Haematologist
Royal Prince Alfred Hospital
A/Prof Ian Kerridge
Staff Specialist Haematologist / Bone
Marrow Transplant
Physician
Westmead Hospital
Dr Rob Lindeman
Haematologist
Prince of Wales Hospital
Prof David Ma
Haematologist
St Vincent’s Hospital
Ms Deidre Mathis
Cancer Care Coordinator Haematology
The Canberra Hospital
Dr Kim Poh Tehl
Senior Pharmacist
Cancer Services
St George Hospital
Dr Ian Prosser
Clinical Haematologist
The Canberra Hospital
Prof John Rasko
Haematologist
Royal Prince Alfred Hospital
Dr David Rosenfeld
Haematologist
Liverpool Hospital
Ms Patricia Ryan
Cancer Care Coordinator Haematology
Liverpool Hospital
Dr Michael Seldon
Director Haematology
Newcastle Mater Misericordiae Hospital
Ms Leonie Snowdon
Support Services
Coordinator
Leukaemia Foundation
Dr Richard Stark
Haematologist
Port Macquarie Base Hospital
Ms Moira Stephens
Cancer Care Coordinator Haematology /
Oncology
Liverpool Hospital
Dr Elizabeth Tegg
Cancer Institute NSW Clinical Fellow
Royal North Shore Hospital
Dr Campbell Tiley
(Deputy Chair)
Haematologist
Gosford Hospital
Dr Judith Trotman
Haematologist
Concord Repatriation
General Hospital
Dr Pauline Warburton
Haematologist
South Eastern Sydney Illawarra Area
Health Service
A/Prof Graham Young
Senior Staff Specialist Haematology
Royal Prince Alfred Hospital
Cancer Institute NSW: Annual Report 2005–2006
123
NSWOG Melanoma
124
Member
Position
Institution
Dr Chris Anderson
Dermatologist
Liverpool Hospital
Prof Bruce Armstrong
Head School of Public Health
University of Sydney
Prof Bruce Barraclough
Chairman
Australian Council for Safety
and Quality in Health Care
Dr Peter Barry Surgeon
Surgeon
The Canberra Hospital
Dr Frances Boyle
Medical Oncologist
The Mater Hospital
Ms Marjorie Colman
Database Manager
Royal Prince Alfred Hospital
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Dr Austin Curtin
Surgeon Northern Clinical School
University of Sydney
Ms Anita Dessaix
Program Manager Cancer Prevention
Cancer Institute NSW
Dr Gerald Fogarty
Radiation Oncologist
St Vincent’s Hospital
Dr Richard Harrison
Surgeon
Wagga Wagga Base Hospital
Prof Peter Hersey
Immunologist
Royal North Shore Hospital
Dr Phoebe Holt
Senior Associate Sydney Health Projects
Group
University of Sydney
Dr Angela Hong
Radiation Oncologist
Royal Prince Alfred Hospital
Dr George Hruby
Radiation Oncologist
Royal Prince Alfred Hospital
Dr Michael Hughes (Deputy Chair)
Surgeon
Westmead Hospital
Prof Peter Kam
Public Health Officer
St George Hospital
Prof Richard Kefford
Medical Oncologist
Westmead Institute for Cancer Research
Dr Peter Lye
Director
Chatswood Skin Cancer Clinic
Ms Christine Madronio
Research Officer
Royal Prince Alfred Hospital
Dr Graham Mann
Program Leader
Westmead Institute for Cancer Research
Prof William McCarthy
Surgeon
Royal Prince Alfred Hospital
A/Prof Scott Menzies
Lead Investigator
Royal Prince Alfred Hospital
Ms Rachael Morton
Clinical Trials
Royal Prince Alfred Hospital
Ms Sophie Noble
Community Representative
Dr Michael Quinn
Surgeon
Royal Prince Alfred Hospital
Dr Robyn Saw
Surgeon
Royal Prince Alfred Hospital
Dr Richard Scolyer
Histopathology
Royal Prince Alfred Hospital
Dr Kerwin Shannon
Surgeon
Royal Prince Alfred Hospital
Dr Bob Sillar
Surgeon
Hunter New England
Area Health Service
Dr Andrew Spillane
Surgeon
Royal Prince Alfred Hospital
Ms Jacquie Stratford
General Manager
Melanoma Foundation
Dr Jonathan Stretch
Surgeon
Royal North Shore Hospital /
The Mater Hospital /
Royal Prince Alfred Hospital
Prof John Thompson (Chair)
Surgeon
Royal Prince Alfred Hospital
Ms Leanne Watson
Clinical Nurse Specialist
Westmead Hospital
Cancer Institute NSW: Annual Report 2005–2006
NSWOG Neuro-Oncology
Member
Position
Institution / Location
Dr Leslie Ashton
Senior Lecturer
Children’s Cancer Institute Australia
Ms Jeanne Barr
Clinical Nurse Consultant Neuroscience
Royal North Shore Hospital
A/Prof Michael Barton (Chair)
Research Director Collaboration for
Cancer Outcomes Research and
Evaluation (CCORE)
Liverpool Hospital
Dr Jane Beith
Staff Specialist
Royal Prince Alfred Hospital
Prof Michael Besser (Deputy Chair)
Neurosurgeon
Royal Prince Alfred Hospital
Ms Elizabeth Bland
Clinical Nurse Consultant Care
Coordinator Neuro-Oncology
South Eastern Sydney Illawarra Area
Health Service
Prof Fran Boyle
Medical Oncologist
Royal North Shore Hospital
Dr Janice Brewer
Neuropathologist
Royal North Shore Hospital
Ms Angelina Catanzariti
Clinical Trials Manager
Cancer Institute NSW
Dr Paul Clouston
Neurologist
Westmead Hospital
Dr Richard Cohn
Paediatric Haematologist / Oncologist
Hunter New England
Area Health Service /
University of New South Wales
A/Prof Andrew Cole
Rehabilitation Physician
Braeside Hospital /
St George Hospital
Dr Ray Cook
Surgeon
Royal North Shore Hospital
Dr Paul Craft
Director Medical Oncology
The Canberra Hospital
Ms Laraine Cross
Social Worker
Newcastle Mater Misericordiae Hospital
Dr David Dalley
Medical Oncologist
St Vincent’s Hospital
Dr Gordon Dandie
Neurosurgeon
Westmead Hospital
Dr Paul de Souza
Medical Oncologist
St George Hospital
Dr Mark Dexter
Neurosurgeon
Westmead Hospital
Ms Maggie Drummond
Executive Director
The Madeline Foundation for
Neurosurgical Research
Ms Kaye Duffy
Consumer Representative
Brain Tumour Australia
Ms Carmel Edwards
Director Cancer Research
Cancer Institute NSW
Dr Michael Fearnside
Director Surgical Services
Westmead Hospital
Miss Rochelle Firth
Neurosurgery
Royal North Shore Hospital
Prof Michael Friedlander
Professor of Medicine
Prince of Wales Hospital
A/Prof Michael Fulham
Director Positron Emission Tomography
(PET) and Nuclear Medicine Unit
Royal Prince Alfred Hospital
Dr Ray Garrick
Neurologist
St Vincent’s Hospital
Dr Peter Graham
Senior Staff Specialist Radiation
Oncologist
St George Hospital
Prof Clive Harper
Professor of Neuropathology
University of Sydney
Ms Bronwyn Heron
Community Palliative Care
Liverpool Hospital
Dr Elizabeth Hovey
Medical Oncology
Liverpool Hospital
Dr Rina Hui
Staff Specialist Medical Oncology
University of Sydney
Dr Jayasingham Jayamohan
Radiation Oncologist
Westmead Hospital
Dr Lindy Jeffree
Pathologist
Royal Prince Alfred Hospital
Prof Rick Kefford
Professor of Medicine / Director
University of Sydney / Westmead
Institute for Cancer Research
Ms Anne Knevitt
Nurse Manager Sacred Heart Palliative
Care and Rehabilitation Services
St Vincent’s Hospital
Dr Bernard Kwok
Neurosurgeon
Prince of Wales Hospital
Ms Heather McConachie
Sydney Neuro-Oncology Group
Coordinator
Royal North Shore Hospital
Dr Kerrie McDonald
Brain Tumour Research Kolling Institute
University of Sydney /
Royal North Shore Hospital
Cancer Institute NSW: Annual Report 2005–2006
125
Member
Position
Institution / Location
Dr Susan Murphy-Poulton
Oncologist
Royal North Shore Hospital
Ms Lou Orszulak
Multidisciplinary Team Project Officer
Cancer Services
Westmead Hospital
Dr Jonathon Parkinson
Advanced Neurosurgical Trainee Kolling
Institute
University of Sydney /
Royal North Shore Hospital
Dr Nick Pavlakis
Medical Oncologist
Royal North Shore Hospital
Prof Roger Reddel
Head Cancer Research Unit
Children’s Medical Research Institute
Dr Michael Rodriguez
Neuropathologist
Central Sydney Laboratory Services
Ms Susan Rutkowski
Director Spinal Cord Injuries
Outpatients and Research
Royal North Shore Hospital
Dr Jenny Shannon
Surgeon
Nepean Hospital
Dr Louise Sharpe
Senior Lecturer
University of Sydney
Dr Mark Sheridan
Neurosugeon
Liverpool Hospital
Ms Teresa Simpson
Social Worker
Liverpool Hospital
Dr Bob Smee
Radiation Oncologist
Prince of Wales Hospital
Ms Sally Smith
Senior Cancer Information Manager
Royal North Shore Hospital
Ms Linda Spitzer
Cancer Support Coordinator
Queensland Cancer Fund
Dr Warwick Stening
Area Director of Neurosugery
South Eastern Sydney Illawarra Area
Health Service / NSW Neurosurgical
Association
Dr Denis Strangman
Chairman / Member
International Brain Tumour Alliance /
Canberra and NSW Southern Region
Cancer Services
Dr Charles Teo
Surgeon
Prince of Wales Hospital
Dr Stephen Thompson
Radiation Oncologist
Prince of Wales Hospital
Dr Mo Mo Tin
Radiation Oncologist
Royal Prince Alfred Hospital
Mr Leanne Turner
Clinical Service Unit Manager Epilepsy
Research Centre
Austin Hospital (VIC)
Dr James VanGelder
Surgeon
Liverpool Hospital
Dr Helen Wheeler
Medical Oncologist
Royal North Shore Hospital
Dr Jonathon Wood
Neurologist
Nepean Hospital
Ms Kylie Wright
Neuro-Oncology
Liverpool Hospital
Dr Desmond Yip
Staff Specialist
The Canberra Hospital
Dr Phillip Yuile
Radiation Oncologist
Newcastle Mater Misericordiae Hospital
NSWOG Palliative Care
126
Member
Position
Institution / Location
Ms Penny Adams
Manager Access
Cancer Institute NSW
Dr Meera Agar
Staff Specialist Palliative Care
Liverpool Hospital Cancer
Therapy Centre
Dr Ghauri Aggarwal
Palliative Medicine
Concord Repatriation General Hospital
Dr Roland Alvandi
Radiation Oncology
Westmead Hospital
Ms Patricia Austin
Head of Psychology Department
St Vincent’s Hospital
Dr Andrew Broadbent
Palliative Care
Braeside Hospital
Dr Victor Chan
Community Palliative Care Physician
Cabramatta
A/Prof Richard Chye (Chair)
Palliative Physician
St Vincent’s Hospital
Mr Peter Cleasby
Clinical Nurse Consultant Palliative Care
Northern Sydney Central Coast Area
Health Service
Ms Melissa Cumming
Clinical Nurse Consultant Palliative Care
and Cancer Services
Greater Western Area Health Service
Ms Michelle Davies
Palliative Care Coordinator
Bloomfield Hospital
Ms Pauline Davis
Palliative Care Nurse Practitioner
Prairiewood Community
Health Centre
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Dr Joanne Doran
Area Palliative Care Director
St Vincent’s Hospital
Ms Julie Garrard
Senior Social Worker
Calvary Health Care Sydney
Dr Jonathan Gillis
Palliative Pharmacist Paediatrics
The Children’s Hospital at Westmead
Prof Afaf Girgis
Director Centre for Health Research and
Psycho-Oncology
University of Newcastle
Ms Sue Giugni
Pastoral Care Coordinator
St Vincent’s Hospital
A/Prof Paul Glare
Palliative Physician
Royal Prince Alfred Hospital
A/Prof Sue Hanson
Director Clinical Governance / President
Palliative Care Association of NSW
Ms Janeane Harlum
(Deputy Chair)
Clinical Nurse Consultant Palliative Care
Braeside Hospital
Ms Pauline Heath
Clinical Nurse Consultant
Palliative Care
Mercy Health Service
Ms Bronwen Hewitt
Physiotherapy
St Vincent’s Hospital
Dr Jane Ingham
Lead Clinician in Palliative Care
Westmead Hospital
Ms Rada Kusic
Clinical Trials Manager
Westmead Hospital
Dr Philip Lee
Palliative Physician
Westmead Hospital
Dr Michael Noel
Director Palliative Care
Nepean Cancer Care Centre
Ms Toni Payne
Manager Training and Policy
Carers NSW
Ms Jane Phillips
Program Coordinator
Mid North Coast Division of General
Practice
Dr Peter Ravenscroft
Palliative Physician
Newcastle Mater Misericordiae Hospital
Ms Ros Savage
Physiotherapist
Calvary Health Care Sydney
Ms Alex Sydney-Jones
Occupational Therapy
St Vincent’s Hospital
Ms Kelly Tank
Clinical Nurse Consultant
St Vincent’s Hospital
Ms Louisa Thompson
Volunteer Coordinator
Albury Base Hospital
Ms Kate White
Research Development and Support Unit
University of Sydney
Dr Sharon Wiley
Coordinator of Medical Education
University of Sydney
Dr Jennifer Wiltshire
Palliative Physician
Braeside Hospital
Ms Judy Winning
Pharmacist
Neringah Hospital / Greenwich Hospital
Member
Position
Institution / Location
Ms Penny Adams
Manager Access
Cancer Institute NSW
Dr Rosemary Balleine
Translational Oncology
Sydney West Area Health Service /
Westmead Institute for Cancer Research
A/Prof Michael Bilous (Chair)
Anatomical Pathology
Westmead Hospital
Dr Stephen Braye
Anatomical Pathology
Hunter Area Pathology Service
Dr Warwick Delprado
Director Histopathology
Douglass Hanly Moir Pathology
Prof Robert Eckstein
Anatomical Pathology
Royal North Shore Hospital
Dr Paul McKenzie
Anatomical Pathology
Royal Prince Alfred Hospital
Dr Adrienne Morey
(Deputy Chair)
Anatomical Pathology
St Vincent’s Hospital
Mr Michael Rodriguez
Consumer Representative
Prof Peter Russell
Medical Director
NSWOG Pathology
Symbion Laverty Pathology
Dr Richard Scolyer
Anatomical Pathology
Royal Prince Alfred Hospital
Prof Cheok Soon Lee
Anatomical Pathology
Royal Prince Alfred Hospital
Dr Con Theocharous
Anatomical Pathology
South Eastern Area Laboratory Service
Dr Tamsin Waterhouse
Deputy Chief Executive Officer
Royal College of Pathologists of
Australasia
Dr Zuo Yeqin
Manager Pap Test Register
Cancer Institute NSW
Dr Claire Cooke-Yarborough
Medical Adviser
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
127
NSWOG Patient Support Sub-Committee
NOTE: This committee ceased to exist in May 2006. A joint Cancer Institute NSW and The Cancer Council NSW
Patient Support and Information Advisory Committee will be established in 2006-2007.
Member
Position
Institution / Location
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Dr Fran Boyle
Director Medical Oncology
Royal North Shore Hospital
Prof Phyllis Butow
Director Medical Psychology Research
Unit
University of Sydney
Ms Angela Cotroneo
Social Worker
Sydney Cancer Centre
Ms Jane Cruickshank
Community Representative
Cancer Voices NSW
Ms Allison Dawes
Palliative Care Nurse Manager
Lourdes Hospital and Community
Services Dubbo
Prof Afaf Girgis (Deputy Chair)
Director Centre for Health Research and
Psycho-Oncology
University of Newcastle
Ms Dianne Head
Clinical Nurse Consultant Chemotherapy
Westmead Hospital
Ms Kim Hobbs
Social Worker Department of
Gynaecological Oncology
Westmead Hospital
Prof Brian Kelly
NSW Centre for Rural and Remote
Mental Health
Bloomfield Hospital Orange
Ms Bev Kuschert
Community Representative
Cancer Voices NSW
Dr Catherine Mason (Chair)
Psychiatrist
Westmead Hospital
Ms Cathy McDonnell
Clinical Nurse Consultant Palliative Care
Concord Repatriation General Hospital
Ms Kerrie McFarland
Cancer Nurse Specialist Oncology
Port Macquarie Base Hospital
Ms Amanda O’Reilly
Manager Cancer Support Clinical
Oncology
Royal North Shore Hospital
Ms Chris Packer
Cancer Services Development Manager
Greater Southern
Area Health Service
Mr Michael Parle
Consultant clinical psychologist
Paddington
Dr Nicole Rankin
Manager Patient Support
Cancer Institute NSW
Ms Gina Svolos
Volunteer Coordinator
Sydney Cancer Centre
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Kerry Tiller
Psychologist Research Psychologist
Institute of Oncology
Prince of Wales Hospital
NSWOG Radiotherapy
128
Member
Position
Institution / Location
Dr Roger Allison
Division of Oncology
Royal Brisbane Hospital
Ms Sue Ball
Oncology Department
St Vincent’s Hospital
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Prof James Boehm
Radiation Oncology Department
St George Hospital
Dr Colin Bull (Chair)
Radiation Oncology
Westmead Hospital
Mr Harry Collins
Community Representative
Cancer Voices NSW
A/Prof Geoff Delaney
Director Radiation Oncology
Western Zone
Sydney South West
Area Health Service
Dr Richard Foster
Director Radiation Oncology
Sydney Adventist Hospital
Mr Gary Goozee
Director Medical Physics
Liverpool Cancer Therapy Centre
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Ms Jill Harris
Chief Radiation Therapist
Westmead Hospital
Ms Elizabeth Koff
Director Health Services Development
South Eastern Sydney Illawarra Area
Health Service
Dr Denise Lonergan
Director Radiation Oncology
Prince of Wales Hospital
Dr Nigel Lyons
Director Clinical Operations
Hunter New England
Area Health Service
Ms Kathy Meleady
Director Statewide Services
NSW Health
Prof Peter Metcalfe
Radiation Physicist
Wollongong Hospital
A/Prof Chris Milross
Director Radiation Oncology
Royal Prince Alfred Hospital
Dr Graeme Morgan
Director Radiation Oncology
Royal North Shore Hospital
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Ms Kim Small
Radiation Therapist
St George Hospital
Dr Chris Wratten
Director Radiation Oncology
Newcastle Mater Misericordiae Hospital
NSWOG Rural Oncology
Member
Position
Institution / Location
Ms Penny Adams
Manager Access
Cancer Institute NSW
Dr Philip Beale
Medical Oncologist
Royal Prince Alfred Hospital
Dr Stephen Begbie (Chair)
Director of Oncology
Port Macquarie Base Hospital
Dr Adam Boyce
Director of Medical Oncology
Lismore Base Hospital
Mrs Noeline Brown
Treasurer of the Hospital Visiting
Committee
Country Women’s Association
of NSW
Ms Melissa Cumming
Area Clinical Nurse Consultant Palliative
Care
Broken Hill Base Hospital
Ms Linda Cutler
Executive Director
NSW Institute of Rural Clinical Services
and Teaching
Ms Libby Emmett
Nurse Manager
Jean Colvin Hospital
Ms Diana Fisher
Regional Programs Coordinator
The Cancer Council NSW
Mrs Karen Gorzynska
Cancer Nurse Coordinator
Coffs Harbour Health Campus
Mr William Jansens
Rural Cancer Nurse Coordinator
Shoalhaven Hospital
Ms Ros Johnson
Manager Rural Health Implementation
Statewide Services
NSW Health
Ms Ruth Jones
Cancer Services Development Manager
Bloomfield Hospital
Mr Andrew Kovendy
Chief Physicist
North Coast Area Health Service
Mrs Patricia Luker
Consumer Representative
Ms Fiona Ord
Social Worker
Armidale Hospital
Chris Packer
Cancer Services Development Manager
Greater Southern Area Health Service
Mr Terry Smith
Rural Coordinator
Cancer Voices NSW
Ms Helen Snodgrass
Clinical Nurse Consultant
Oncology / Executive
Bloomfield Hospital / NSW Institute of
Rural Clinical Services and Teaching
Dr John Stewart
Medical Oncologist
Newcastle Mater Misericordiae Hospital
Prof Robin Stuart-Harris
Director Capitol Regional
Cancer Service
The Canberra Hospital
Ms Lyn Taylor
Cancer Nurse Coordinator Melanoma
Royal Prince Alfred Hospital
Mr Damien Williams
Manager/Chief Radiation Therapist
Riverina Cancer Care Centre
Cancer Institute NSW: Annual Report 2005–2006
129
NSWOG Upper Gastrointestinal
Member
130
Position
Institution / Location
Dr Rodney Aroney
Medical Oncologist
Gosford Hospital
Dr Stephen Begbie
Director of Oncology
Port Macquarie Base Hospital
Dr Andrew Biankin
Head Pancreatic Cancer Research
Garvan Institute of Medical Research
Dr Tony Bonaventura
Medical Oncologist
Hunter New England
Area Health Service
Dr Adam Boyce
Director of Medical Oncology
Lismore Base Hospital
Dr Susan Carroll
Radiation Oncologist
Prince of Wales Hospital
Dr Stanley Chen
Surgeon
John Hunter Hospital
Dr Katy Clark
Palliative Care Specialist
Royal Prince Alfred Hospital
Dr Maxwell Coleman
Surgeon
St Vincent’s Clinic
Ms Jan Maree Davis
Palliative Care
Calvary Hospital
Ms Karen Eaton
Cancer Care Coordinator
Prince of Wales Hospital
Dr Richard Eek
Oncologist
Liverpool Hospital
Dr Greg Falk
Surgeon
Concord Repatriation General Hospital
Dr Doug Fenton-Lee
Surgeon
St Vincent’s Clinic
Dr James Gallagher
Surgeon
Royal Prince Alfred Hospital
Dr Jon Gani
Surgeon
Hunter New England
Area Health Service
Dr David Goldstein
Medical Oncologist
Prince of Wales Hospital
Dr Howard Gurney
Medical Oncologist
Westmead Hospital
Dr Mike Hollands
Surgeon / Chairman
Royal Australasian College
of Surgeons
Dr Thomas Hugh
Surgeon
Royal North Shore Hospital
Dr Jane Ingham
Lead Clinician in Palliative Care
Westmead Hospital
Dr Fred Kirsten
Director of Clinical Oncology
Bankstown Hospital
Dr Andrew Kneebone
Staff Specialist in Radiation Oncology
Liverpool Hospital
Dr Henry Pleass
Surgeon
Westmead Hospital
Dr Steven Leibman
Surgeon
Royal North Shore Hospital
Dr Winston Liauw
Clinical Trials Centre Registrar
St Vincent’s Hospital
Dr Reg Lord
Upper Gastrointestinal Surgeon
St Vincent’s Hospital
Dr David Martin
Upper Gastrointestinal Surgeon
Royal Prince Alfred Hospital
Dr Neil Merrett
Surgeon
Liverpool Hospital
Dr Ian Norton
Gastroenterologist
Concord Repatriation
General Hospital
Dr Nick Pavlakis
Medical Oncologist
Royal North Shore Hospital
Dr Jaswinder Samra
Surgeon
Royal North Shore Hospital
Dr Eva Segelov
Medical Oncologist
St Vincent’s Hospital
Dr Jenny Shannon
Medical Oncologist
Nepean Hospital
Dr Garett Smith
Surgeon
Royal North Shore Hospital
Dr Ross Smith (Deputy Chair)
Surgeon
Royal North Shore Hospital
Dr David Storey (Chair)
Surgeon
Royal Prince Alfred Hospital
A/Prof Simone Strasser
Gastroenterologist
Royal Prince Alfred Hospital
Dr Stephen Thompson
Surgeon
Prince of Wales Hospital
Ms Elizabeth Tracey
Strategic Manager NSW Central Cancer
Registry
Cancer Institute NSW
Prof Craig Underhill
Medical oncologist
Albury Base Hospital / Murray Valley
Hospital
Cancer Institute NSW: Annual Report 2005–2006
Member
Position
Institution / Location
Ms Francina Wade
Cancer Nurse Coordinator Upper
Gastrointestinal
Royal North Shore Hospital
Dr Vanessa Wills
Surgeon
Hunter New England Area Health Service
Dr Robert Wilson
Surgeon
Liverpool Hospital
Member
Position
Institution / Location
Dr Paul Ainsworth
Urologist
Maitland
Dr Nader Awad
Urologist
Port Macquarie
Dr Philip Bergersen
Urologist
Bondi Junction
Prof Martin Berry (Deputy Chair)
Director Cancer Services
Sydney South West
Area Health Service
Prof Jim Bishop
Chief Cancer Officer and
Chief Executive Officer
Cancer Institute NSW
Dr Tony Bonaventura
Medical Oncologist
Newcastle Mater Misericordiae Hospital
Dr Andrew Brooks (Chair)
Urologist
Westmead Hospital
Dr Joseph Bucci
Radiation Oncologist
St George Hospital
Dr Paul De Souza
Medical Oncologist
St George Hospital
Dr Warwick Delprado
Director Histopathology
Douglass Hanly Moir Pathology
Dr Paul Gassner
Urological Surgeon
Bondi Junction
Mr Andrew Giles
Chief Executive Officer
Prostate Cancer Foundation of Australia
Prof John Grygiel
Medical Oncologist
St Vincent’s Hospital
Dr Howard Gurney
Medical Oncologist
Westmead Hospital
Dr Vanessa Hayes
Project Leader Cancer
Genetics
Garvan Institute of Medical Research
A/Prof Susan Henshell
Senior Researcher
Garvan Institute of
Medical Research
Dr Lisa Horvath
Medical Oncologist / Researcher
Royal Prince Alfred
Dr Paul Jackson
Oncology Researcher
Prince of Wales Hospital
Dr Paul Jelfs
Director Cancer Information and
Registries
Cancer Institute NSW
Prof James Kench
Pathologist
Westmead Hospital
Dr Andrew Kneebone
Staff Specialist in Radiation Oncology
Liverpool Hospital
Dr Andre Lalak
Urologist
Concord Repatriation
General Hospital
Dr William Lynch
Urologist
St George Private Medical Centre
Dr Gavin Marx
Medical Oncologist
Sydney Haematology
Oncology Clinic
Dr Manish Patel
Urologist
Westmead Private Hospital
Dr Nick Pavlakis
Medical Oncologist
Royal North Shore Hospital
Mr John Ramsay
Consumer Representative
Prostate Cancer Foundation
of Australia
Dr Kris Rasiah
Urologist
Garvan Institute of
Medical Research
NSWOG Urology
Prof Pamela Russell
Oncology Researcher
Prince of Wales Hospital
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Dr David Smith
Oncology Researcher
The Cancer Council NSW
Dr Phillip Sprott
Urologist
Royal Newcastle Hospital
Dr Mark Stevens
Radiation Oncologist
St Vincent’s Hospital
Cancer Institute NSW: Annual Report 2005–2006
131
Member
Position
Institution / Location
Prof Martin Stockler
Medical Oncologist
Royal Prince Alfred Hospital
Dr Phillip Stricker
Urologist
St Vincent’s Hospital
Dr Paul Sved
Urologist
Royal Prince Alfred Hospital
Dr Sandra Turner
Radiation Oncologist
Westmead Hospital
Ms Kate Tynan
Researcher
Liverpool Cancer Therapy Centre
Dr Henry Woo
Urologist
Westmead Private Hospital
NSW Skin Cancer Prevention Committee
Member
Position
Institution / Location
Ms Kay Coppa
Manager Skin Cancer Prevention
The Cancer Council NSW
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Ms Anita Dessaix
Program Manager Cancer Prevention
Cancer Institute NSW
Ms Jenny Hughes
Manager Health Promotion Strategies
and Settings Branch
NSW Health
Ms Nidia Marneros
Senior Project Officer Settings and
Equity
NSW Health
Ms Anita Tang
Director Health Strategies
The Cancer Council NSW
Pap Test Register Advisory Committee
132
Member
Position
Institution / Location
Dr Claire Biro
Chief Gynaecological Pathologist
Symbion Laverty Pathology
The Royal College of Pathologists of
Australasia
Dr Chris Dalrymple
Gynaecological Oncologist
Royal Prince Alfred Hospital
Dr Suzanne Hyne
Gynaecological Pathologist Symbion
Laverty Pathology
Histology representative
Dr Paul Jelfs (Acting Chair)
Director Cancer Information and
Registries
Cancer Institute NSW
Dr Amanda McBride
General Practitioner
Northern Sydney Central Coast Area
Health Service
Ms Jane McQueen
Manager Clinical Services Cervical
Screening NSW
Cancer Institute NSW
Ms Jane Mills
Consumer Representative
n/a
Dr Helen Moore
Manager Population Health Indicators
and Reporting Branch
Centre for Epidemiology and Research
NSW Health
Dr Gerry Wain
Scientific Director Cervical Screening
Program
Cancer Institute NSW
Ms Yeqin Zuo
Manager NSW Pap Test Register
Cancer Institute NSW
Ms Liping Qian
Follow-up Coordinator NSW Pap Test
Register
Cancer Institute NSW
Cancer Institute NSW: Annual Report 2005–2006
Quality and Clinical Effectiveness Advisory Committee
Member
Position
Institution / Location
Prof Bruce Barraclough
Chairman
Australian Council for Safety and Quality
in Health Care
A/Prof Michael Barton
Research Director Collaboration for
Cancer Outcomes Research and
Evaluation (CCORE)
Liverpool Hospital
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Ms Michelle Davies
Palliative Care and Oncology Services
Coordinator
Greater Western Area Health Service
Prof Stewart Dunn
(Deputy Chair)
Pam McLean Cancer Communication
Centre
Northern Sydney Central Coast Area
Health Service
Ms Anthea Hepburn
Project Officer
Cancer Institute NSW
Mr Neil Herron
Project Manager
Northern Sydney Central Coast Area
Health Service
Prof Clifford Hughes (Chair)
Chief Executive Officer
Clinical Excellence Commission
Dr Cynthia Lean
Manager Collaboration and Information
Cancer Institute NSW
Ms Anne Lloyd
Community Services Development
Manager
Cancer Services Without Walls
Dr Karen Luxford
Deputy Director
National Breast Cancer Centre
Ms Louise Maher
Deputy Director
Sydney West Area Health Service
Dr Michael Smith
Director Quality and Safety Branch
NSW Health
Ms Catherine Murray
Clinical Manager Community Services
Sydney South West
Area Health Service
Mr John Stubbs
Consumer Representative
Cancer Voices NSW
Dr David Townend
Surgeon
St Vincent’s Hospital Lismore
Dr Craig Underhill
Medical Oncologist
Border Medical Oncology
Quitline Steering Committee
Member
Position
Institution / Location
Ms Trish Cotter (Chair)
Director Cancer Prevention
Cancer Institute NSW
Ms Bronwyn Crosby
Deputy Director Alcohol and
Drug Service
St Vincent’s Hospital
Ms Anita Dessaix
Program Manager Cancer Prevention
Cancer Institute NSW
Ms Elayne Mitchell
Senior Policy Analyst Cessation
NSW Health
Ms Donna Perez
Project Officer Research and Evaluation
Cancer Institute NSW
Mr Peter Todaro
Director
NSW Multicultural Health
Communication Service
Mr Brendon Walker
Call Centre Manager
NSW Quitline
Dr Alex Wodak
Director Alcohol and Drug Service
St Vincent’s Hospital
Cancer Institute NSW: Annual Report 2005–2006
133
Radiotherapy Joint Advisory Committee
134
Member
Position
Institution / Location
Ms Penny Adams
Manager Access
Cancer Institute NSW
Mr Roger Allison
Division of Oncology
Royal Brisbane Hospital
Ms Sue Ball
Radiation Oncology Department
Department St Vincent’s Hospital
Prof Jim Bishop
Chief Cancer Officer and
Chief Executive Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Prof James Boehm
Radiation Oncology Department
St George Hospital
Dr Colin Bull (Chair)
Director Radiation Oncology
Westmead Hospital
A/Prof Geoff Delaney
Director Radiation Oncology
Western Zone
Sydney South West
Area Health Service
Dr Richard Foster
Director Radiation Oncology
The Sydney Adventist Hospital
Mr Gary Goozee
Director Medical Physics
Liverpool Cancer Therapy Centre
Ms Jill Harris
Chief Radiation Therapist
Westmead Hospital
Ms Elizabeth Koff
Director Health Services Development
South Eastern Sydney Illawarra Area
Health Service
Dr Denise Lonergan
Director Radiation Oncology
Prince of Wales Hospital
Dr Nigel Lyons
A/Chief Executive
Greater Southern
Area Health Service
Ms Kathy Meleady
Director Statewide Services
NSW Health
Prof Peter Metcalfe
Cancer Institute NSW Chair of Radiation
Oncology Medical Physicist
University of Wollongong
Mr Matthew Mikus-Wellings
Project Officer
Cancer Institute NSW
A/Prof Chris Milross
Director Radiation Oncology
Royal Prince Alfred Hospital
A/Prof Graeme Morgan
Director Radiation Oncology
Royal North Shore Hospital
A/Prof Tom Shakespeare
Director Area Cancer Services
North Coast Area Health Service
Ms Kim Small
Chief Radiation Therapist
St George Hospital
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Dr Chris Wratten
Director Radiation Oncology
Newcastle Mater Misericordiae Hospital
Cancer Institute NSW: Annual Report 2005–2006
Rural Oncology Sub-Committee
Member
Position
Institution / Location
Ms Penny Adams
Manager Access
Cancer Institute NSW
Dr Philip Beale
Medical Oncologist
Royal Prince Alfred Hospital
Dr Stephen Begbie (Chair)
Director of Oncology
Port Macquarie Base Hospital
Prof Jim Bishop
Chief Cancer Officer and Chief Executive
Officer
Cancer Institute NSW
Mr Neville Board
Acting Director Cancer Services and
Education Division
Cancer Institute NSW
Dr Adam Boyce
Director of Medical Oncology
Lismore Base Hospital
Mrs Noeline Brown
Community Representative
Country Women’s Association
of NSW
Ms Philippa Cahill
Manager Clinical Workforce
Cancer Institute NSW
Ms Melissa Cumming
Area Cancer Nurse Coordinator Palliative
Care
Broken Hill Base Hospital
Ms Linda Cutler
Executive Director
NSW Institute of Rural Clinical Services
and Teaching
Ms Libby Emmett
Nurse Manager
Jean Colvin Hospital
Ms Kim Faulkner
Project Officer
Cancer Institute NSW
Ms Diana Fisher
Regional Programs Coordinator
The Cancer Council NSW
Mrs Karen Gorzynska
Cancer Nurse Coordinator
Coffs Harbour Health Campus
Mr William Jansens
Cancer Nurse Coordinator
Shoalhaven Hospital
Ms Ros Johnson
Manager Rural Health Implementation
Statewide Services
NSW Health
Ms Ruth Jones
Cancer Services Development Manager
Greater Western
Area Health Service
Mr Andrew Kovendy
Chief Physicist
North Coast Area Health Service
Mrs Patricia Luker
Community Representative
Bega Valley Hospital Auxiliary
Ms Fiona Ord
Social Worker
Armidale Hospital
Ms Chris Packer
Cancer Services Development Manager
Greater Southern Area Health Service
Mr Terry Smith
Community Representative
Cancer Voices NSW
Ms Helen Snodgrass
(Deputy Chair)
Clinical Nurse Consultant
Oncology / Executive
Bloomfield Hospital / NSW Institute of
Rural Clinical Services and Teaching
Dr John Stewart
Medical Oncologist
Newcastle Mater Misericordiae Hospital
A/Prof Robin Stuart-Harris
Director Capitol Regional
Cancer Service
The Canberra Hospital
Ms Lyn Taylor
Cancer Nurse Coordinator
Sydney Melanoma Unit
Ms Denise Thomas
Director Cancer Screening
Cancer Institute NSW
Ms Louise Whitaker
Project Coordinator
Cancer Institute NSW
Mr Damien Williams
Manager / Chief Radiation Therapist
Riverina Cancer Care Centre
Cancer Institute NSW: Annual Report 2005–2006
135
Sponsorship Committee
Member
Position
Institution / Location
Ms Trish Cotter
Director Cancer Prevention
Cancer Institute NSW
Ms Beth Macauley
Chief Operating Officer
Cancer Institute NSW
Mr Scott Maunder
Manager Statewide
Corporate Services
Cancer Institute NSW
Mr David Sabanayagam
Finance and Administration Manager
Cancer Institute NSW
Consultants
During the reporting year, the Cancer Institute NSW engaged 18 consultants to provide expert advice on cancer
research and clinical programs. The total cost of the consultancies was $117,557.81. This included the following
consultancy equal to or more than $30,000.
Company
Consultant
Service provided
Cost
Eismaihen Pty Ltd
Dr John Funder
Chair of the Research Grants
Review Committee
$59,400
Credit Card Certification
•
It is affirmed that for the 2005-2006 financial year
Cancer Institute NSW’s credit card use is within
credit card use within the Cancer Institute NSW
the guidelines issued.
was in accordance with Premier’s memoranda and
Treasurer’s Directions.
Six-monthly reports / compliance surveys are
submitted to NSW Treasury, certifying that the
Credit Card Use
Electronic Service
Delivery
Credit card use within the Cancer Institute NSW is
As part of our commitment to electronic service
largely limited to:
delivery, the Cancer Institute NSW implemented a
•
The reimbursement of travel and subsistence
expense
range of initiatives in 2005-2006:
•
Enhancement of a searchable web-based
module on cancer incidence and mortality
•
The purchase of books and publications
•
Seminar and conference deposits
•
Travel bookings deposits
•
Official business use while engaged in
textbooks for clinicians throughout the NSW
overseas travel
Health system
•
Development of over 300 web-based standard
cancer treatment programs (CI-SCaT)
•
Documenting Credit Card Use
•
Provision of a suite of cancer journals and
Pilot of electronic cancer notification from
laboratories to the NSW Central Cancer Registry
The following measures are used to monitor the use
of credit cards within the Cancer Institute NSW:
•
Development of online hospital cancer activity
reports for Area Health Services and Cancer
•
The Cancer Institute NSW’s credit card policy is
documented.
•
Reports and statements on the appropriateness
of credit card usage are periodically lodged for
management consideration.
136
Cancer Institute NSW: Annual Report 2005–2006
Institute NSW advisory committees.
Energy Management
Events
The Cancer Institute NSW is committed to achieving
savings in energy usage and applies, where
Date
Event
possible, sustainable energy management principles
26 June 2006
BreastScreen NSW Croydon
Launch
Policy for Reducing Greenhouse Emissions.
May-August 2006
Rock Eisteddfod Challenge 2006
This includes the purchase of energy efficient office
25 May 2006
Premier’s Awards for Excellence
in Cancer Research 2006
8 May 2006
Graphic Warnings Launch,
Gangrene, Powerhouse Museum
10 May 2006
Fundraising Round Table,
Dockside, Darling Harbour
26 – 28 May 2006
General Practitioners Conference
and Exhibition, Sydney
Showground
25 and 26 May 2006
CI-SCaT Nurses Reference
Group Workshop, Brighton Beach
Novotel
10 May 2006
Breast Cancer Nurses
Conference, Star City
27 April 2006
Australian Technology Showcase /
CI-SCaT, Royal Randwick
10 March 2006
Complementary Medicines
Seminar, Australian Technology
Park
8 March 2006
Clinical Fellows Launch Australian Technology Park
15 January 2006
Melanoma Launch, Bondi Beach
3 November 2005
Lung Disease TVC Launch,
Cancer Institute NSW
15 – 18 November
2005
Clinical Oncological Society
of Australia (COSA), Brisbane,
Queensland
18 October 2005
CI-SCaT Launch, St Vincent’s
Hospital, Sydney
12 October 2005
BreastScreen NSW Van Launch,
Sydney Opera House
May-June 2005
Rural Community Patient Forums
at eight regional locations
in line with the Government’s Energy Management
equipment (including computers, computer screens,
printers, copies etc) and educating staff about ways
of reducing energy usage.
The Cancer Institute NSW occupies two floors of
the Biomedical Building, located at the Australian
Technology Park, Redfern, which are leased from
Australia Technology Park Precinct Management
Ltd (which is an entity controlled by the Redfern–
Waterloo Authority). We work closely with our
landlord to enable more efficient management of
energy and water use.
The Cancer Institute NSW has minimal opportunities
to achieve savings in fuel usage as our fleet consists
of only one vehicle.
Future Actions
Over the course of the coming year the Cancer
Institute NSW will work closely with Australia
Technology Park Precinct Management Ltd to
obtain an accredited Australian Building Greenhouse
Rating (ABGR) for our office premises that meets
the Government’s initiatives for improving the
‘greenhouse’ performance of government office
buildings.
Cancer Institute NSW: Annual Report 2005–2006
137
Financial Overview 2005-2006
The actual spending proportions for the various areas of activity in the Cancer Institute NSW are in line with
budgeted proportions. For details of financial performance for 2005-2006, please refer to audited financial
statements in this report.
Cancer Communication
1% Admin, IT and HR
5%
Cancer Prevention
8%
Cancer Communication
1% Admin, IT and HR
4%
Cancer Prevention
8%
Cancer Information
and Registries
9%
Cancer Information
and Registries
11%
Cancer
Research
17%
Cancer
Research
16%
Cancer Screening
36%
Cancer Services
and Education
24%
Cancer Screening
35%
Cancer Services
and Education
25%
Budget ($103.6m)
Actual ($94.9m)
The surplus for the financial year 2005-2006 has been allocated to Cancer Institute NSW programs in the
2006-2007 financial year.
Budget 2006-2007
The Cancer Institute NSW has received its 2006-2007 allocation of $126.4 million from NSW Health.
The proportions of expenditure proposed are shown below,
Cancer Communication
1%
Admin, IT and HR
4%
Cancer Prevention
12%
Cancer Information
and Registries
9%
Cancer
Research
20%
Cancer Screening
31%
Cancer Services
and Education
23%
Budget ($126.4m)
138
Cancer Institute NSW: Annual Report 2005–2006
Freedom of Information
The Cancer Institute NSW is currently not prescribed under the Freedom of Information Act 1989 and does
not have a Principal Officer under Schedule 1 of the Act. All requests for information under the Freedom of
Information Act are managed by NSW Health. There were no requests for information relating to the Cancer
Institute NSW during the 2005-2006 financial year.
Guarantee of Service
The Cancer Institute NSW has established standards and guidelines for responding to requests from health
consumers for information and non medical advice concerning cancer, whether received by phone, fax, email or
written correspondence. These standards ensure that informative, timely responses are provided to inquiries.
Media Releases
Date
Media Release
26 June 2006
New BreastScreen Service for Inner-West Women
7 June 2006
Spotlight on Bowel Cancer for Awareness Week
31 May 2006
World No Tobacco Day 2006: Record calls to Quitline as women
get the message
25 May 2006
World-Leading Cancer Researchers Honoured in Sydney
12 May 2006
NSW Cancer Patients Get Extra Help with Travel and Stays
8 May 2006
Graphic Quit Smoking Campaign: ‘Amputation’ starts tonight.
8 May 2006
Smoking Can Cost an Arm or a Leg
19 April 2006
New Campaign Shows Smokers How to Kick the Habit
28 March 2006
Smokers and Drinkers at Earlier Risk for Large Bowel Cancer?
16 March 2006
Cancer Australia Begins to Take Shape
14 March 2006
Oral Cancer Still A Risk, But Awareness Drags
9 March 2006
Mammography Screening: 15 Minutes That Can Save A Woman’s Life
9 March 2006
90 Lives Saved Every Year Through Breast Screening in NSW
9 March 2006
New Awards to Help the Hunter’s Brightest Cancer Doctors
27 February 2006
Will Graphic Pack Warnings Change Smokers’ Minds?
14 February 2006
Graphic Health Warnings to Inspire Aussie Smokers to Quit
13 February 2006
Trade in the Smokes for Flowers this Valentine’s Day
2 February 2006
Cancer: What You Need to Know But Couldn’t Find
10 January 2006
Cancer Institute NSW to Increase Research Funding
5 January 2006
New Melanoma Map Reveals the Highest Skin Cancer Risk Areas in NSW
22 December 2005
$9 Million On New Awareness Campaign Corrects Misconception
About Light Cigarettes
21 December 2005
Holiday Revellers Warned: Link Between Alcohol and Cancer
13 December 2005
Beauty News: Sunscreen - The Best Product to Protect Your Skin
8 December 2005
Melanoma Threat On The Increase, Says New Figures
7 December 2005
NSW Looks For a Common Front in Cancer Research
28 November 2005
Will Cervical Cancer get a ‘Gina Gold effect’?
24 November 2005
Smoking, Drugs, Genes and Vaccines - A Brave New World?
23 November 2005
3rd Australian Tobacco Control Conference
Cancer Institute NSW: Annual Report 2005–2006
139
Date
Media Release
22 November 2005
NSW GPs Get Help in Front Line Fight Against Cancer
21 November 2005
Cancer Institute NSW Board Appointments
16 November 2005
Sweeter Dreams If You Quit Smoking
16 November 2005
Peter Harvey Raises His Voice on Smoking
3 November 2005
When Every Breath You Take Gets Harder - New Lung Disease
Campaign Launch
18 October 2005
NSW Cancer Treatment Gets an Online Revolution
12 October 2005
$4.2 Million to Extend Cancer Screening Services
2 October 2005
Cancer Roundtable to Help Coordinate Fund Raising
19 September 2005
Digital Breast Screens give Technological Edge
19 September 2005
Is Family the Hidden Key to Quitting Smoking?
4 September 2005
Dad, You Should Have Been There
24 August 2005
NSW To Get More Clinical Cancer Trials
25 August 2005
The Cancer Council NSW Review Recommends Private Company
Ministerial Representations Received
Item
Ministerial correspondence
(NSW Health)
140
Cancer Institute NSW: Annual Report 2005–2006
2005-2006
140
Overseas Travel
Staff Members Name
Conference
Place
Date
Prof James Bishop
First International Cancer
Control Congress
Vancouver, Canada
22-27 October 2005
Prof James Bishop
American Association of Cancer
Research
Washington, USA
31 March – 10 April 2006
Prof James Bishop
American Society of Clinical
Oncology Conference
Los Angeles, USA
1-7 June 2006
Dr Paul Jelfs
First International Cancer
Control Congress
Vancouver, Canada
19-28 October 2005
Dr Paul Jelfs
International Association of
Cancer Registries
Entebbe, Uganda
10-19 September 2005
Ms Jill Miller
Radiological Society of North
America
Chicago, USA
25 November –
4 December 2005
Ms Mary Rickard
Radiological Society of North
America
Chicago, USA
25 November –
4 December 2005
Privacy Management
Plan
The Cancer Institute NSW Privacy Management
Publications
General
Plan identifies how the Cancer Institute NSW and all
J Bichel-Findlay (2005) Cancer Institute NSW
agencies and health services funded by the Institute
Standard Cancer Treatments (CI-SCaT) Cancer
will comply with privacy legislation.
Forum 29(3) 163-164.
Tracey EA, Roder D, Bishop J, Chen S, Chen W,
The Plan provides detail of how the Institute intends
to protect the privacy of its clients, staff and the
Cancer in New South Wales: Incidence and Mortality
2003. Sydney: Cancer Institute NSW, 2005.
public when it processes personal information,
to assist people who may wish to exercise their
Breast screening
rights under the Privacy and Personal Information
Clayton Chiu, Stephen Morrell, Andrew Page,
Protection (PPIP) Act 1998 or the Health Records
Mary Rickard, Ann Brassil, Richard Taylor (2006).
and Information Privacy (HRIP) Act 2002 and make
Population based mammography screening and
a complaint or request for an internal review. For
breast cancer incidence in New South Wales,
the reporting period there have been no complaints
Australia. Cancer Causes and Control 17:153-160.
received by the Cancer Institute NSW regarding
its dealings with personal information under the
PPIP Act and personal health information under the
HRIP Act that have resulted in the requirement for a
Request for Internal Review.
Mary Rickard, Richard Taylor, Andrew Page, Jane
Estoesta (2006) Cancer Detection and mammogram
volume of Radiologists in a population based
screening program. The Breast 15: 39-43.
Cervical screening
Taylor R, Morrell S, Mamoon H, Wain G, Ross J
(2006). Decline in cervical cancer incidence and
mortality in New South Wales in relation to control
activities. Cancer Causes and Control. 17(3):
299-306.
Cancer Institute NSW: Annual Report 2005–2006
141
Morrell S, Taylor R, Wain G (2005). A study of Pap test
history and histologically determined cervical cancer
in NSW women, 1997-2003. Journal of
Medical Screening. 12(4):190-196.
Risk Management
The Cancer Institute NSW identifies and manages its
business and operational risks within an integrated
Morrell S, Taylor R, Zeckendorf S, Niciak A, Wain
G, Ross J (2005). How much does a reminder letter
increase cervical screening among under-screened
women in NSW? Australian and New Zealand Journal
of Public Health. 29(1):78-84.
Joint Publications
Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki
K, Tracey E, Andersen A, Brewster DH, Pukkala E,
McBride ML, Kliewer EV, Tonita JM, Kee-Seng C,
Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P,
Brennan P. Risk of second cancer among women with
breast cancer. Int J Cancer. 2006 May 1;118(9):
2285-92.
Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki
K, Pukkala E, Tracey E, Brewster DH, McBride ML,
Pompe-Kirn V, Kliewer EV, Tonita JM, Chia KS, Martos
C,Jonasson JG, Colin D, Scelo G, Brennan P. A pooled
analysis of second primary pancreatic cancer.
Am J Epidemiol. 2006 Mar 15;163(6):502-11.
Epub 2006 Jan 18.
Sandeep TC, Strachan MW, Reynolds RM, Brewster
DH, Scelo G, Pukkala E, Hemminki K, Anderson A,
Tracey E, Friis S, McBride ML, Kee-Seng C,
Pompe-Kirn V,Kliewer EV, Tonita JM, Jonasson JG,
Martos C, Boffetta P, Brennan P. Second primary
cancers in thyroid cancer patients: a multinational
record linkage study.J Clin Endocrinol Metab. 2006
May;91(5):1819-25. Epub 2006 Feb 14.
Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen
JH, Andersen A, Tracey E, Brewster DH, McBride
ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia
KS, Jonasson JG, Martos C, Colin D, Brennan P.
Associations between small intestine cancer and other
primary cancers: an international population-based
study. Int J Cancer. 2006 Jan 1;118(1):189-96.
Brennan P, Scelo G, Hemminki K, Mellemkjaer L,
Tracey E, Andersen A, Brewster DH, Pukkala E,
McBride ML, Kliewer EV, Tonita JM, Seow A,
Pompe-Kirn V,Martos C, Jonasson JG, Colin D,
Boffetta P. Second primary cancers among 109 000
cases of non-Hodgkin’s lymphoma. Br J Cancer.
2005 Jul 11;93(1):159-66.
Hemminki K, Scelo G, Boffetta P, Mellemkjaer L,
Tracey E, Andersen A, Brewster DH, Pukkala E,
McBride M, Kliewer EV, Chia KS, Pompe-Kirn V,
Martos C, Jonasson JG, Li X, Brennan P. Second
primary malignancies in patients with male breast
cancer.Br J Cancer. 2005 Apr 11;92(7):1288-92.
142
Cancer Institute NSW: Annual Report 2005–2006
risk management framework including the following
elements:
•
Periodic risk assessment and analysis performed
as part of the Internal Audit Program
•
Periodic updates of the risk register and risk action
plan and ongoing monitoring of risk
management strategies
•
A risk-based Internal Audit Program, and
•
Oversight of all elements of the risk management
framework by the Audit Committee of the Board.
Sponsorships and Community Grants
Sponsorships 2005-2006
Purpose
Organisation
Amount
Rock Eisteddfod Challenge
Rock Eisteddfod Challenge Foundation
$100,000
Support for seven NSW based cancer
researchers’ attendance at the Clinical
Trials Methodology Workshop
Medical Oncology Group Of Australia
Incorporated
$21,818
Visiting Speaker Prof Ruth Warren
- Breast MRI
Sydney Cancer Centre
$20,000
Conference Sponsorship - National
Breast Care Nurses Conference
National Breast Care Nurses Conference
2006
$15,000
Conference Sponsorship - 2006
General Practitioner Conference and
Exhibition
General Practitioner Conference
and Exhibition
$11,240
Speaker Sponsorship - Head and Neck
Conference
Royal Australasian College of
Surgeons
$10,000
Annual Scientific Meeting for 2006
Trans-Tasman Radiation
Oncology Group
$9,900
Micro and Mini Dosimetry (MMD)
and International Prostate Cancer
Treatment (IPCT) 2005 Sponsorship
Centre for Medical Radiation Physics,
University of Wollongong
$9,091
Speaker Support for Scientific Meeting
Royal Australasian College of Surgeons
$9,091
Clinical Oncological Society of Australia
(COSA) Conference Sponsorship
Clinical Oncological Society of
Australia (COSA)
Sponsorship – Australian Lung
Conference
The Australian Lung Foundation
Total
$11,554
$7,500
$225,194
Community Grants 2005-2006
Purpose
Organisation
15th Annual Symposium of the Sydney
Institute of Palliative Medicine
Sydney Institute of Palliative
Medicine
$5,000
Community grant for Parents Quit
Smoking campaign
Greek Welfare Centre
$5,000
Development of materials for Family
History campaign
Northern Sydney Central Coast
Area Health Service
$5,000
Grant for Health Warnings campaign
The Millennium Foundation
$4,545
NSW Radiation Oncology Clinical Trials
forum
Trans Tasman Radiation
Oncology Group
$4,545
Purchase of a laptop and a digital
projector
Myeloma Foundation
$3,636
Total
Amount
$27,727
Cancer Institute NSW: Annual Report 2005–2006
143
Staffing
Staff Profile
The following table details the number of Officers in the Cancer Institute NSW in various categories as at 30 June
in the past two years.
Staff Profile – Two Year Comparison
2004-2005
Level
Total
Men
4
2
HSM 4-6
14.63
HSM 1-3
2005-2006
Total
Men
2
6.9
2
4.9
7
7.63
20.26
7
13.26
21.77
5
16.77
52.54
15.84
36.7
20.9
3
17.9
21.54
2.05
19.49
Staff Specialists
2
2
-
0.9
0.3
0.6
Analysts
-
-
-
1
-
1
63.3
19
44.3
103.15
27.19
76.96
SES
Admin Officers
Total
Women
Women
Chief and Senior Executive Officers
2004-2005
Level
2005-2006
Total
Men
Women
Total
Men
Women
7
1
1
-
1
1
-
2
3
1
2
3
1
2
1
-
-
-
3
-
3
Total
4
2
2
7
2
5
During 2005-2006, the positions of Director Cancer Prevention, Director Cancer Research and Director Cancer
Communication were added to the Cancer Institute NSW Senior Executive establishment.
Cancer Institute NSW Staff at 30 June 2006
Executive
Prof Jim Bishop
Chief Cancer Officer and Chief Executive Officer
Beth Macauley
Chief Operating Officer
Executive Office and Administration
Executive Unit
Christine Ford
Executive Assistant to Chief Operating Officer
Parisa Glass
Research Officer
Charles Latimer
Policy Adviser / Executive Officer to the Chief Cancer Officer and Chief
Kelly Smith
Executive Assistant to Chief Cancer Officer
Executive Officer
144
Cancer Institute NSW: Annual Report 2005–2006
Finance
Rekha Bandna
Finance Officer
Anton Liyanage
Management Accountant
Emma Niccol
Receptionist/Admin Support Officer
David Sabanayagam
Finance and Administration Manager
Rosanna Simone
Administration Support Officer
Human Resources
Mirjana Juka
Human Resources Adviser
Katherine MacHutchison
Human Resources Manager
Sharon McIvor
Human Resources Adviser
Information Technology
Brendan Fahey
Senior Systems Administrator
William Hu
Network Analyst
Ajeet Nagdev
Network Support Officer
Perry Ramen
Systems Support Analyst
David Schanzer
Senior Analyst/Programmer
Michael Schmitz
Information Technology Manager
Sanjeev Sharma
System Administrator
Deirdre Slattery
Project Officer Records and Knowledge Management
David Wyndham
Analyst/Programmer
Cancer Prevention Division
Emma Bolger
Executive Assisant
Angela Corlett
Project Officer Cancer Prevention
Trish Cotter
Director Cancer Prevention
Anita Dessaix
Program Manager Cancer Prevention
Graeme Hickey
Administration Assistant
Donna Perez
Project Officer Research and Evaluation
Sabrina Ostowari
Project Officer
Cancer Screen Division
Clare Banks
Research Officer – Monitoring, Evaluation and Research
Tara Bowman
Project Officer Bowel Screen
Ann Brassil
Program Director BreastScreen
Mark Costello
Operations Manager BreastScreen NSW
Shashi Dandekar
Project Manager
Jane Estoesta
State Data and Evaluation Manager
Fran Hartman
Senior Project Officer
Connie Ho
Senior Data Manager
William Hu
State Information Technology Manager
Michelle Hughes
Project Officer Bowel Screen
Arthur Hung
Research Officer
Ingrid Hutchinson
Project Officer Cervical Screen
Scott Maunder
Manager Statewide Corporate Services
Warwick May
Service Development and Training
Jane McQueen
Manager Clinical Services Cervical Screening NSW
Jill Miller
State Radiographer and Manager
Steve Morrell
Manager Research and Epidemiologist
Venu Muddasani
Senior Analyst
Kojo Odoom
Data Manager
Mayanne Oo
Marketing Assistant
Cancer Institute NSW: Annual Report 2005–2006
145
Andrew Page
Research Officer
Nirmala Pimenta
State Marketing Officer
Vanessa Pollett
Marketing Assistant
Jayne Ross
Program Manager
Denise Thomas
Director Cancer Screening
Carolyn Der Vartanian
Senior Project Officer
Gerry Wain
Scientific Director Cervical Screening NSW
Calvin Yeoh
State Marketing Officer
Cancer Services and Education Division
Penny Adams
Manager Access
Catherine Bullivant
Admin Support Officer
Philippa Cahill
Manager Clinical Workforce
Louise Farrell
Project Officer
Paul Harnett
Senior Staff Specialist
Richard Hawkins
Clinical Program Manager
Anthea Hepburn
Project Officer
Terry Juarez
Executive Assistant
Cynthia Lean
Manager Collaboration and Information
Julie MacDonald
Administrative Support Officer
Fiona McIntyre
Administrative Support Officer
Matt Mikus-Wellings
Project Officer
Paula Mohacsi
Project Officer
Nicole Rankin
Program Manager
Fiona Shipman
Manager Cancer Education and Training
Louise Whitaker
Project Coordinator, Clinical Workforce
Cancer Research Division
Angelina Catanzariti
Clinical Trials Manager
Rodney Ecclestone
Ethics Manager
Carmel Edwards
Director Research Programs
Christine Filetti
Executive Assistant
Judith Hudson
Research Grants and Infrastructure Manager
Kirsten Legione
Project Officer Ethics
Garry Way
Project Officer Research
Cancer Information and Registries Division
146
Deborah Baker
Manager Monitoring, Evaluation and Research
Jen Bichel-Findlay
Program Manager Quality Cancer
Neville Board
Acting Director Cancer Services and Education Division
Nari Clarke
Project Officer, Clinical
Claire Cooke-Yarborough
Senior Staff Specialist
Jennifer Duncombe
Project Officer Monitoring, Evaluation and Research
Paul Jelfs
Director, Information and Registries
John Leonard
Data Officer
Rachael Rodd
Information Officer
Shelley Rushton
Project Officer
Amy Stratford
Admin Support Officer
Toni Ann Wearn
Executive Assistant
Cancer Institute NSW: Annual Report 2005–2006
NSW Central Cancer Registry
Maria Arcorace
Coding Supervisor
Lisa Barry
Senior Medical Coder
Denise Bradfield
Medical Data Clerk
Heather Byrne
Medical Coder
Shuling Chen
Biostatistician
Wendy Chen
Medical Coder/Analyst
Celia Ching
Administration and Data Clerk
Marylon Coates
Medical Coder/Statistical Analyst
Bruna Corti
Senior Medical Coder
Michelle Emanuels
Data Clerk
Diana Fletcher
Data Clerk
Basil Goonewardene
Medical Data Clerk
Vijay Gounder
Medical Data Clerk
Tanya Johannesen
Patient Recruitment Officer
Janet Lee
Medical Coder
Dale Matthews
Senior Medical Coder
Karen Mulherin
Notifications Coordinator
Anne Pelquest-Hunt
Senior Medical Coder
Sharon Pettigrew
Senior Medical Coder
Lesley Porter
Medical Coder
Brenda Potter
Data Clerk
Lilian Scafaro
Data Clerk
Clementina Squadrito
Senior Medical Coder
Elizabeth Tracey
Strategic Manager NSW Central Cancer Registry
Robyn Ward
Senior Staff Specialist
Kylie Willows
Notifications Coordinator
Haining Xie
Medical Coder
Laila Zarour
Data Officer
NSW Pap Test Register
Noore Alam
Project Officer
Maureen Allemann
Administration Officer
Nadine Ben-Mayor
Data Officer
Yvonne Bowyer
Data Manager, NSW Pap Test Register
Jayne Court
Data Officer
Flora Ding
Assistant Data Manager
Dianne Gallagher
Information Officer
Kathleen Holm
Information Officer
Meg Kaegi
Data officer
Grace Kwaan
Data Manager
Julianne O’Flynn
Data Manager
Liping Qian
Follow Up Coordinator
Suzanne Voysey
Assistant Follow Up Coordinator
Yeqin Zuo
Pap Test Register Manager
Cancer Communication Division
Lancia Jordana
Director Cancer Communication
Cancer Institute NSW: Annual Report 2005–2006
147
Performance Statements
Prof James F. Bishop
MD MMed MBBS FRACP FRCPA
Chief Cancer Officer and CEO,
Cancer Institute NSW
Professor of Cancer Medicine,
Cancer Research
•
Research Fellowships established
•
Health Service Fellowship established
•
Patterns of care program developed
•
University of Sydney
Health Service and Translational Research
Programs developed
Contract commenced on 8 October 2003
Total remuneration package:
$361,200
Prof Bishop’s performance was last reviewed by the
Cancer Institute NSW Board in November 2005. This
performance review is therefore in respect of the first
Cancer Information and Registries
•
Clinical Cancer Registry reporting developed
•
Additional cancer reports for clinicians
•
Standard cancer treatment protocols established
half of 2005-2006.
Cancer Communication
A panel from the Cancer Institute NSW Board,
chaired by the then Acting Chair of the Board, Jill
Boehm, conducted Prof Bishop’s performance
review. The Board expressed a unanimous view
that Prof Bishop exceeded expectations in his
performance as the CEO and Chief Cancer Officer.
•
Position papers developed
•
Website upgraded
•
Ministerial system efficient
•
Committees/workshops providing key policy
advice
The Board particularly noted the achievements
of Prof Bishop in each of the high priority areas
•
identified in the performance agreement.
Key cancer messages are communicated
effectively to the relevant stakeholders
Key activities undertaken by Prof Bishop during
Administration
2005-2006 include:
•
Satisfactory internal and external audit and risk
management processes established
Cancer Prevention
•
•
Graphic Health warnings, Quitline and parents
•
Successful budget management
campaign
•
High performance from staff members and teams
Melanoma campaigns developed
Cancer Screening
•
•
Clinical Fellowships established
•
Scholarship programs established
•
Multidisciplinary teams program established
•
Standard protocols launched
•
NSW Oncology Group established
Cancer Institute NSW: Annual Report 2005–2006
Annual Report and Report to Parliament
2004-2005 completed
•
Cancer incidence, cancer risk, survival and
mortality reports 2004
Screening coordination units restructured
Cancer Services and Education
148
•
Business planning of screening programs
completed
•
Reports and Evaluation
•
Developed new reports and publications based
on reviews and the Cancer Institute NSW
databases
Occupational Health and Safety
•
The development of a Performance Development
Process. A team of internal staff worked on the
The Cancer Institute NSW has had a pleasing
design of the process to ensure that it would
performance on Occupational Health and Safety
meet the needs of all staff.
matters in 2005-2006. Particular achievements
during 2005-2006 include:
Equity Plans 2006-2007
•
•
the Occupational Health and Safety Committee
have met regularly met to review and mitigate
key health and safety issues and have produced
The EAPS Program will be progressively
implemented in 2006-2007.
•
an Occupational Health and Safety Policy
Targets for recruitment of particular EEO Groups
will be established.
Statement and a Consultation Policy and
Statement
•
The Cancer Institute NSW is to establish
a Spokeswomen’s Program in the coming
•
all staff were given the opportunity to undertaken
ergonomic training and individual ergonomic
workplace assessments
•
the Cancer Institute NSW has six first aid officers
year in accordance with Government policy
and Program guidelines established by
the Spokeswoman Program Management
Committee and the Premier’s Department.
who have undertaken the appropriate training
EEO tables
•
all staff had the opportunity to attend safety
A. Trends in the Representation of EEO Groups
briefings with the Redfern police.
EEO Group
Benchmark
2005-2006
Employment Equity
Women
50%
75%
The Cancer Institute NSW has in place a number of
Aboriginal People and
Torres Strait Islanders
2%
0%
20%
21%
aimed at ensuring equitable employment is pursued
People whose first
language was not
English
in all of the Cancer Institute NSW’s activities
People with a disability
12%
0%
policies, including an Equal Employment Opportunity
(EEO) plan and an Ethnic Affairs Priorities Statement,
Equity achievements in 2005-2006 are identified
B. Trends in the Distribution of EEO Groups
below. Policies and practices within the Cancer
EEO Group
Benchmark
2005-2006
Institute NSW will continue to accord with public
Women
100
81
Aboriginal People and
Torres Strait Islanders
100
0
People whose first
language was not
English
100
112
People with a disability
100
0
sector requirements.
Achievements 2005-2006
•
Merit based recruitment processes continue
to be the foundation of selection at the Cancer
Institute NSW.
•
Promotion of working arrangements which
respect and accommodate cultural and religious
differences
•
Incorporation of employment equity clauses into
key employment documentation.
•
Development of an Ethnic Affairs Priorities
Statement (EAPs).
•
Provision of interpreters for job candidates as
necessary.
•
Recruitment of a significant percentage of staff
whose first language is not English.
Cancer Institute NSW: Annual Report 2005–2006
149
Ethnic Affairs Priorities
Statement
Our programs aimed at women also recognise
The Cancer Institute NSW recognises the cultural
framework for advancing the health and wellbeing of
and linguistic diversity of the NSW community and
disadvantaged women in NSW.
the Women’s Health Outcomes Framework
developed by NSW Health, which provides a
we are committed to ensuring that our services are
provided in a culturally appropriate and competent
Our major program and campaign areas that
manner.
address the prevention, early detection and
treatment of cancers in women are:
Our Ethnic Affairs Priority Statement (EAPS)
Management Plan sets out strategies for ensuring
BreastScreen NSW
our services are accessible to all members of
BreastScreen NSW is a free breast screening service
the public, including those from culturally and
targeting women aged 50 to 69 years but available
linguistically diverse communities who may
to all women over 40 years of age. This service is
otherwise face difficulties in finding out about our
managed by the Cancer Institute NSW and aims
services and understanding how we may be able
to detect breast cancer in its early stages, when
to help them. Specifically, our EAPS Management
treatment can be most effective.
Plan aims to improve community access to cancer
services across NSW thus enhancing the quality of
NSW Pap Test Register
care and the health of the community.
The Pap Test Register provides a follow-up and
reminder service to women to encourage them
The Cancer Institute NSW also works closely with
to have regular Pap tests every two years or as
NSW Health and Area Health Services across
recommended by their doctor or nurse.
NSW who are responsible for the delivery of
cancer services. Each of these organisations have
NSW Cervical Screen Program
implemented measures that are aimed at improving
•
Develops and implements strategies to recruit
community access to cancer services across NSW
all women in the target groups to undergo
that recognise the cultural and linguistic diversity of
regular two yearly Pap tests, including providing
the NSW community.
appropriate information and ensuring access to
appropriate services.
NSW Government Action Plan
for Women
•
Supports General Practitioner structures
and activities to facilitate their primary role in
The NSW Government Action Plan for Women
developing acceptable Pap test services to
outlines the Government’s commitments, priorities
women.
and initiatives for women.
•
cervical screening.
The Action Plan focuses on initiatives specially
designed to meet women’s needs and ways in
Works with laboratories to optimise their role in
•
which Government agencies take account of women
Promotes best clinical practice in cervical
screening.
in delivering their core services. In the case of the
Cancer Institute NSW this is especially relevant with
Undertakes ongoing operations-oriented
respect to women’s health issues and in particular
research, monitoring and evaluation to support
our programs and services that address the
and guide the directions of the Program.
prevention, early detection and treatment of
cancers in women.
The Cancer Institute NSW has statutory
responsibilities to substantially improve cancer
control in NSW and has developed, through the
NSW Cancer Plan 2004 – 2006, initiatives and
programs that are directly aimed at improving the
health and quality of life of women in NSW.
150
•
Cancer Institute NSW: Annual Report 2005–2006
Spokeswomen’s Program
Increasing Resource Recovery
The Cancer Institute NSW is to establish a
The Cancer Institute NSW returns all used toner
Spokeswomen’s program in the coming year in
cartridges (printers and copies) for recycling and
accordance with Government policy and Program
paper waste is collected within strategically placed
guidelines established by the Spokeswomen
bins for collection and recycling by a contracted
Program Management Committee and the Premier’s
service provider.
Department.
Waste reduction
Increasing Usage of
Recycled Material
The Cancer Institute NSW continued to observe
The Cancer Institute NSW purchases recycled
and practice the principles contained within the
content product when feasible and cost effective.
Government’s Waste Reduction and Purchasing
Policy by implementing an action plan promoting the
minimisation and recycling of generated waste and
the use/purchase of recycled materials, when and
where appropriate:
Reducing Waste Generation
The Cancer Institute NSW reduces its generation
of waste paper by using electronic communication
methods, including email and making published
reports, papers and brochures available on the
Cancer Institute NSW’s website. Our new records
management system will ultimately accommodate
full electronic document management and greatly
reduce the volume of paper-based records. The
generation of waste paper is further reduced by
double sided printing and copying, which is
actively encouraged across all areas of the
Cancer Institute NSW.
Cancer Institute NSW: Annual Report 2005–2006
151
Glossary
Term
Definition
Accreditation
The process by which a private or public agency evaluates and recognises an
institution as fulfilling applicable standards. The determination that an institution
meets these standards is also referred to as accreditation of the program or
institution.
Allied health
professionals
Specially trained and/or licensed health care workers, other than physicians,
Ambulatory care
Health services provided without the patient being admitted to hospital. Also called
dentists. Refers to podiatrists, chiropractors, optometrists and nurses.
outpatient care.
Cancer control
An integrated and coordinated approach to reducing cancer incidence, morbidity,
and mortality through prevention, early detection, treatment, rehabilitation and
palliation.
Cancer incidence
The number of new cases of cancer occurring in a defined population during a given
period.
Cancer mortality
Deaths from cancer in a defined population during a specified period. It may be
used to denote numbers or rates.
Cancer Nurse
Coordinator
A nurse with specialist and expert training in cancer care who facilitates patient-
Cancer prevalence
Cancer prevalence is defined as the number of people alive on a certain date in a
centred cancer care, and continuity of care throughout the patient’s care journey.
population who have been previously diagnosed with the disease. It includes new
cancers (incidence) and pre-existing cancers and represents the number of people
both newly diagnosed and surviving.
Cases
These are individual cancers. A person may have more than one cancer, giving rise
to multiple cases in the same person. Second cases in one person are counted only
if they are of different cell type or originate in a different organ.
Central Cancer
Registry
Also known as a population-based cancer registry. Central cancer registries
collect incidence and survival data on all cancer patients who reside in a defined
geographical area or who are diagnosed and/or treated for cancer in a geographical
area. Population based cancer registries are essential for assessing the extent of
cancer burden in a specific geographic area.
Clinical Cancer
Registry
Cancer information system that allows monitoring of quality of care and outcomes
Chronic disease
Diseases that have one or more of the following characteristics: they are permanent,
for cancer patients and their carers.
leave residual disability, are caused by non-reversible pathological alteration, require
special training of the patient for rehabilitation, or may be expected to require a long
period of supervision, observation or care.
Clinical pathway
Multidisciplinary plans of best clinical practice for specified groups of patients with a
particular diagnosis, that aid in the coordination and delivery of high quality care.
152
Cancer Institute NSW: Annual Report 2005–2006
Clinical practice
guidelines
Published guidelines issued by a central authority that are aimed at informing
medical practitioners of treatment and investigation methods preferred by experts
and/or proven by research.
Clinical trial
Research conducted with the patient’s permission, usually involving a comparison
of two or more treatments or diagnostic methods, with the aim of gaining better
understanding of the underlying disease process and/ or methods by which it
may be treated. A clinical trial is conducted with rigorous scientific method for
determining the effectiveness of a proposed treatment.
Combine modality
treatment
The integration of two or more forms of treatment to combat cancer, i.e. radiation
Complementary
therapies
A range of approaches to care provision aimed at enhancing quality of life, including
and surgery, radiation and chemotherapy or surgery, radiation and chemotherapy.
(but not limited to) relaxation therapy, music, art, prayer, visualisation, guided
imagery, massage, aromatherapy and dietary therapies, and other socialisation
programs aimed at good health.
Community
The broad range of stakeholders with an interest in health services. This includes
individual consumers, organisations and groups, health professionals and specific
populations.
(Source: NSW Department of Health, Circular 2003/1, January 2003)
Consumer
An individual who uses or is a potential user of health services, including the family
and carers of patients and clients.
(Source: NSW Department of Health, Circular 2003/1, January 2003)
Crude rate
An estimate of the proportion of a population that is diagnosed with (or dies from)
cancer during a specified period. It is usually expressed per 100,000 people in the
population per year.
Lead Clinician
A clinician member of an area-wide, site-specific clinical group who takes
responsibility for the group’s coordination and operation. This clinician need not
necessarily be the most professionally or academically senior member of the group.
(Source: NSW Health (2003) A Clinical Service Framework for Optimising Cancer
Care in NSW
Linear accelerator
Machinery that produces beams of X-rays or high-energy electrons that are focused
onto a tumour within the body. Also known as a linac.
Lymphoedema
Swelling of the subcutaneous tissues caused by obstruction of the lymphatic
drainage. This results from fluid accumulation and may arise from surgery, radiation
or the presence of a tumour in the area of the lymph nodes.
Medical oncologist
A specialist medical practitioner who studies and treats cancer using chemotherapy
and other drugs.
Medical physicist
Scientific specialist who establishes, implements and monitors processes that allow
optimal treatment using radiation, taking account of the radiation protection of
patients and others.
Medicare
A national, Government-funded scheme that covers all Australians to help them
afford medical care, by subsidising the cost of personal medical services.
Cancer Institute NSW: Annual Report 2005–2006
153
Medicare Benefits
Schedule
The listing of item numbers (including a description of procedures) claimable
through Medicare. This listing shows the scheduled fee as well as 75% and 5%
reimbursement rates.
Multidisciplinary care
An approach combining the knowledge, skills and expertise of a range of
organisations and professionals, whereby all members of the team liaise and
cooperate together with the patient to diagnose, treat and manage the condition to
the highest possible standard of care.
Oncology
The science of the treatment of malignant cancers, either with surgery, radiotherapy,
chemotherapy or combinations of these modalities.
Palliation
The alleviation of symptoms due to the underlying disease or condition.
Palliative care
The active total care of patients whose disease is not responsive to curative
treatment. Control of pain, of other symptoms, and of psychological, social and
spiritual problems is paramount. The goal of palliative care is to achieve the best
quality of life for patients and their families.
Pathology
The branch of medicine concerned with disease, especially its structure and its
functional effects on the body.
Peer Review
A process whereby peers professionally evaluate a colleague’s work.
Population health
The health of groups, families and communities. Populations may be defined
by locality, biological criteria such as age or gender, social criteria such as
socioeconomic status, or cultural criteria.
Population health
outcomes
Used to describe a change in the health status of a population due to a planned
program or series of programs, regardless of whether such programs were intended
to change health status.
Population screening
The process of looking for disease in a defined population that has no obvious
symptoms.
Psychosocial support
The culturally sensitive provision of psychological, social and spiritual care.
Quitline
Australia-wide telephone information and advice service for people who want to quit
smoking.
Radiation oncologist
A medical practitioner who specialises in the treatment of patients suffering from
cancer.
Radiation oncology
The study and treatment of cancers using radiation (X-rays, gamma rays or
electrons).
Radiation therapist
A radiation treatment specialist who is directly responsible for the practical
implementation of the prescribed course of radiotherapy.
Site
The place in the body where the cancer occurs.
Treatment protocol
A treatment plan or outline. In clinical trials, a protocol is the plan for using an
experimental procedure or treatment.
154
Cancer Institute NSW: Annual Report 2005–2006
Index
A
Accounts payable performance report
97
Achievements and activities
5,10,22-53,148,149
Agreements and joint programs
46,98
Appendices
96-107
Audit committee
49,100,142
B
Benchmarks
37,40,50
Board of the Cancer Institute NSW
4,12,18
Bowel Screen NSW
27,30,32
BreastScreen NSW
27,30,31
Budget
19,33,49,138,148
Business plans
6,41,51,148
C
Cancer Communication
47-48
Cancer Information and Registries
44-46
Cancer Plan
5,6,9,10,22,34,38,49,52,53,98,150
Cancer Prevention
22-26
Cancer Research
39-43
Cancer Screening
27-32
Cancer Services and Education
33-38
Cervical Screening
28,29,31
Chief Cancer Officer’s Report
5
Chief Operating Officer
16,19,100,112,136,144
Clients
46,140,153
Code of conduct
15,100
Committees
7,13,14,42,98,100,136,148
Consultants
136
Corporate development
6,49
Corporate governance
40,127
Credit card certification
136
D
Disability action plan
148,152
Discussion paper
52
E
Employee satisfaction
18,19,50
Energy management
137
Environmental management
137
Equal employment and opportunity
148
Ethnic affairs priority statement
150
Events
47,48,97,137
Executive management team
16-19
F
Finance and administration
49
Financial audits
19,40,48,49,54,100,136,138,139
Financial overview 2005-2006
138
Financial statements
54-95
Freedom of information
139
Future challenges
6,9,29,34,42,46,52,97,99,137
G
Glossary
152-154
Guiding principles
9
Guarantee of service
139
H
Highlights
22,27,33,39,44,47,48,50,51
Human Resources
50
I
Income statement
48,49,54
Independent audit report
7,20
Industrial relations
18,50
Information management
46
Information technology
51
K
Key program areas
9
L
Legislation
8
Learning and development
19
M
Measuring progress
9
Media Releases
47,48,139
Minister Assisting the Minister for Health (Cancer)
4,7
Ministerial representations received
140
Mission
16,29,30,34,44,45
N
NSW Cancer Plan
5,9,10,22,34,38,52,53,98,150
NSW Government Action Plan for Women
150
NSW Health
7,30,32,34,44,53
O
Objectives
4,8,9,21,48,98
Occupational health and safety
149
Organisational structure
11,50
Organisational functions
19
Overseas travel
136,141
P
Pap Test Register
17,19,21,28,42,51,98,150
Performance management
49
Privacy management plan
140,141
Programs
4,6-9,14-53,98,129-153
Progress Report
5,10,34,52
Publications
21,46,136,142,141,148
R
Recruitment
19,147,149
Risk management
6,19,49,100,142,148
Rural services
7
S
Senior executive performance statement
144
Sponsorships and community grants
143
Staffing
34,144
Stakeholders/clients
5,9,20,37,44,48,53,148,153
Strategic plan
9,19,48,98
T
The Cancer Council NSW
4,5,7,12,38,40,46,98,109,110
112,122,128,129,131,132,135,140
Training
6,33,34,36,44,50,149,152
W
Waste reduction
151
Cancer Institute NSW: Annual Report 2005–2006
155
Contact Directory
Cancer Institute NSW
Level 1, Biomedical Building
Australian Technology Park
1 Central Avenue
Eveleigh NSW 2015
Australia
PO Box 41
Alexandria NSW 1435
Australia
Tel:
+ 61 2 8374 5600
Fax:
+ 61 2 8374 5700
Web:
www.cancerinstitute.org.au
Email:
[email protected]
Quitline:
13 7848 (13 QUIT)
BreastScreen:
13 2050
[email protected]
Cervical Screening:
13 1556
[email protected]
Bowel Screening:
1800 118 868 (National Bowel Cancer
Screening Program Information Line)
Report Production Details
500 copies were produced. Total external costs were $30,000 (excluding
GST) and included design and printing.
Design and Printing: Salmat – www.salmat.com.au
156
Cancer Institute NSW: Annual Report 2005–2006
Legislation administered
Cancer Institute (NSW) Act 2003
Copyright © Cancer Institute NSW October 2006
This work is copyright. It may be reproduced in whole
or part for study or training purposes subject to the
inclusion of acknowledgement of the source. It may
not be reproduced for commercial usage or sale.
Reproduction for purposes other than those indicated
above requires written permission from the
Cancer Institute NSW.
SHPH: (NCI) 060 162
ISBN: 1741870097
Suggested citation for manuscripts and publications:
Cancer Institute NSW: Annual Report 2005 - 2006
Cancer Institute NSW, Sydney, 2006
Further copies of this publication can be download from:
www.cancerinstitute.org.au
Cancer Institute NSW
Level 1, Biomedical Building
Central Avenue
Australian Technology Park, Eveleigh
PO Box 41, Alexandria NSW 1435
Tel:
Fax:
Web:
+ 61 2 8374 5600
+ 61 2 8374 5700
www.cancerinstitute.org.au
Email: [email protected]
Emails sent to this address are forwarded
to the appropriate person for action.
Cover Photo: Belinda Kendall, A/Nurse Unit Manager,
Cancer Care Centre, St George Hospital
CANCER ANNUAL REPORT COVER (12 spine).indd 2
7/11/2006 8:48:30 AM
1 Central Avenue
Australian Technology Park
Eveleigh NSW
www.cancerinstitute.org.au
CANCER INSTITUTE NSW
Level 1, Biomedical Building
CANCER INSTITUTE NSW ANNUAL REPORT 2005 - 2006
Cancer Institute NSW
ANNUAL REPORT 2005-2006
ANNUAL REPORT 2005-2006
CANCER ANNUAL REPORT COVER (12 spine).indd 1
7/11/2006 8:45:34 AM